date,open,high,low,close,volume,title,description,title_sentiment,desc_sentiment,daily_change_pct,market_sentiment,next_day_change_pct,next_day_sentiment
2020-06-01 08:29:00,4077.6,4092.35,3941.05,3951.5,1368761.0,"Buy Dr Reddy’s Laboratories, target price Rs 4,250: Chandan Taparia",The analyst suggested a stoploss at Rs 3980.,neutral,neutral,-3.0925053953305843,negative,-2.107904642409034,negative
2020-06-03 12:20:00,3959.9,4057.0,3956.65,3995.35,1199292.0,Share market update: Pharma shares climb; Dr Reddy’s Labs gains 2%,The Nifty Pharma index was trading 0.76 per cent up at 9908.5.,positive,positive,0.8952246268845128,neutral,0.1380785928423088,neutral
2020-06-04 08:59:25,3959.9,4057.0,3956.65,3995.35,1199292.0,"Top Buy And Sell Ideas By Ashwani Gujral, Sudarshan Sukhani, Mitesh Thakkar For Short Term","Sudarshan Sukhani of s2analytics.com recommends buying Dr Reddy’s Labs with a stop loss of Rs 3,870, target at Rs 4,100 and Indraprastha Gas with a stop loss of Rs 483, target at Rs 503.",neutral,neutral,0.8952246268845128,neutral,0.1380785928423088,neutral
2020-06-04 11:48:12,3959.9,4057.0,3956.65,3995.35,1199292.0,"D-Street Buzz: Nifty Pharma Gains Led By Biocon; Lupin; Volumes Of Sun Pharma, Aurobindo Pharma Rise","Among the sectors, Nifty Pharma added over a percent led by Sun Pharma, Biocon, Lupin and Torrent Pharma which gained 2 percent each followed by Aurobindo Pharma, Cipla, Divis Labs and Dr Reddy’s Labs among others.",neutral,positive,0.8952246268845128,neutral,0.1380785928423088,neutral
2020-06-09 11:51:08,3930.0,4142.0,3930.0,4120.0,2274774.0,D-Street Buzz: Nifty Pharma Outperforms Led By Sun Pharma; Dr Reddy’s Labs Up 3%,Experts feel that the current environment is more conducive for the Pharma sector and the rally is likely to continue.,neutral,positive,4.8346055979643765,positive,-0.6031363088057901,neutral
2020-06-10 07:06:58,4145.0,4190.0,4087.7,4120.0,1553138.0,"Hot Stocks | Tech Mahindra, Dr Reddy’s Labs, UBL Can Give Up To 11% Return In Short Term","On the higher side, 10,334 - 10,351 will continue to act as a stiff resistance zone for Nifty which needs to be taken out on a closing basis for the extension of the rally.",neutral,neutral,-0.6031363088057901,neutral,-1.3797714563578896,negative
2020-06-10 07:45:00,4145.0,4190.0,4087.7,4120.0,1553138.0,"Nifty outlook and stock pick by HDFC Sec: Buy Dr Reddy’s Labs, L&T Infotech","Looking at the strong setup on the medium term charts, it would be advisable to buy Nifty around 9,900, for the upside target of 10,300.",neutral,positive,-0.6031363088057901,neutral,-1.3797714563578896,negative
2020-06-10 20:48:41,4113.0,4127.95,4037.0,4056.25,827295.0,Dr Reddy’s completes acquisition of Wockhardt’s branded generics business,"Dr Reddy’s Laboratories has completed the acquisition of select divisions of Wockhardt’s branded generics business in India and a few other international territories — Nepal, Sri Lanka, Bhutan and the",positive,positive,-1.3797714563578896,negative,0.3507014028056112,neutral
2020-06-12 05:30:00,3992.0,4036.6,3981.0,4006.0,782134.0,BRIEF-Dr.Reddy’s Labs Announces Launch Of Colchicine Tablets In U.S. Market - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,0.3507014028056112,neutral,-0.9967885375494048,negative
2020-06-12 18:11:59,3992.0,4036.6,3981.0,4006.0,782134.0,Dr Reddy’s launches generic fever drug in the US,"Pharma major Dr Reddy’s Laboratories Ltd, based in Hyderabad, has launched Colchicine tablets. The drug is a therapeutic equivalent generic version of Colcrys (colchicine) approved by the US Food and",neutral,neutral,0.3507014028056112,neutral,-0.9967885375494048,negative
2020-06-15 07:36:57,4048.0,4126.9,3960.6,4007.65,1391799.0,"In Pics | Stocks In The News: RIL, AstraZeneca, Aarey Drugs, Wipro, IDFC, Castrol India, Hindalco, Cadila Health","Cox & Kings Financial, Godrej Properties, , Eicher Motors, Kirloskar Electric Company, Dr Reddy’s Labs are also some of the stocks in focus today.",neutral,neutral,-0.9967885375494048,negative,-1.2558425584255886,negative
2020-06-15 11:23:00,4048.0,4126.9,3960.6,4007.65,1391799.0,"Stocks in the news: RIL, Vodafone Idea, Tata Motors, Dr Reddy’s Labs and BHEL","CSB Bank, JK Tyre, Pfizer, Shalby, Shoppers Stop and Ramky Infra are among companies which will announce Q4 results today.",neutral,neutral,-0.9967885375494048,negative,-1.2558425584255886,negative
2020-06-15 17:38:00,4065.0,4080.0,3952.75,4013.95,779852.0,Dr Reddy’s Labs stock gains 3% on deal for producing COVID-19 drug Remdesivir,"The agreement will grant the drugmaker right to register, manufacture and sell Gilead’s investigational drug, Remdesivir, a potential treatment for Covid-19 in 127 countries including India",positive,positive,-1.2558425584255886,negative,-0.6091700058669972,neutral
2020-06-18 12:21:00,4020.25,4044.9,3992.0,4010.0,730690.0,Share market update: Pharma shares mixed; Dr Reddy’s Labs up 1%,The Nifty Pharma index was trading 0.05 per cent up at 9982.15.,positive,positive,-0.2549592687021951,neutral,0.1488095238095238,neutral
2020-06-19 05:30:00,4020.25,4044.9,3992.0,4010.0,730690.0,BRIEF-Dr.Reddy’s Laboratories Says Launch Of Abiraterone Acetate Tablets In U.S. Market - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-0.2549592687021951,neutral,0.1488095238095238,neutral
2020-06-19 15:12:26,4020.25,4044.9,3992.0,4010.0,730690.0,Dr Reddy’s launches cancer drug generic in US,"Pharma major Dr Reddy’s Laboratories Ltd has launched abiraterone acetate tablets, a therapeutic equivalent generic version of Zytiga, in the US market. The drug has been approved by the US Food and D",neutral,positive,-0.2549592687021951,neutral,0.1488095238095238,neutral
2020-06-19 17:44:00,4020.25,4044.9,3992.0,4010.0,730690.0,Dr Reddy’s launches generic prostate cancer treatment drug in US,"Pharma major Dr Reddy’s Laboratories on Friday said it has launched generic Abiraterone Acetate tablets, used for treatment of prostate cancer, in the US market.",neutral,positive,-0.2549592687021951,neutral,0.1488095238095238,neutral
2020-06-19 18:28:05,4020.25,4044.9,3992.0,4010.0,730690.0,Dr Reddy’s Laboratories Launches Generic Prostate Cancer Treatment Drug In The US,"The company has launched Abiraterone Acetate tablets USP in the strength of 250 mg, after the approval from the United States Food and Drug Administration (USFDA), Dr Reddy’s Laboratories said in a filing to the BSE.",neutral,positive,-0.2549592687021951,neutral,0.1488095238095238,neutral
2020-06-19 21:10:24,4020.25,4044.9,3992.0,4010.0,730690.0,Dr Reddy’s launches generic prostate cancer drug in US,"Pharma major Dr Reddy’s Laboratories on Friday said it has launched generic Abiraterone Acetate tablets, used for treatment of prostate cancer, in the US market.The company has launched Abiraterone Ac",neutral,positive,-0.2549592687021951,neutral,0.1488095238095238,neutral
2020-06-22 15:49:27,4047.9,4130.0,4040.1,4102.0,959594.0,"These 2 Nifty50 Stocks More Than Doubled Since First 10,200 Closing, But 9 Stocks Lost Over 50%","Among others, Dr Reddy’s Laboratories, Hindustan Unilever, Tata Consultancy Services, Titan Company, Britannia Industries and Infosys rallied 50-66 percent.",neutral,positive,1.3364954667852444,positive,-1.5234227771766136,negative
2020-06-26 14:46:05,4015.0,4065.0,3965.0,4004.0,743774.0,"Merck Sharp & Dohme Corp Sue Dr Reddy’s Labs Over Januvia, Janumet Generics",Merck has filed the possible patent infringement petition against Dr Reddy’s in the United States District Court for the District of Delaware on four counts.,neutral,neutral,-0.273972602739726,neutral,-0.7691345672836418,neutral
2020-06-28 13:33:05,3998.0,4044.0,3958.75,3967.25,538371.0,Expect To Launch 25 Products In US This Fiscal: Dr Reddy’s Laboratories,"On new pipeline of products, he said the company is also working on a few molecules related to COVID-19.",neutral,neutral,-0.7691345672836418,neutral,-1.24375,negative
2020-06-28 14:33:00,3998.0,4044.0,3958.75,3967.25,538371.0,Expect to launch 25 products in US this fiscal: Dr Reddy’s,"Dr Reddy’s Laboratories expects to launch 25 products in the US market in the current financial year, according to a top company official. The drug major has also earmarked a capital expenditure (capex) of Rs 1,000 crore for finding various projects during the ongoing financial year.",neutral,positive,-0.7691345672836418,neutral,-1.24375,negative
2020-07-01 14:02:32,3946.0,3979.0,3901.0,3918.0,742187.0,"Covid-19: Dr Reddy’s partners with Fujifilm, Global Response Aid for Avigan tablets","Dr Reddy’s Laboratories Ltd has teamed up with Fujifilm Corporation through Fujifilm Toyama Chemical Co Ltd and Global Response Aid for the development, manufacture and sales of Avigan tablets.Avigan",neutral,neutral,-0.7095793208312215,neutral,-0.5444162436548178,neutral
2020-07-02 08:34:00,3946.0,3979.0,3901.0,3918.0,742187.0,"Stocks in the news: Axis Bank, Dr Reddy’s Labs, Adani Ports, Hero MotoCorp and Coal India",Uflex has reported a 43.30 per cent rise in consolidated net profit at Rs 100.90 crore for the fourth quarter.,neutral,positive,-0.7095793208312215,neutral,-0.5444162436548178,neutral
2020-07-02 09:06:41,3946.0,3979.0,3901.0,3918.0,742187.0,"Stocks in focus: Axis Bank, Abbott India, Pfizer, Hero MotoCorp, Dr Reddy’s Laboratories, India Cements","Aarti Industries, Ipca LabAdani Gas, ICICI General Insurance, PI Industries, and Trent, L&T Infotech, HDFC AMC, and Deepak Nitrite are among 11 stocks that are likely to be included in the futures & options (F&O) segment",neutral,neutral,-0.7095793208312215,neutral,-0.5444162436548178,neutral
2020-09-17 10:37:00,4704.0,4845.55,4654.95,4825.0,8407468.0,Dr Reddy’s Labs gains for second straight day on Covid vaccine deal,"Upon regulatory approval in India, RDIF shall supply to Dr. Reddys 100 million doses of the vaccine",positive,positive,2.572278911564626,positive,6.158999999999996,positive
2020-09-17 17:10:12,5000.0,5496.95,4950.25,5307.95,21934757.0,Dr Reddy’s settles patent suit with Celgene,"Dr Reddy’s Laboratories Ltd has announced the settlement of its litigation with Celgene, a wholly-owned subsidiary of Bristol Myers Squibb, relating to patents for Revlimid (lenalidomide) capsules.In",neutral,positive,6.158999999999996,positive,-3.8128005849981785,negative
2020-09-18 11:36:10,5000.0,5496.95,4950.25,5307.95,21934757.0,"Dr Reddy’s Lab shares today hit new highs, extend weekly gains to 20%","Dr Reddy’s Laboratories said it has settled a litigation with a unit of Bristol Myers Squibb.Earlier this week, it had reached an agreement to buy Russia covid vaccines",positive,positive,6.158999999999996,positive,-3.8128005849981785,negative
2020-09-18 14:31:55,5000.0,5496.95,4950.25,5307.95,21934757.0,COVID-19 vaccine update: Dr Reddy’s Laboratories’ Sputnik V deal raises hopes of vaccine for India by year-end,DRL has stated that it has reached an agreement with the Russian sovereign wealth fund involved in the talks – Russian Direct Investment Fund (RDIF) – to conduct phase 3 human clinical trials of the Sputnik V vaccine in India.,positive,positive,6.158999999999996,positive,-3.8128005849981785,negative
2020-09-18 16:37:52,5000.0,5496.95,4950.25,5307.95,21934757.0,"Dr Reddy’s Labs Rally 14 per cent Intra-Day, Becomes 2nd Most Valuable Indian Pharma Company Again","On Friday afternoon, Dr Reddy’s Labs market cap stood at Rs 90,348 crore, BSE data shows. Sun Pharma is the most valued listed company of India with market cap of Rs 1.26 trillion.",neutral,neutral,6.158999999999996,positive,-3.8128005849981785,negative
2020-09-21 14:36:00,5214.0,5260.0,5055.0,5200.0,7693788.0,Buy Dr Reddy’s Laboratories; target of Rs 5710: ICICI Direct,"ICICI Direct is bullish on Dr Reddy’s Laboratories recommended buy rating on the stock with a target price of Rs 5710 in its research report dated September 18, 2020.",neutral,positive,-0.2685078634445723,neutral,-3.226788432267892,negative
2020-09-21 23:23:43,5214.0,5260.0,5055.0,5200.0,7693788.0,Dr Reddy’s Laboratories Rating’ buy’; patent deal dispels launch uncertainties,"Despite initial volume curbs, Revlimid to be a meaningful opportunity; FY21-23e EPS up 1-3%; TP raised to Rs 5,400",neutral,positive,-0.2685078634445723,neutral,-3.226788432267892,negative
2020-09-24 08:26:00,5060.0,5202.9,5002.5,5058.0,5190432.0,"Stocks in the news | TCS, NLC India, Dr Reddy’s Labs, Seamec, Emami, Mahindra CIE, Tata Chemicals","Satin Creditcare Network, Shree Rama Newsprint, Future Consumer, Jindal Stainless, Jindal Steel & Power, Lactose (India), Gateway Distriparks, IIFL Securities are also among the stocks in focus today.",neutral,neutral,-0.0395256916996047,neutral,0.0,neutral
2020-09-24 09:58:00,5060.0,5202.9,5002.5,5058.0,5190432.0,Betting on momentum? These 56 BSE500 stocks hit fresh record highs in a falling market,"The 56 stocks which hit fresh record highs in September include prominent names like RIL, Infosys, TCS, HCL Tech, Asian Paints, Dr Reddy’s Laboratories, L&T Infotech, and Jubilant FoodWorks etc.",negative,neutral,-0.0395256916996047,neutral,0.0,neutral
2020-09-25 12:55:35,5120.0,5153.0,5044.0,5120.0,3507932.0,Dr Reddy’s shares up 2% on launch of Dexmedetomidine injection in the US market,"The pharma major Dr Reddy's Laboratories on Friday announced the launch of Dexmedetomidine Hydrochloride in 0.9% Sodium Chloride Injection, in the US market.The Precedex in 0.9% sodium chloride in",positive,neutral,0.0,neutral,-1.479821921364625,negative
2020-09-25 17:34:52,5120.0,5153.0,5044.0,5120.0,3507932.0,Coronavirus vaccine tracker: How close are we to a COVID-19 vaccine? Check latest status,"Coronavirus COVID19 vaccine update, tracker: Dr Reddy’s Laboratories Ltd could begin late-stage Indian clinical trials of Russia’s potential coronavirus vaccine in the next few weeks, as per a Reuters report.",neutral,positive,0.0,neutral,-1.479821921364625,negative
2020-09-28 07:19:00,5199.95,5200.0,5090.8,5123.0,2489061.0,"Stocks in the news: RIL, Vodafone Idea, Dr Reddy’s Labs, Mindtree and Sun Pharma","Dr Reddy’s Laboratories on Saturday said it has launched Dimethyl Fumarate delayed-release capsules, used to treat multiple sclerosis (MS), in the US market.",neutral,positive,-1.479821921364625,negative,-1.1539961013645188,negative
2020-10-01 08:53:00,5225.0,5256.0,5088.4,5116.2,2273073.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani for short term","Sudarshan Sukhani of s2analytics.com suggests buying Berger Paints with a stop loss of Rs 573, target at Rs 590 and Dr Reddy’s Labs with a stop loss of Rs 5,080, target at Rs 5,300.",neutral,neutral,-2.0822966507177068,negative,0.2311411992263021,neutral
2020-10-05 16:44:00,5159.5,5226.75,5112.2,5136.0,1685046.0,Dr Reddy’s says it aims to cut greenhouse gas emissions by 55% by 2030,Dr Reddy’s Laboratories on Monday said it has committed to reduce its greenhouse gas emissions by 55 per cent by 2030.,positive,positive,-0.4554704913266789,neutral,-0.5850340136054493,neutral
2020-10-06 00:36:52,5159.5,5226.75,5112.2,5136.0,1685046.0,"Dr Reddy’s Asked To Resubmit Application For Both Phase 2,3 Trials Of Russian COVID-19 Vaccine","An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy’s Laboratories to submit a revised protocol for conducting both phase 2 and phase 3 human clinical trials for the Russian vaccine against COVID-19, Sputnik V, in India, sources said Monday.	The Hyderabad-ba…",neutral,neutral,-0.4554704913266789,neutral,-0.5850340136054493,neutral
2020-10-06 08:47:10,5159.5,5226.75,5112.2,5136.0,1685046.0,"Covid vaccine in India: Pharma firms on different stages of trial, other updates",An expert panel at the Central Drugs Standard Control Organisation (CDSCO) has asked Dr Reddy’s Laboratories to submit a revised protocol for conducting both phase 2 and phase 3 human clinical trials,neutral,neutral,-0.4554704913266789,neutral,-0.5850340136054493,neutral
2020-10-06 09:05:19,5159.5,5226.75,5112.2,5136.0,1685046.0,Dr Reddy’s Laboratories joins global eco-friendly initiative,Becomes first Indian and third Asian pharma company to set target to minimise environmental impact,neutral,positive,-0.4554704913266789,neutral,-0.5850340136054493,neutral
2020-10-06 10:56:00,5159.5,5226.75,5112.2,5136.0,1685046.0,Dr Reddy’s Laboratories to submit a revised protocol for conducting clinical trials of Russian COVID-19 vaccine,"In a meeting held on Monday, Subject Expert Committee (SEC) on COVID-19 at the CDSCO, deliberated on the application and asked the firm to resubmit a revised protocol as it was not satisfied with the data of Phase II trials submitted by the company, sources told ET.",neutral,neutral,-0.4554704913266789,neutral,-0.5850340136054493,neutral
2020-10-06 18:17:49,5145.0,5195.0,5093.2,5114.9,1580383.0,Coronavirus LIVE Updates: Dr Reddy’s Approaches DCGI to Begin Clinical Trials of Sputnik V,Coronavirus LIVE Updates: Hyderabad-based pharmaceutical company Dr Reddy’s Laboratories has approached the Drug Controller General of India (DGCI) to begin the clinical trials of Russian vaccine Sputnik V.,neutral,neutral,-0.5850340136054493,neutral,1.2830482115085535,positive
2020-10-08 07:19:23,5144.0,5214.8,5056.0,5210.0,2216765.0,India Declines Proposal To Test Sputnik-V COVID-19 Vaccine In Large Study,India’s drug regulator has knocked back a proposal from Dr Reddy’s Laboratories Ltd to conduct a large study in the country to evaluate Russia’s SputnikV COVID19 vaccine and has asked it to first test the vaccine in a smaller trial.,neutral,neutral,1.2830482115085535,positive,0.13589594253543,neutral
2020-10-08 07:37:00,5144.0,5214.8,5056.0,5210.0,2216765.0,India declines proposal to test Russia’s COVID-19 vaccine Sputnik-V in large study,"The RDIF, which is marketing the Sputnik V, and Dr Reddy’s Laboratories in September announced their partnership to run clinical trials and distribute the vaccine in India.",neutral,positive,1.2830482115085535,positive,0.13589594253543,neutral
2020-10-14 21:50:53,5148.65,5165.0,5020.1,5070.0,1765201.0,Dr Reddy’s resubmits application for combined phase 2&3 trials,Our Bureau Hyderabad-based Dr Reddy's Laboratories has resubmitted its application seeking permission from the Drug Controller General of India (DCGI) to conduct combined phase 2 and 3 clinical,positive,positive,-1.5275849008963445,negative,1.243050039714066,positive
2020-10-18 02:35:21,5211.0,5215.0,5042.05,5054.0,2137695.0,DCGI nod to Russian Covid-19 vaccine; Sputnik V to enter trial space in India,"India’s drug regulator has granted approval to Hyderabad-based pharma major Dr Reddy’s Laboratories to conduct the Phase 2 and 3 clinical human trials of Sputnik V, a Covid-19 vaccine made by Russia. On September 16, the Russian Direct Investment Fund (RDIF) and Dr Reddy’s had agreed to co…",neutral,positive,-3.0128574170024947,negative,0.2926665282433123,neutral
2020-10-19 07:24:00,5211.0,5215.0,5042.05,5054.0,2137695.0,"Stock in the news: HDFC Bank, Dr Reddy’s Labs, Britannia, ACC and HDFC Life","L&T Tech, Bank of Maharashtra, Rallis India and CSB Bank are slated to announce their Q2 results on Monday.",neutral,neutral,-3.0128574170024947,negative,0.2926665282433123,neutral
2020-10-19 08:02:00,5211.0,5215.0,5042.05,5054.0,2137695.0,"Stocks in the news | HDFC Bank, IIFL Securities, Route Mobile, HSIL, RIL, Shoppers Stop, SRF","Avenue Supermarts, Dr Reddy’s Labs, IndusInd Bank, Cadila Healthcare, Prestige Estates Projects, Sadbhav Infrastructure Project, Likhitha Infrastructure, Infosys, Suzlon Energy, NLC India are also among the stocks in focus today",neutral,neutral,-3.0128574170024947,negative,0.2926665282433123,neutral
2020-10-19 08:56:19,5211.0,5215.0,5042.05,5054.0,2137695.0,"Stocks in focus: RIL, Infosys, HDFC Bank, Britannia, ACC, SBI, Dr Reddy’s Labs, Likhitha Infra, DLF","Nifty 50 critical support at 11,600 and its breakdown could result in a further slide to 11,400. On the flip side, the 11,850-12,100 zone would act as a hurdle in case of a rebound",neutral,negative,-3.0128574170024947,negative,0.2926665282433123,neutral
2020-10-20 16:32:00,5096.55,5096.55,4906.55,5030.3,1599132.0,Dr Reddy’s launches Famotidine generic product in US to treat acidity,"Dr Reddy’s Laboratories on Tuesday said it has launched over-the-counter (OTC) drug Famotidine tablets, used to treat gastroesophageal reflux disease, in the American market.",neutral,positive,-1.2998989512513366,negative,-0.1498997359382171,neutral
2020-10-22 11:23:00,5036.7,5044.7,4831.0,5029.15,4917130.0,Dr Reddy’s Labs falls 3% as report says company shuts operations at key plants,"ET Now, citing sources, said the company has shut all key plants across the globe due to the data breach",negative,negative,-0.1498997359382171,neutral,-0.8513165709760443,neutral
2020-10-22 12:02:56,5051.0,5091.0,4996.0,5008.0,1813283.0,"Dr Reddy’s Laboratories facing cyber attack, isolates all data centres","Pharma major Dr Reddy Laboratories Ltd is facing a cyber-attack and has isolated all data centre services.“In the wake of a detected cyber-attack, we have isolated all data centre services to take req",neutral,neutral,-0.8513165709760443,neutral,-1.1321884984025523,negative
2020-10-22 12:14:00,5051.0,5091.0,4996.0,5008.0,1813283.0,Breaking News: Data breach at Dr Reddy’s; pharma major shuts down all offices,"The Dr Reddy’s Laboratories’ stock is about 2.96% or Rs 149.20 down at Rs 4,897.55 compared to the previous session’s close of Rs 5,046.75 on the National Stock Exchange",negative,negative,-0.8513165709760443,neutral,-1.1321884984025523,negative
2020-10-22 12:26:00,5051.0,5091.0,4996.0,5008.0,1813283.0,Dr Reddy’s Labs slips on isolating all data center services after cyber attack,"Dr Reddys Laboratories fell 1.96% to Rs 4,947.50 after the company said that it has isolated all data center services to take required preventive actions in the wake of a cyber attack.",neutral,negative,-0.8513165709760443,neutral,-1.1321884984025523,negative
2020-10-22 12:43:00,5051.0,5091.0,4996.0,5008.0,1813283.0,Dr Reddy’s Labs share slips over 4% as firm shuts plants after cyberattack,"Dr Reddy’s Laboratories share fell over 4% in afternoon trade today after the pharma firm said that it has isolated all its data center services across the world after detection of a cyber-attack. Dr Reddy’s Labs share fell up to 4.24% to Rs 4,832 against",negative,negative,-0.8513165709760443,neutral,-1.1321884984025523,negative
2020-10-22 12:47:00,5051.0,5091.0,4996.0,5008.0,1813283.0,Dr Reddy’s Labs isolates data centre services due to cyber attack,Dr Reddys Laboratories on Thursday said it has isolated all data centre services following a cyber-attack,neutral,negative,-0.8513165709760443,neutral,-1.1321884984025523,negative
2020-10-22 13:01:00,5051.0,5091.0,4996.0,5008.0,1813283.0,Dr Reddy’s isolates data centre services after detecting cyber-attack,Hyderabad-based drugmaker Dr Reddy’s Laboratories Thursday said that it has isolated all data centre services following a cyber-attack.,neutral,negative,-0.8513165709760443,neutral,-1.1321884984025523,negative
2020-10-22 13:09:00,5051.0,5091.0,4996.0,5008.0,1813283.0,Dr Reddy’s Labs shares trade lower as data breach forces the company to shut plants,"The company is currently reviewing its IT network systems, and trying to find out how the breach took place, sources said.",negative,neutral,-0.8513165709760443,neutral,-1.1321884984025523,negative
2020-10-22 22:26:00,5051.0,5091.0,4996.0,5008.0,1813283.0,Dr Reddy’s Laboratories shuts all units after cyber attack on servers,Security breach comes days after firm got approval to conduct trials for Covid-19 vaccine candidate Sputnik V,neutral,neutral,-0.8513165709760443,neutral,-1.1321884984025523,negative
2020-10-22 23:34:00,5051.0,5091.0,4996.0,5008.0,1813283.0,Dr Reddy’s under cyber attack: How India will investigate the matter,"On October 22, domestic pharmaceutical major Dr Reddy’s Laboratories informed the stock exchanges that the company had been the target of a cyber attack the previous night",neutral,negative,-0.8513165709760443,neutral,-1.1321884984025523,negative
2020-10-23 19:47:00,5051.0,5091.0,4996.0,5008.0,1813283.0,COVID-19 vaccine update: Russia’s Sputnik to be tested on 100 Indian volunteers,"Dr Reddy`s Laboratories has been given permission to conduct the trails of Russian COVID-19 vaccine Sputnik V, though, the date and time of the test will be determined by the company",neutral,neutral,-0.8513165709760443,neutral,-1.1321884984025523,negative
2020-10-26 08:09:00,5008.0,5062.0,4951.25,4951.3,1405635.0,"Stocks in the news | Punjab & Sind Bank, Mahanagar Gas, HFCL, OnMobile Global, JSW Steel, Bank of Baroda","Yes Bank, Tech Mahindra, Nestle, Asian Granito India, Shipping Corporation of India, Dr Reddy’s Laboratories, NTPC, Supreme Petrochem, Sudarshan Chemical Industries, Wabco India, Bhageria Industries, ICICI Lombard are also among the stocks in focus today.",neutral,neutral,-1.1321884984025523,negative,2.4028056112224374,positive
2020-10-28 05:30:00,5110.0,5150.0,4920.0,4938.0,3621892.0,BRIEF-India’s Dr.Reddy’s Laboratories Sept-Quarter Consol Net Profit Falls - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-3.3659491193737767,negative,0.1016260162601626,neutral
2020-10-28 05:30:00,5110.0,5150.0,4920.0,4938.0,3621892.0,BRIEF-Dr.Reddy’s Labs Names Parag Agarwal CFO - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,-3.3659491193737767,negative,0.1016260162601626,neutral
2020-10-28 09:01:00,5110.0,5150.0,4920.0,4938.0,3621892.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term","Mitessh Thakkar of mitesshthakkar.com suggests buying Divi’s Labs with a stop loss of Rs 3,095, target at Rs 3,250 and Dr Reddy’s Labs with a stop loss of Rs 5,040, target at Rs 5,250.",neutral,neutral,-3.3659491193737767,negative,0.1016260162601626,neutral
2020-10-28 14:12:00,4920.0,5040.0,4894.95,4925.0,2303204.0,Dr Reddy’s Labs Q2 Results: Profit dips 30% YoY to Rs 762 crore but beats market estimates,"The revenue for the quarter rose to Rs 4,896.7 crore from Rs 4,800.9 crore, a gain of 1.99 per cent YoY.",positive,positive,0.1016260162601626,neutral,-1.7691998391636508,negative
2020-10-28 14:14:00,4920.0,5040.0,4894.95,4925.0,2303204.0,"Dr Reddy’s Labs Q2 profit falls 30% to Rs 762 crore, global generics business up 21%","The YoY revenue growth stood at 20 percent after adjusted for proprietary products out-licensing income in the previous year, the company said in its BSE filing.",positive,positive,0.1016260162601626,neutral,-1.7691998391636508,negative
2020-10-28 14:15:43,4920.0,5040.0,4894.95,4925.0,2303204.0,Dr Reddy’s Laboratories Q2 net falls 30% to ₹762 crore,"Pharma major Dr Reddy's Laboratories Ltd's consolidated net profit for the second quarter ended September 30, 2020 declined 30 per cent to ₹762 crore, compared to ₹1,092 crore in the corresp",neutral,negative,0.1016260162601626,neutral,-1.7691998391636508,negative
2020-10-28 14:39:00,4920.0,5040.0,4894.95,4925.0,2303204.0,Dr Reddy’s Labs share price trades lower after Q2 profit dips 30% YoY,"The company’s consolidated profit declined to Rs 762 crore from Rs 1,092.5 crore in the year-ago period but increased 32 percent sequentially.",negative,negative,0.1016260162601626,neutral,-1.7691998391636508,negative
2020-10-28 14:44:00,4920.0,5040.0,4894.95,4925.0,2303204.0,Dr Reddy’s Laboratories Q2 results: Net profit falls 30% to Rs 762 crore; revenue up 2%,"Dr Reddy’s Laboratories (DRL) on Wednesday posted a 30 per cent rise in net profit to Rs 762.3 crore in the second quarter of FY21 as against Rs 1,092.5 crore in the corresponding period of last year",positive,positive,0.1016260162601626,neutral,-1.7691998391636508,negative
2020-10-28 15:10:00,4920.0,5040.0,4894.95,4925.0,2303204.0,Dr Reddy’s Laboratories consolidated net profit declines 30.27% in the September 2020 quarter,Sales rise 2.00% to Rs 4896.70 crore,negative,positive,0.1016260162601626,neutral,-1.7691998391636508,negative
2020-10-28 16:25:00,4920.0,5040.0,4894.95,4925.0,2303204.0,Dr Reddy’s Labs share slips over 3% post weak Q2 earnings,"Dr Reddy’s Laboratories share fell over 3% today after the firm reported a 43% fall in Q2 profit. The stock touched an intraday low of Rs 4921.5, down 3.51%. The share trades higher than 50 day, 100 day and 200 day moving averages but lower than 5 day and",negative,negative,0.1016260162601626,neutral,-1.7691998391636508,negative
2020-10-28 22:10:23,4920.0,5040.0,4894.95,4925.0,2303204.0,Dr Reddy’s Laboratories Q2 net down 30% at ₹762 crore,"Pharma major Dr Reddy’s Laboratories Ltd’s consolidated net profit declined 30 per cent at ₹762 crore in the second quarter, compared to ₹1,092 crore in the same period last year.The total revenue of",negative,negative,0.1016260162601626,neutral,-1.7691998391636508,negative
2020-10-29 11:18:00,4920.0,5040.0,4894.95,4925.0,2303204.0,"Dr Reddy’s Labs shares jump after Credit Suisse maintains outperform rating, expects earnings momentum to continue",Credit Suisse is of the view that Q2 was better than expected with strength driven by US sales. Earnings momentum should continue with more limited competition launches.,positive,positive,0.1016260162601626,neutral,-1.7691998391636508,negative
2020-10-29 20:56:00,4974.0,4978.05,4870.15,4886.0,1259800.0,Covid vaccine: Dr Reddy’s teams up with BIRAC for clinical trials of Sputnik V,"Dr Reddy’s Laboratories Ltd has teamed up with the Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT), Government of India, for advisory support on clinical",neutral,positive,-1.7691998391636508,negative,-0.9191176470588236,negative
2020-10-29 20:57:02,4974.0,4978.05,4870.15,4886.0,1259800.0,Generics business drives Dr Reddy’s Labs Q2 performance,Acquired business of Wockhardt and North America market contribute to the growth,neutral,positive,-1.7691998391636508,negative,-0.9191176470588236,negative
2020-10-29 22:53:22,4974.0,4978.05,4870.15,4886.0,1259800.0,"Corona Vaccine Tracker on Oct 29, 2020","Dr Reddy’s Laboratories Ltd on Thursday announced its partnership with Biotechnology Industry Research Assistance Council (BIRAC), Department of Biotechnology (DBT), for advisory support on clinical trials of Sputnik V vaccine in India.",neutral,positive,-1.7691998391636508,negative,-0.9191176470588236,negative
2020-11-02 22:14:05,4851.0,4920.0,4831.1,4880.0,1456508.0,DCGI rejects Dr Reddy’s Laboratories’ application seeking full marketing authorisation of remdesivir,India’s central drug regulator has rejected Dr Reddy’s Laboratories’ application seeking approval for full marketing authorisation of anti-viral drug remdesivir which has so far been allowed restricted emergency use on COVID-19 patients in the country. The Hyderabad-based pharmaceutical co…,neutral,positive,0.5978148835291692,neutral,0.7599326771051155,neutral
2020-11-03 07:35:00,4851.0,4920.0,4831.1,4880.0,1456508.0,"Stocks in the news: Sun Pharma, L&T, NTPC, ZEEL, PNB and Dr Reddy’s Labs","Larsen and Toubro (L&T) emerged as the lowest bidder for another package connecting Vadodara with Ahmedabad, a source aware of the matter said.",neutral,positive,0.5978148835291692,neutral,0.7599326771051155,neutral
2020-11-03 16:58:00,4901.75,4964.8,4877.4,4939.0,1517233.0,Accumulate Dr Reddy’s Laboratories; target of Rs 5414: Dolat Capital Market,"Dolat Capital Market recommended accumulate rating on Dr Reddy’s Laboratories with a target price of Rs 5414 in its research report dated October 28, 2020.",neutral,positive,0.7599326771051155,neutral,-0.276506962948067,neutral
2020-11-04 21:50:00,4972.75,4999.3,4922.1,4959.0,1030713.0,Buy Dr Reddy’s Laboratories; target of Rs 6000: ICICI Direct,"ICICI Direct is bullish on Dr Reddy’s Laboratories recommended buy rating on the stock with a target price of Rs 6000 in its research report dated October 29, 2020.",neutral,positive,-0.276506962948067,neutral,-1.1868061012714268,negative
2020-11-05 15:00:50,4962.9,4962.9,4890.85,4904.0,1088775.0,"Lupin confirms ‘security incident’, days after Dr Reddy’s cyber attack",Drugmaker Lupin has confirmed an “information security incident” that has affected its IT systems. The incident comes barely a fortnight after Dr Reddy’s Laboratories reported a cyber-attack and isola,neutral,neutral,-1.1868061012714268,negative,-0.7329949238578753,neutral
2020-11-12 21:25:16,4850.0,4884.85,4830.05,4869.95,1089066.0,Dr Reddy’s Laboratories launches succinylcholine chloride injection in US,"Dr Reddy’s Laboratories Ltd has launched Succinylcholine Chloride injection, a therapeutic equivalent generic version of Quelicin (Succinylcholine Chloride) injection, in the US market.The Quelicin br",neutral,positive,0.4113402061855633,neutral,-0.1147258870769371,neutral
2020-11-13 08:02:00,4850.0,4884.85,4830.05,4869.95,1089066.0,"Stocks in the news | Just Dial, Reliance Industries, HUDCO, Indiabulls Real Estate","Mahanagar Gas, Eicher Motors, Sun TV Network, Grasim Industries, Dr Reddy’s Laboratories, Generic Engineering Construction and Projects, are also among the stocks in focus today.",neutral,neutral,0.4113402061855633,neutral,-0.1147258870769371,neutral
2020-11-13 14:34:00,4881.2,4898.0,4830.0,4875.6,133268.0,"Mutual Funds made fresh buying into 11 stocks, completely exited 7 in October","Among Nifty50 stocks, the highest buying by mutual funds was seen in Bajaj Auto, BPCL, Dr Reddy’s Labs, Hindalco, ICICI Bank, SBI, UPL and Maruti Suzuki India",neutral,positive,-0.1147258870769371,neutral,-1.8256410256410252,negative
2020-11-13 18:18:20,4881.2,4898.0,4830.0,4875.6,133268.0,Covid vaccine: Dr Reddy’s to complete phase-II trials of Sputnik in December,Pharma major Dr Reddy’s Laboratories Ltd will be completing phase two trials of Covid vaccine candidate Sputnik V in December.When contacted a spokesperson of Dr Reddy’s told BusinessLine: “Phase-II c,neutral,positive,-0.1147258870769371,neutral,-1.8256410256410252,negative
2020-11-17 08:39:00,4875.0,4879.85,4770.0,4786.0,1275770.0,"Nifty Pharma under pressure; Torrent Pharma, Lupin, Biocon drag the performance",Pfizer Inc and its group companies have filed a petition against Aurobindo Pharma Ltd and Dr Reddy’s Laboratories in a US court.,positive,neutral,-1.8256410256410252,negative,-1.6927899686520376,negative
2020-11-17 16:30:10,4785.0,4795.0,4675.0,4704.0,1296863.0,"Pfizer sues Aurobindo, Dr Reddy’s over generic version of cancer drug",Pfizer Inc has filed a petition in a US court against Aurobindo Pharma Ltd and Dr Reddy’s Laboratories Ltd on their alleged separate plans to launch generic versions of its drug Ibrance (palbociclib),neutral,negative,-1.6927899686520376,negative,1.06951871657754,positive
2020-11-17 19:44:00,4785.0,4795.0,4675.0,4704.0,1296863.0,India pins hopes on locally-tested COVID-19 vaccines given Pfizer constraints,"The five candidates include Russia’s Sputnik-V whose Phase-II going to Phase-III trials in India will start next week in collaboration with Dr Reddy’s Laboratories, Vinod Paul, the head of a committee advising the prime minister, said.",neutral,positive,-1.6927899686520376,negative,1.06951871657754,positive
2020-11-19 10:31:00,4675.0,4811.8,4657.0,4725.0,1759968.0,Dr Reddy’s starts detailed investigation into anonymous complaint,"Dr Reddy’s Laboratories has commenced a detailed investigation into an anonymous complaint. The complaint alleges that healthcare professionals in Ukraine and potentially in other countries were provided with improper benefits in violation of US laws, the company said in a regulatory filing.",neutral,neutral,1.06951871657754,positive,-1.1205073995771668,negative
2020-11-19 13:53:00,4730.0,4752.3,4656.3,4677.0,952242.0,Bet on these 3 pharma stocks for impressive returns - Pharma bets,"With multiple factors being in favour of the pharmaceutical sector, Haitong Securities is most bullish on Dr Reddy’s Laboratories, Eris Lifesciences and Alkem Laboratories. In a note released today, the brokerage said pharma companies have posted strong operational numbers for the second straight qu…",positive,positive,-1.1205073995771668,negative,3.2017075773745995,positive
2020-11-19 16:15:00,4730.0,4752.3,4656.3,4677.0,952242.0,Dr Reddy’s Laboratories investigates complaint alleging violation of US laws,A reputed independent US law firm has been appointed the investigator to the complaint.,neutral,neutral,-1.1205073995771668,negative,3.2017075773745995,positive
2020-11-24 08:40:00,4850.0,4940.0,4785.8,4940.0,1918281.0,"Nifty Pharma picks up pace as investors turn bullish; Aurobindo Pharma, Biocon rallies","Dr Reddy’s Laboratories , Sun Pharma and Lupin were also among the top gainers to trade over 1%.",positive,positive,1.855670103092784,positive,-3.92156862745098,negative
2020-11-25 09:04:00,4998.0,5017.0,4781.0,4802.0,2647964.0,"Top buy and sell ideas by Ashwani Gujral, Sudarshan Sukhani, Mitessh Thakkar for short term","Mitessh Thakkar of mitesshthakkar.com recommends buying Biocon with a stop loss of Rs 425, target at Rs 450 and Dr Reddy’s Labs with a stop loss of Rs 4,840, target at Rs 5,130.",neutral,neutral,-3.92156862745098,negative,1.9750519750519755,positive
2020-11-30 16:09:00,4870.0,4870.0,4806.0,4835.1,1116983.0,"PM Modi interacts with teams involved in developing, manufacturing COVID-19 vaccine","Prime Minister Narendra Modi interacted with 3 teams working on developing and manufacturing vaccine for COVID-19 on November 30. These teams were from Pune’s Gennova Biopharmaceuticals Ltd, Hyderabad’s Biological E Ltd and Dr Reddy’s Laboratories Ltd. The event was held through video conferencing. …",neutral,neutral,-0.7166324435318201,neutral,-0.0772861235341398,neutral
2020-12-01 07:34:00,4870.0,4870.0,4806.0,4835.1,1116983.0,"Stocks in the news: Maruti, M&M, ONGC, Dr Reddy’s Labs, Infibeam and Route Mobile",Dr Reddy’s Laboratories on Saturday said it has inked a pact with Glenmark Pharmaceuticals to acquire its select anti-allergy brands.,neutral,positive,-0.7166324435318201,neutral,-0.0772861235341398,neutral
2020-12-01 18:53:12,4852.1,4889.0,4811.0,4848.35,1218392.0,"Dr Reddy’s, RDIF commence clinical trials for Sputnik V vaccine in India",Dr Reddy’s Laboratories Ltd. and the Russian Direct Investment Fund (RDIF) on Tuesday announced commencement of adaptive phase 2/3 clinical trials for COVID-19 vaccine Sputnik V in India after receivi,positive,positive,-0.0772861235341398,neutral,1.273100616016427,positive
2020-12-02 00:58:00,4852.1,4889.0,4811.0,4848.35,1218392.0,"DRL, RDIF commence clinical trials for Sputnik V Covid-19 vaccine in India",Dr Reddy’s Laboratories and Russian Direct Investment Fund (RDIF) on Tuesday said they have commenced adaptive phase 2/3 clinical trials for the Sputnik V COVID-19 vaccine in India.,positive,positive,-0.0772861235341398,neutral,1.273100616016427,positive
2020-12-02 07:47:54,4852.1,4889.0,4811.0,4848.35,1218392.0,"Stocks in the news | Sun Pharma Advanced Research, Tata Motors, Dr Reddy’s, Eicher Motors, Vikas Multicorp","Hemisphere Properties, Praj Industries, Snowman Logistics, Subex, Tata Coffee, KDDL, Dr Reddy’s Labs, SML Isuzu, Godrej Industries, Hero MotoCorp, Xtglobal Infotech are also among the stocks in focus today",neutral,neutral,-0.0772861235341398,neutral,1.273100616016427,positive
2020-12-02 10:01:00,4852.1,4889.0,4811.0,4848.35,1218392.0,Dr Reddy’s Labs begins phase 2/3 trials for Russia’s Sputnik V COVID-19 vaccine,"JSS Medical Research was roped in as clinical partner to conduct the multi-centre and randomised controlled study that includes safety and immunogenicity study, Dr Reddy’s & RDIF said in a joint statement.",neutral,neutral,-0.0772861235341398,neutral,1.273100616016427,positive
2020-12-02 10:12:50,4852.1,4889.0,4811.0,4848.35,1218392.0,Dr Reddy’s Laboratories shares gain as firm commences clinical trials for Sputnik V vaccine,The clinical trials are being conducted by JSS Medical Research who are the clinical research partner.,positive,neutral,-0.0772861235341398,neutral,1.273100616016427,positive
2020-12-11 13:33:00,5055.1,5084.05,4984.8,5013.0,766746.0,Russia alleges West campaigning to malign its COVID-19 vaccine Sputnik V,"Sputnik V in India: India’s Dr Reddy’s Laboratories and Hetero Drugs have a license to sell 100 million doses of the vaccine in India and limited trials are also being done in the country, as part of the approval process",neutral,neutral,-0.8328222982730383,neutral,1.4539579967689822,positive
2020-12-20 21:36:12,5243.0,5274.2,4962.05,5068.0,1807657.0,Stock picks of the week,"The stock of Dr Reddy’s Laboratories, which bounced from around ₹2,500 in March, rallied in the subsequent months and hit a fresh lifetime high of ₹5,512.6 in September. But the uptrend lost strength",neutral,positive,-3.337783711615487,negative,0.9064745384419638,positive
2020-12-29 09:20:37,5225.0,5269.0,5145.6,5155.0,880716.0,"Top Buy And Sell Ideas By Sudarshan Sukhani, Mitessh Thakkar For Short Term","Sudarshan Sukhani of s2analytics.com suggests buying Dr Reddy’s Labs with a stop loss of Rs 5,140, target at Rs 5,280 and Larsen & Toubro with a stop loss of Rs 1,270, target at Rs 1,320.",neutral,neutral,-1.3397129186602872,negative,-0.5094915678663923,neutral
2021-01-08 11:33:48,5299.9,5360.0,5279.0,5344.15,805581.0,"D-Street Buzz: Pharma Stocks Gain Led By Sun Pharma, Biocon; CLSA Picks DRL, Downgrades Aurobindo Pharma","CLSA has a buy on Sun Pharma, Cadila Healthcare and Dr Reddy’s Labs and has a sell on Biocon and Lupin. The research firm has downgraded Aurobindo Pharma to underperform from outperform.",neutral,positive,0.8349214136115776,neutral,1.234094311377242,positive
2021-01-11 05:30:00,5344.0,5427.0,5326.0,5409.95,918871.0,BRIEF-Dr.Reddy’s Labs Launches Febuxostat Tablets In U.S. Market - Investing.com India,"The Financial News section features stock market news in addition to stories about bonds, forex, commodities and economic releases.",neutral,neutral,1.234094311377242,positive,-1.579687370771645,negative
2021-01-11 16:38:14,5440.95,5443.5,5329.45,5355.0,746522.0,Dr Reddy’s Laboratories launches Febuxostat tablets,"Dr Reddy’s Laboratories Ltd has launched Febuxostat Tablets, a therapeutic equivalent generic version of Uloric (Febuxostat) tablets approved by the US Food and Drug Administration (USFDA).The Uloric",neutral,positive,-1.579687370771645,negative,-1.5843429636533086,negative
2021-01-11 17:02:00,5440.95,5443.5,5329.45,5355.0,746522.0,"Covid vaccine to be a massive opportunity from 1-year perspective: GV Prasad, Dr Reddy’s","Pricing pressure has decreased in the regulated market, said GV Prasad, Co-Chairman, Dr Reddy’s Laboratories. He also told ET NOW that he expects regulatory collaboration with pharma industry to continue.",positive,negative,-1.579687370771645,negative,-1.5843429636533086,negative
2021-01-12 06:55:00,5440.95,5443.5,5329.45,5355.0,746522.0,Dr Reddy’s Laboratories gets approval for phase 3 trials of Sputnik V Covid vaccine,"“The Indian clinical trial being conducted by Dr Reddys and RDIF is an adaptive design phase 2/3 trial. It is a bridging study to the larger global phase 3 study on 31,000 subjects. The phase 2 study in India showed a very good safety profile, said Dr. Reddys co-chairman G V Prasad.",positive,neutral,-1.579687370771645,negative,-1.5843429636533086,negative
2021-01-12 07:39:00,5440.95,5443.5,5329.45,5355.0,746522.0,"Stocks in the news: Adani Green, RIL, GAIL, Karnataka Bank, Tata Elxsi and Dr Reddy’s Labs","Reliance Retail will exit direct sale of packaged food, grocery and FMCG goods on its e-commerce platform JioMart.",neutral,neutral,-1.579687370771645,negative,-1.5843429636533086,negative
2021-01-13 13:01:12,5304.9,5328.0,5265.0,5317.6,534554.0,Buy Dr Reddy’s Laboratories: Target Of Rs 6500: Sharekhan,"Sharekhan is bullish on Dr Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 6500 in its research report dated January 12, 2020.",neutral,positive,0.2394013082244854,neutral,-1.936030103480708,negative
2021-01-19 11:13:51,5088.0,5104.95,5036.55,5085.3,796972.0,Brokerages Say These 13 Largecaps Are Likely To Give 11-32% Return; Do You Own Any?,"HPCL, Wipro, Marico, Avenue Supermarts and Dr Reddy’s Laboratories among 13 largecaps which could give 11-32% return.",neutral,neutral,-0.0530660377358454,neutral,-0.3410226760480674,neutral
2021-01-27 10:12:00,5052.4,5052.4,4832.8,4900.0,1050882.0,Dr Reddy’s Laboratories terminate Avigan trial study in Kuwait,"On Sensex, Dr Reddy’s closed at Rs4908.85 per piece down by Rs173.25 or 3.41%.",neutral,negative,-3.01638825112817,negative,-0.0825593395252838,neutral
2021-01-27 16:42:00,4845.0,4903.95,4777.0,4841.0,1030230.0,Dr Reddy’s Labs terminates Kuwait-based Covid-19 treatment study,Dr Reddy’s Laboratories on Wednesday announced termination of Avigan trial study being conducted in Kuwait,neutral,negative,-0.0825593395252838,neutral,-6.49693251533742,negative
2021-01-27 18:23:55,4845.0,4903.95,4777.0,4841.0,1030230.0,"Dr Reddy’s, GRA terminate Avigan study on hospitalised Covid cases in Kuwait",Dr Reddy’s Laboratories Ltd and Global Response Aid FZCO (GRA) on Wednesday announced the termination of an Avigan Trial Study conducted in Kuwait focussed on moderate to severe Covid patients in a h,neutral,negative,-0.0825593395252838,neutral,-6.49693251533742,negative
2021-01-29 05:30:00,4890.0,4915.0,4550.0,4572.3,2956210.0,BRIEF-Dr.Reddy’s Laboratories Takes Qtrly Impairment Charge Of 6.00 Bln Rupees,BRIEF-Dr.Reddy’s Laboratories Takes Qtrly Impairment Charge Of 6.00 Bln Rupees,neutral,neutral,-6.49693251533742,negative,-2.7576452012587582,negative
2021-01-29 05:30:00,4890.0,4915.0,4550.0,4572.3,2956210.0,BRIEF-India’s Dr.Reddy’s Laboratories Posts Dec-Qtr Consol Net Profit,BRIEF-India’s Dr.Reddy’s Laboratories Posts Dec-Qtr Consol Net Profit,neutral,neutral,-6.49693251533742,negative,-2.7576452012587582,negative
2021-01-29 07:28:56,4890.0,4915.0,4550.0,4572.3,2956210.0,"Dr Reddy’s Labs Q3 Preview: YoY Rise In Sales, Profit Expected; Updates On Niche ANDA Filings, New Launches To Be In Focus","Brokerage firm Kotak Institutional Equities expects the company’s US business to increase by $8 mn quarter-on-quarter (QoQ) to $255 mn, led by the launch of Kuvan.",neutral,positive,-6.49693251533742,negative,-2.7576452012587582,negative
2021-01-29 12:02:00,4890.0,4915.0,4550.0,4572.3,2956210.0,Dr Reddy’s Laboratories reports consolidated net profit of Rs 27.90 crore in the December 2020 quarter,Sales rise 12.45% to Rs 4929.60 crore,neutral,positive,-6.49693251533742,negative,-2.7576452012587582,negative
2021-01-29 12:08:25,4890.0,4915.0,4550.0,4572.3,2956210.0,"Dr Reddy’s Labs Q3 Profit At Rs 20 Crore, Revenue Rises 12% YoY",The company said the Q3FY21 PAT was impacted primarily due to the non-recognition of deferred tax assets on impairment.,neutral,negative,-6.49693251533742,negative,-2.7576452012587582,negative
2021-01-29 12:55:00,4890.0,4915.0,4550.0,4572.3,2956210.0,"Dr Reddy’s posts Q3 profit of Rs 20 crore, revenues at Rs 4,930 crore",Dr Reddy’s Laboratories on Friday reported a consolidated net profit of Rs 20 crore for the October to December quarter as against a consolidated net loss of Rs 570 crore in the year-ago period.,neutral,positive,-6.49693251533742,negative,-2.7576452012587582,negative
2021-01-29 13:47:22,4890.0,4915.0,4550.0,4572.3,2956210.0,Dr Reddy’s Labs posts ₹20 crore net in Q3,"‘Trigger-based impairment charge taken on a few acquired products including Nuvaring, hurt profits; progressing well on Phase 3 clinical trials for Sputnik V vaccine in India’",neutral,positive,-6.49693251533742,negative,-2.7576452012587582,negative
2021-01-29 17:36:00,4890.0,4915.0,4550.0,4572.3,2956210.0,Dr Reddy’s Labs share closes over 5% lower after Q3 profit misses estimates,"Dr Reddy’s Labs share closed 5.69% or Rs 277 lower at Rs 4,598 against previous close of Rs 4,876 on BSE",negative,negative,-6.49693251533742,negative,-2.7576452012587582,negative
2021-02-02 15:01:00,4578.95,4761.6,4542.45,4660.0,3436739.0,Dr Reddy’s launches generic epilepsy drug in US market,"“We are pleased that this product has been designated as a Competitive Generic Therapy (CGT) by the FDA,” Dr Reddy’s Laboratories North America Generics CEO Marc Kikuchi said in a statement.",neutral,positive,1.7700564539905477,positive,-0.6562966119752862,neutral
2021-02-03 09:49:00,4578.95,4761.6,4542.45,4660.0,3436739.0,"Sensex rises over 100 points, Nifty near 14,700; Dr Reddy’s Labs jumps","Sensex gains over 100 points, Nifty near 14,700 amid volatile trade; Dr Reddy’s Labs jumps.",neutral,positive,1.7700564539905477,positive,-0.6562966119752862,neutral
2021-02-04 17:22:13,4685.0,4830.0,4625.65,4800.0,2406191.0,Buy Dr Reddy’s Laboratories; Target Of Rs 5525: ICICI Direct,"ICICI Direct is bullish on Dr Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 5525 in its research report dated January 30, 2021.",neutral,positive,2.454642475987193,positive,-0.0822199383350462,neutral
2021-02-05 09:23:16,4685.0,4830.0,4625.65,4800.0,2406191.0,Weekly Tactical Pick | Dr Reddy’s Laboratories,"Vaccine scope, strong product pipeline to act as tonic for Dr Reddy’s Laboratories",neutral,positive,2.454642475987193,positive,-0.0822199383350462,neutral
2021-02-09 15:49:31,4845.0,4884.1,4761.0,4815.0,1152649.0,"From 1,107 in 1996 to 15,000-level in 2021: Here’s Nifty’s journey in last 25 years","For the first time in history, the Nifty has closed above the psychological mark of 15,000 on February 8, 2021. Only 13 companies have traversed the entire journey. Of the 50 stocks in the Nifty, thirteen companies -- HDFC Bank, RIL, HDFC, ITC, HUL, L&T, SBI, Tata Motors, Dr Reddy`s Labs, Tata Steel…",neutral,neutral,-0.6191950464396285,neutral,0.2489110143123833,neutral
2021-02-09 22:52:17,4845.0,4884.1,4761.0,4815.0,1152649.0,Buy Dr Reddy’s Laboratories; Target Of Rs 6500: Sharekhan,"Sharekhan is bullish on Dr Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 6500 in its research report dated January 29, 2021.",neutral,positive,-0.6191950464396285,neutral,0.2489110143123833,neutral
2021-02-09 23:48:07,4845.0,4884.1,4761.0,4815.0,1152649.0,Buy Dr Reddy’s Laboratories; Target Of Rs 5200: Dolat Capital Market,"Dolat Capital Market is bullish on Dr Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 5200 in its research report dated January 31, 2021.",neutral,positive,-0.6191950464396285,neutral,0.2489110143123833,neutral
2021-02-17 10:43:39,4696.6,4709.95,4580.0,4595.25,1020203.0,Former Dr Reddy’s Exec Is New CEO Of Swiss Pharma Company PolyPeptide,"Raymond De Vre, a Belgian who previously worked at Indian contract manufacturer Dr Reddy’s Laboratories as global head of biologics, will join PolyPeptide Group as CEO-elect in April.",neutral,neutral,-2.1579440446280365,negative,0.3364445409159974,neutral
2021-02-17 10:54:05,4696.6,4709.95,4580.0,4595.25,1020203.0,"BRIEF-Dr.Reddy’s Labs Launces Capecitabine Tablets, USP In U.S. Market By Reuters","BRIEF-Dr.Reddy’s Labs Launces Capecitabine Tablets, USP In U.S. Market",neutral,neutral,-2.1579440446280365,negative,0.3364445409159974,neutral
2021-02-17 11:53:00,4696.6,4709.95,4580.0,4595.25,1020203.0,Dr Reddy’s Laboratories launches cancer treatment drug Capecitabine in US,The product is a therapeutic equivalent generic version of Xeloda (capecitabine) tablets approved by the US Food and Drug Administration (USFDA),neutral,neutral,-2.1579440446280365,negative,0.3364445409159974,neutral
2021-02-17 16:52:46,4607.0,4663.85,4560.0,4622.5,1029388.0,Dr Reddy’s Labs launches Capecitabine tablets in US market,The tablets are available in 150/500 mg strengths,positive,neutral,0.3364445409159974,neutral,2.6944806605823555,positive
2021-02-18 05:30:00,4607.0,4663.85,4560.0,4622.5,1029388.0,BRIEF-Dr.Reddy’s Labs Launches Fluphenazine Hydrochloride Tablets In U.S.,BRIEF-Dr.Reddy’s Labs Launches Fluphenazine Hydrochloride Tablets In U.S.,neutral,neutral,0.3364445409159974,neutral,2.6944806605823555,positive
2021-02-18 10:54:00,4607.0,4663.85,4560.0,4622.5,1029388.0,Dr Reddy’s Lab launches Fluphenazine Tablets in US,"Dr Reddy’s Laboratories along with its subsidiaries announced the launch of Fluphenazine Hydrochloride Tablets, USP, in the U.S. market.",neutral,positive,0.3364445409159974,neutral,2.6944806605823555,positive
2021-02-19 15:21:00,4602.0,4728.0,4530.0,4726.0,1277002.0,Dr Reddys Lab gains on seeking emergency use authorisation for Sputnik V in India,Dr Reddy’s Laboratories rose 1.12% to Rs 4669.40 after the company announced that it has initiated process for emergency use authorization of Sputnik V vaccine.,positive,positive,2.6944806605823555,positive,-4.88636363636364,negative
2021-02-19 17:03:12,4602.0,4728.0,4530.0,4726.0,1277002.0,Dr Reddy’s Begins Process for Emergency Use Authorisation of Russian Covid-19 Vaccine Sputnik V,The Hyderabad-based Dr Reddy’s Laboratories on Friday said it has sought emergency use authorisation of Russian Covid-19 vaccine Sputnik V from Drugs Controller General of India (DCGI).,neutral,neutral,2.6944806605823555,positive,-4.88636363636364,negative
2021-02-22 05:30:00,4708.0,4726.95,4443.15,4477.95,1389656.0,BRIEF-Dr.Reddy’s Labs Launches Lansoprazole DR Orally Disintegrating Tablets In U.S.,BRIEF-Dr.Reddy’s Labs Launches Lansoprazole DR Orally Disintegrating Tablets In U.S.,neutral,neutral,-4.88636363636364,negative,-0.4001778568252557,neutral
2021-02-22 08:57:55,4708.0,4726.95,4443.15,4477.95,1389656.0,"Top Buy And Sell Ideas By Sudarshan Sukhani, Mitessh Thakkar For Short Term","Mitessh Thakkar of mitesshthakkar.com recommends buying Bajaj Auto with a stop loss of Rs 3,970, target at Rs 4,080 and Dr Reddy’s Labs with a stop loss of Rs 4,650, target at Rs 4,750.",neutral,neutral,-4.88636363636364,negative,-0.4001778568252557,neutral
2021-02-22 16:23:19,4498.0,4534.3,4420.5,4480.0,1061046.0,"Taking Stock: Sensex Tanks More Than 1,100 Points, Bears Drag Nifty Below 14,700","Tech Mahindra, M&M, Dr Reddy’s Labs, ITC and IndusInd Bank were the major losers on the Nifty. The gainers included Adani Ports, JSW Steel, Hindalco Industries, Tata Steel and ONGC.",neutral,negative,-0.4001778568252557,neutral,-1.428205955307383,negative
2021-02-24 10:33:06,4495.15,4523.75,4377.0,4430.95,735351.0,Committee to meet today to discuss approval for Sputnik V Covid vaccine in India,Dr Reddy’s Laboratories Ltd had last week applied to the Drugs Controller General of India (DCGI) for an emergency licence for the Russian vaccine,neutral,neutral,-1.428205955307383,negative,1.466812933286597,positive
2021-02-24 11:58:21,4495.15,4523.75,4377.0,4430.95,735351.0,Coronavirus Vaccine Update: Three More ‘Made In India’ COVID-19 Vaccines On Way,"Three companies -- Dr Reddy’s Laboratories, Serum Institute of India, and Biological E -- are preparing to submit data for approval of their vaccines or to start phase-3 trials",neutral,neutral,-1.428205955307383,negative,1.466812933286597,positive
2021-02-24 22:32:00,4421.15,4590.0,4421.15,4486.0,1699755.0,"Expert panel reviews EUA application for Sputnik V vaccine; seeks immunogenicity, safety data",Dr Reddy’s Laboratories on February 19 said it had approached drugs regulator DCGI for emergency use authorisation (EUA) for the Russian vaccine.,neutral,positive,1.466812933286597,positive,-0.7847533632286996,neutral
2021-02-24 22:40:50,4421.15,4590.0,4421.15,4486.0,1699755.0,Expert Panel Reviews Emergency Use Authorisation for Sputnik V Vaccine; Seeks Safety Data,"An expert panel of India’s Central Drug Authority which reviewed the application of Dr Reddy’s Laboratories seeking emergency use authorisation for the COVID-19 vaccine Sputnik V on Wednesday recommended that the firm present immunogenicity and safety data, sources said.",neutral,neutral,1.466812933286597,positive,-0.7847533632286996,neutral
2021-02-25 07:40:00,4421.15,4590.0,4421.15,4486.0,1699755.0,"Stocks in the news: Nureca, Dr Reddy’s Labs, Affle India, Max Financial and HGS","Indias drug regulator has not cleared the application of Dr Reddys Laboratories seeking approval to market the Sputnik V Covid-19 vaccine, citing lack of data.",neutral,neutral,1.466812933286597,positive,-0.7847533632286996,neutral
2021-02-26 12:23:00,4460.0,4558.6,4405.0,4425.0,1504433.0,Investors turn to pharma stocks amid market crash; Nifty Pharma gains 1.5%,"Among individual stocks, Lupin zoomed 3.4 per cent in the intra-day trade and hit a high of Rs 1,060, Sun Pharmaceuticals advanced 2 per cent, and Dr Reddy’s Labs gained 1.7 per cent.",positive,positive,-0.7847533632286996,neutral,0.3149606299212598,neutral
2021-03-02 18:08:02,4465.0,4515.75,4426.0,4499.0,845563.0,"Sensex reclaims 50,000-benchmark amid hectic buying in IT, auto, FMCG sectors; Nifty ends in green - Business News , Firstpost","The top five gainers were Tata Motors, M&M, Wipro, Adani Ports and NTPC, while the top losers were ONGC, HDFC, Dr Reddy’s Labs, Coal India and Power Grid Corp",neutral,neutral,0.761478163493841,neutral,1.896474788041053,positive
2021-03-05 08:11:00,4550.0,4560.0,4484.0,4493.0,824056.0,Bull Spread strategy on Dr Reddy’s Labs by Nandish Shah of HDFC Securities,The stock price has broken out on the daily chart where it closed above 200-day EMA with higher volumes,neutral,neutral,-1.2527472527472527,negative,-0.3333333333333333,neutral
2021-03-05 13:34:37,4550.0,4560.0,4484.0,4493.0,824056.0,Buy Dr Reddy’s Laboratories: Target Of Rs 6500: Sharekhan,"Sharekhan is bullish on Dr Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 6500 in its research report dated March 04, 2021.",neutral,positive,-1.2527472527472527,negative,-0.3333333333333333,neutral
2021-03-11 07:26:00,4520.0,4529.95,4403.1,4425.5,686190.0,"Sun Pharmaceutical, Dr Reddy’s Labs, JB Pharmaceuticals, Torrent Pharma and Piramal Pharma eye Oaknet Healthcare","Investment bank Rothschild is advising the fund to find a potential buyer for the business at a valuation of $100 million (about Rs 700 crore), said multiple people aware of the development.",neutral,neutral,-2.09070796460177,negative,-2.600896860986547,negative
2021-03-14 12:43:57,4460.0,4462.2,4285.0,4344.0,921429.0,"Sun Pharma, Dr Reddy’s, Aurobindo recall products in the U.S. market","Dr Reddy’s Laboratories is recalling 2,24,710 (500 count) bottles of Atorvastatin Calcium tablets.",negative,negative,-2.600896860986547,negative,1.6894591447683842,positive
2021-03-16 00:30:35,4380.1,4466.7,4365.0,4454.1,932685.0,Dr Reddy’s Laboratories rating – Buy: API supplies for Vascepa are an issue,"Gradual ramp-up of drug expected through FY22, with US revenues of $25 m; FY22e EPS down 1%; ‘Buy’ retained with TP of Rs 5,533",neutral,negative,1.6894591447683842,positive,-2.0372159920893465,negative
2021-03-18 07:48:00,4370.0,4378.5,4195.05,4230.0,1208828.0,"Covid scare, rise in bond yield spook mkts for 5th day; Sensex dips 585 pts","HCL Tech, Infosys, Dr Reddy’s Labs, NTPC, TCS, Reliance Industries, and Tech Mahindra, all down between 2 per cent and 3.5 per cent, were the top losers on the Sensex",negative,negative,-3.203661327231121,negative,1.5890736342042668,positive
2021-03-22 15:55:00,4350.0,4403.0,4322.1,4362.0,663669.0,Hyderabad’s Virchow to produce 200 million doses of Russia’s Sputnik V vaccine,Virchow is the fifth Indian company to have an agreement with RDIF on Sputnik V. Dr Reddy’s Laboratories was the first to announce a tie-up with RDIF to conduct the bridge studies (clinical trials) of Sputnik V vaccine,neutral,neutral,0.2758620689655172,neutral,-0.1459686224929685,neutral
2021-03-30 00:42:00,4429.95,4527.45,4421.05,4519.35,863625.0,Wait for Sputnik V Covid-19 vaccine may get over in a few weeks: DRL,"“We expect to get the approval in the next few weeks,” said Deepak Sapra, CEO, API and pharmaceutical services, Dr Reddy’s Laboratories (DRL)",neutral,positive,2.018081468188141,positive,0.0665188470066518,neutral
2021-03-30 08:29:00,4429.95,4527.45,4421.05,4519.35,863625.0,"Stocks to watch: Nazara Tech, DRL, Adani Transmission, JSW Steel, Biocon","Pharma major Dr Reddy’s Laboratories (DRL) expects the Russian coronavirus vaccine Sputnik V to get approval from the Indian regulator in the next few weeks, a company official has said",neutral,positive,2.018081468188141,positive,0.0665188470066518,neutral
2021-03-31 05:30:00,4510.0,4546.7,4481.0,4513.0,767729.0,BRIEF-Dr.Reddy’s Laboratories Says Entered Into A Partnership Agreement With ABCD Technologies LLP,BRIEF-Dr.Reddy’s Laboratories Says Entered Into A Partnership Agreement With ABCD Technologies LLP,neutral,neutral,0.0665188470066518,neutral,0.7703296703296743,neutral
2021-04-01 07:07:49,4550.0,4594.95,4522.05,4585.05,644210.0,"Dr Reddy’s, Cipla invest in ABCD Technologies",Drug majors Dr Reddy’s Laboratories and Cipla on Wednesday said they have entered into a partnership agreement with ABCD Technologies LLP which is to be renamed as IndoHealth Services LLP.The two firms are contributing up to Rs 40 crore each corresponding to the contribution by the other p…,neutral,positive,0.7703296703296743,neutral,0.1096491228070175,neutral
2021-04-07 05:30:00,4662.3,4734.0,4641.0,4685.0,1109791.0,BRIEF-Dr.Reddy’s Laboratories Launches Generic Version Of Sapropterin Dihydrochloride Powder For Oral Solution In U.S.,BRIEF-Dr.Reddy’s Laboratories Launches Generic Version Of Sapropterin Dihydrochloride Powder For Oral Solution In U.S.,neutral,neutral,0.4868841558887205,neutral,0.0479463001438389,neutral
2021-04-09 05:30:00,4692.9,4794.0,4691.25,4765.0,1360754.0,BRIEF-India Drug Regulator Committee Recommends Dr.Reddy’s Labs To Present Additional Data On Sputnik V,BRIEF-India Drug Regulator Committee Recommends Dr.Reddy’s Labs To Present Additional Data On Sputnik V,neutral,neutral,1.536363442647411,positive,6.701570680628273,positive
2021-04-09 19:11:00,4692.9,4794.0,4691.25,4765.0,1360754.0,"As Covid cases rise, Zydus to scale up Remdesivir production","Companies like Cipla, Mylan, Jubilant Life Sciences, Hetero Drugs, Syngene International and Dr Reddy’s Laboratories are also manufacturing Remdesivir for the Indian market.",positive,neutral,1.536363442647411,positive,6.701570680628273,positive
2021-04-11 16:15:00,4775.0,5120.0,4695.0,5095.0,3509252.0,"Five COVID-19 vaccines likely by end of Q3; Sputnik V, Novavax, J&J in line","Russian Direct Investment Fund (RDIF) has tied up with a host of Indian pharma companies such as Dr Reddy’s Laboratories, Hetero Biopharma, Gland Pharma, Stelis Biopharma and Vichrow Biotech for the production of Sputnik V",positive,neutral,6.701570680628273,positive,-6.681633525764378,negative
2021-04-12 17:17:00,5144.7,5144.7,4751.1,4800.95,3902344.0,What led Dr Reddy’s Labs to defy market trend and close 7% higher?,"On NSE, Dr Reddys Labs ended up 7.09 per cent at Rs 5,098. On BSE, it rose 4.83 per cent and was the only gainer among Sensex stocks.",positive,positive,-6.681633525764378,negative,-0.0598814759751313,neutral
2021-04-12 18:59:53,5144.7,5144.7,4751.1,4800.95,3902344.0,Shares of Dr Reddy’s Rally over 4% as Sputnik V Receives Approval for Emergency Use in India,The share price of Dr Reddy’s Laboratories rallied over 4 per cent on Monday after an expert panel of India’s central drug authority recommended granting approval to Russian COVID-19 vaccine Sputnik V for emergency use in the country with certain conditions.,neutral,positive,-6.681633525764378,negative,-0.0598814759751313,neutral
2021-04-12 19:16:37,5144.7,5144.7,4751.1,4800.95,3902344.0,Sputnik V approved: But can it resolve the COVID19 vaccine supply shortage in India?,"Experts don’t see a quick change in vaccine supply scene, but the approval is a good sign for Dr Reddy’s labs.",neutral,positive,-6.681633525764378,negative,-0.0598814759751313,neutral
2021-04-12 22:49:17,5144.7,5144.7,4751.1,4800.95,3902344.0,COVID-19: Panel okays vaccine Sputnik V for emergency use in India,The expert committee on Monday took up the application of Dr Reddy’s Laboratories seeking emergency use authorisation for Sputnik,neutral,neutral,-6.681633525764378,negative,-0.0598814759751313,neutral
2021-04-13 05:30:00,5144.7,5144.7,4751.1,4800.95,3902344.0,BRIEF-Dr.Reddy’s Laboratories Says Got Emergency Use Authorisation For Sputnik V In India,BRIEF-Dr.Reddy’s Laboratories Says Got Emergency Use Authorisation For Sputnik V In India,neutral,neutral,-6.681633525764378,negative,-0.0598814759751313,neutral
2021-04-13 08:07:33,5144.7,5144.7,4751.1,4800.95,3902344.0,"Trade Spotlight: What Should Investors Do With Cipla, Dr Reddy’s & Infosys?","Some of the stocks in focus were Dr Reddy’s Laboratories, which gained nearly 5 percent with strong volumes, Cipla that rose more than 2 percent, and Infosys which fell 1 percent after hitting a fresh 52-week high.",neutral,positive,-6.681633525764378,negative,-0.0598814759751313,neutral
2021-04-13 10:15:14,5144.7,5144.7,4751.1,4800.95,3902344.0,"Tata Consultancy Services, Dr Reddy’s Laboratories, Bandhan Bank: Top Stocks for Investors on April 13","The stock market on Monday, April 12, fell drastically around 3 percent to give a negative ending.",neutral,negative,-6.681633525764378,negative,-0.0598814759751313,neutral
2021-04-13 10:27:00,5144.7,5144.7,4751.1,4800.95,3902344.0,Dr Reddy’s receives DCGI approval for restricted emergency use of Sputnik V,Drug major Dr Reddy’s Laboratories on Tuesday said it has received approval from Indian drug regulator for restricted emergency use of Covid-19 vaccine Sputnik V in the country,positive,positive,-6.681633525764378,negative,-0.0598814759751313,neutral
2021-04-13 13:46:00,5144.7,5144.7,4751.1,4800.95,3902344.0,Accumulate Dr Reddy’s Laboratories; Target Of Rs 5400: Dolat Capital Market,"Dolat Capital Market recommended accumulate rating on Dr. Reddy’s Laboratories with a target price of Rs 5400 in its research report dated April 12, 2021.",neutral,positive,-6.681633525764378,negative,-0.0598814759751313,neutral
2021-04-14 15:01:54,4842.9,4875.05,4785.0,4840.0,1380035.0,Vaccine approval positive for Dr Reddy’s but should you inject your portfolio with Sputnik V?,"With Sputnik V covid-19 vaccine getting the Emergency Use Authorisation (EUA), Dr Reddy’s Laboratories stands to benefit after having secured exclusive marketing and distribution rights for the first 250 million doses of the vaccines in India.",positive,positive,-0.0598814759751313,neutral,0.3947530737283568,neutral
2021-04-14 16:19:00,4842.9,4875.05,4785.0,4840.0,1380035.0,Sputnik V in India: Dr Reddy’s to begin supply of COVID-19 vaccine imported from Russia in May,Drug major Dr Reddy’s Laboratories is also going to tap domestically sourced jabs as their production speeds up in India,neutral,neutral,-0.0598814759751313,neutral,0.3947530737283568,neutral
2021-04-14 17:53:15,4842.9,4875.05,4785.0,4840.0,1380035.0,Dr Reddy’s Working on Stability Data on 2 to 8 C Temperature Range for Sputnik V Vaccine,"Dr Reddy's Laboratories is in the process of generating additional stability data for Russia's COVID-19 vaccine Sputnik V, which has a storage condition of -18C, on 2 to 8 C, a senior official of the drug maker said on Wednesday.",neutral,neutral,-0.0598814759751313,neutral,0.3947530737283568,neutral
2021-04-14 20:39:20,4842.9,4875.05,4785.0,4840.0,1380035.0,"COVID-19: Sputnik V to arrive in India in April-June, says Dr Reddy’s Laboratories","The initial batches of Sputnik V, however, will be imported from Russia, whose Gamaleya Research Institute developed this vaccine",neutral,neutral,-0.0598814759751313,neutral,0.3947530737283568,neutral
2021-04-14 21:37:56,4842.9,4875.05,4785.0,4840.0,1380035.0,"Dr Reddy’s to Start Importing Russia-made Sputnik V Vaccine in April-June, Price under Discussion",Dr Reddy’s Laboratories will start importing bulk doses of its anti-coronavirus vaccine Sputnik V from Russia between mid-April to June.,neutral,neutral,-0.0598814759751313,neutral,0.3947530737283568,neutral
2021-04-19 10:25:00,4893.0,5005.0,4807.05,5005.0,1841113.0,Manic Monday! Here’s what led to a stock market crash today,"Barring shares of Dr Reddy’s Labs, all constituents of the 30-pack index traded in the red",negative,neutral,2.28898426323319,positive,0.8823529411764706,neutral
2021-04-20 08:10:00,5100.0,5210.75,5089.5,5145.0,3471388.0,"Top trading recommendations by Anand Rathi: Buy Dr Reddy’s Labs, Bata India",The price pattern is very strong on the technical parameters and Dr Reddy’s Labs could outperform once there is more clarification on the developments of vaccine,neutral,positive,0.8823529411764706,neutral,0.3861041129740635,neutral
2021-04-20 13:32:55,5100.0,5210.75,5089.5,5145.0,3471388.0,"D-Street Buzz: Pharma Stocks Outperform Led By Dr Reddy’s Labs; Cadila Health, Cipla, Glenmark Hit New 52-week High","S&P BSE Healthcare gained over a percent with the top gainers being RPG Life Sciences which surged over 16 percent followed by Wockhardt, Moepen Labs, Shilpa Medicare, Pfizer, Fortis Healthcare and Dr Reddy’s Labs among others.",neutral,positive,0.8823529411764706,neutral,0.3861041129740635,neutral
2021-04-22 17:32:11,5228.0,5266.15,5030.1,5075.0,2350804.0,COVID-19: India to receive Russia’s Sputnik V vaccine only by end-May,"A day after announcing that Sputnik V vaccine could be sold at around Rs 750 a dose in India, its manufacturer Dr Reddy’s Labs clarified that discussions on the price are still on and there is no final decision yet",neutral,neutral,-2.9265493496557,negative,-1.170731707317073,negative
2021-04-23 07:42:00,5228.0,5266.15,5030.1,5075.0,2350804.0,"MARKET LIVE: Sensex sheds 200 pts, gives up 48k; M&M, Dr Reddy’s top drags","LIVE market update: Power Grid was the top gainer on the Nifty, up 2.75 per cent, followed by Tata Steel, SBI Life, Dr Reddy’s Labs, and Asian Paints",neutral,positive,-2.9265493496557,negative,-1.170731707317073,negative
2021-04-27 16:08:00,5082.55,5106.9,5030.0,5048.0,841708.0,MSD to sign licensing pacts with 5 Indian drug firms for oral drug candidate for COVID-19,"MSD has decided to enter into non-exclusive voluntary licensing agreements for molnupiravir with five established Indian generic manufacturers -- Cipla, Dr Reddy’s Laboratories, Emcure Pharmaceuticals, Hetero Labs and Sun Pharmaceutical Industries, it added.",positive,positive,-0.6797768836509268,neutral,0.7050934372072384,neutral
2021-04-28 06:48:52,5082.55,5106.9,5030.0,5048.0,841708.0,Remdesivir shortfall likely to ease soon,"Remdesivir is manufactured by seven companies in India—Hetero Drugs, Zydus Cadila, Dr Reddy’s Laboratories, Cipla, Jubilant Pharma, Mylan and Syngene International—under a pact with the drug’s US-based innovator Gilead Sciences Inc",positive,neutral,-0.6797768836509268,neutral,0.7050934372072384,neutral
2021-04-28 12:19:00,5070.25,5144.0,5042.3,5106.0,1070305.0,COVID-19 treatment: 5 Indian drugmakers ink pacts with Merck for molnupiravir,"The company, known as Merck in the US and Canada, has inked pacts with Cipla, Dr Reddy’s Laboratories, Sun Pharma, Hetero Labs, and Emcure Pharmaceuticals",positive,positive,0.7050934372072384,neutral,0.5642023346303502,neutral
2021-04-28 23:11:34,5070.25,5144.0,5042.3,5106.0,1070305.0,COVID-19 in Mumbai: Government explores option to import COVID-19 vaccines,"COVID-19: Sputnik V to arrive in India in April-June, says Dr Reddy’s Laboratories.Amidst the constraints in the procurement of COVID-19 vaccines from domestic producers, the Maharashtra government has been exploring the option of importing it to meet its requirement. The government will soon ini…",neutral,neutral,0.7050934372072384,neutral,0.5642023346303502,neutral
2021-04-29 05:30:00,5070.25,5144.0,5042.3,5106.0,1070305.0,"BRIEF-Dr.Reddy’s Laboratories Announces Launch Of Albendazole Tablets, USP In U.S. Market","BRIEF-Dr.Reddy’s Laboratories Announces Launch Of Albendazole Tablets, USP In U.S. Market",neutral,neutral,0.7050934372072384,neutral,0.5642023346303502,neutral
2021-04-30 12:46:23,5140.0,5211.0,5125.15,5169.0,1302890.0,Dr Reddy’s Laboratories Shares Rise 2% On Launch Of Albendazole Tablets In US,"The share touched a 52-week high of Rs 5,514.65 and a 52-week low of Rs 3,613.45 on 21 September 2020 and 18 May 2020, respectively.",neutral,negative,0.5642023346303502,neutral,-0.1915690370527213,neutral
2021-05-02 01:56:17,5193.95,5212.35,5140.0,5184.0,934021.0,Covid-19: India gets first batch of 1.5 lakh doses of Russia’s Sputnik V vaccine,"The vaccines will be delivered to Hyderabad-based Dr Reddy’s Laboratories, which has joined hands with Russian Direct Investment Fund to produce the vaccine in India. The Drugs Controller General of India on April 13 had granted permission to Sputnik V vaccine for restricted use in emergency situati…",neutral,neutral,-0.1915690370527213,neutral,-2.5906735751295336,negative
2021-05-04 07:47:00,5211.0,5222.9,5054.35,5076.0,792803.0,Consolidation continues on D St; Sensex falls 465 pts; Nifty PSU Bank up 3%,"Nearly 35 of the 50 constituents on the index ended the day in the red including Tata Consumer Products (down 4.3 per cent), Cipla, Reliance Industries, Dr Reddy’s Labs, and Hindalco Industries",positive,neutral,-2.5906735751295336,negative,1.1545988258317026,positive
2021-05-09 10:22:00,5380.0,5389.95,5272.0,5334.0,2223453.0,"Q4 earnings, vaccination among key factors that may guide market this week","Among Nifty stocks, Asian Paints, Lupin, UPL, Vedanta, Cipla, Dr Reddy’s Laboratories, and Larsen & Toubro will announce numbers this week.",neutral,neutral,-0.8550185873605948,neutral,-0.6328638497652548,neutral
2021-05-09 14:26:03,5380.0,5389.95,5272.0,5334.0,2223453.0,"‘DRDO’s anti-COVID drug is safe, will help patients recover faster’","2-DG has been developed by INMAS, a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy’s Laboratories (DRL), Hyderabad",positive,neutral,-0.8550185873605948,neutral,-0.6328638497652548,neutral
2021-05-09 19:55:00,5380.0,5389.95,5272.0,5334.0,2223453.0,"Dr Reddy’s Lab will come out with the pricing and roll-out of anti-covid drug 2-DG in a few days: Dr Sudhir Chandna, DRDO","The Institute of Nuclear Medicine and Allied Sciences, a DRDO lab, worked in partnership with Dr Reddy’s Laboratories to develop the drug, with the clinical trials showing it to be effective in controlling the pandemic, officials said.",neutral,positive,-0.8550185873605948,neutral,-0.6328638497652548,neutral
2021-05-10 11:26:26,5380.0,5389.95,5272.0,5334.0,2223453.0,"D-Street Buzz: Pharma Stocks Rise Led By Dr Reddy’s Labs, Cadila Health; Glenmark Hits New 52-week High","Torrent Pharma and Alkem Labs jumped over 5 percent each followed by Dr Reddy’s Labs, Cadila Healthcare, Divis Labs and Sun Pharma which added 2-3 percent each.",neutral,positive,-0.8550185873605948,neutral,-0.6328638497652548,neutral
2021-05-10 12:02:00,5325.0,5349.95,5271.3,5291.3,941603.0,Dr Reddy’s Labs share rises over 4% post DCGI nod to anti-Covid drug,"Dr Reddy’s Laboratories stock touched an intraday high of Rs 5,422, rising 4.8% on BSE",positive,positive,-0.6328638497652548,neutral,-0.2444528018051899,neutral
2021-05-10 15:01:00,5325.0,5349.95,5271.3,5291.3,941603.0,All you need to know about DRDO’s new anti-COVID-19 drug 2-DG,The anti-Covid oral drug has been developed by the Defence Research and Development Organisation’s (DRDO’s) leading laboratory- Institute of Nuclear Medicine and Allied Sciences (INMAS) in collaboration with Dr Reddy’s Laboratories,neutral,positive,-0.6328638497652548,neutral,-0.2444528018051899,neutral
2021-05-11 23:53:08,5318.0,5340.0,5275.0,5305.0,877512.0,Dr Reddy’s Inks Licensing Pact with Eli Lilly for Covid-19 Treatment Drug,Dr Reddy's Laboratories on Tuesday said it has inked a licensing pact with Eli Lilly and Company to produce Baricitinib in the country for treatment of Covid-19.,neutral,positive,-0.2444528018051899,neutral,-2.539078963388939,negative
2021-05-12 08:44:03,5318.0,5340.0,5275.0,5305.0,877512.0,"2-deoxy-D-glucose: DRDO’s anti-COVID-19 drug is safe, will help patients recover faster, says INMAS scientist","Anti-COVID-19 drug 2-deoxy-D-glucose (2-DG) has been developed by INMAS, a lab of Defence Research and Development Organisation (DRDO), in collaboration with Dr Reddy`s Laboratories (DRL), Hyderabad.",positive,neutral,-0.2444528018051899,neutral,-2.539078963388939,negative
2021-05-12 09:17:00,5318.0,5340.0,5275.0,5305.0,877512.0,"Stocks in the news: Asian Paints, Dr Reddy’s Labs, GCPL, Lupin and UPL","Happiest Minds, Apollo Tyres, Birla Corp, Prince Pipes and Fittings, Sonata Softwares, Orient Electric, Borosil Renewables and Saregama India are among companies that will announce their March quarter results today.",neutral,neutral,-0.2444528018051899,neutral,-2.539078963388939,negative
2021-05-12 10:23:50,5318.0,5340.0,5275.0,5305.0,877512.0,Dr Reddy’s Laboratories launch antibiotic medication in US market,"Dr Reddy’s Laboratories on Wednesday said it has launched Ertapenem for Injection, an antibiotic medication, in the US market.The newly launched drug is a therapeutic equivalent generic version of Invanz (ertapenem for injection) for injection, 1 g/vial. It is used for the treatment of inf…",neutral,neutral,-0.2444528018051899,neutral,-2.539078963388939,negative
2021-05-13 19:18:13,5338.55,5398.4,5160.0,5203.0,2972026.0,Govt expects 2.16 billion doses of covid-19 vaccine in August-December,"Russian vaccine Sputnik V will be made available by the local partner Dr Reddy’s Laboratories following the supply of 150,000 doses on 1 May",neutral,neutral,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 05:30:00,5338.55,5398.4,5160.0,5203.0,2972026.0,BRIEF-Dr.Reddy’s Laboratories - Announces Launch Of Sputnik V Vaccine In Indian Market,BRIEF-Dr.Reddy’s Laboratories - Announces Launch Of Sputnik V Vaccine In Indian Market,neutral,neutral,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 05:30:00,5338.55,5398.4,5160.0,5203.0,2972026.0,BRIEF-India’s Dr.Reddy’s Laboratories March-Quarter Consol Net Profit Falls,BRIEF-India’s Dr.Reddy’s Laboratories March-Quarter Consol Net Profit Falls,neutral,neutral,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 08:09:00,5338.55,5398.4,5160.0,5203.0,2972026.0,"Market Ahead Podcast, May 14: Top factors that could guide markets today","A total of 41 companies, including Larsen & Toubro, Dr Reddy’s Laboratories, Cipla, Aditya Birla Capital, Macrotech Developers and Welspun India are scheduled to release their quarterly results today",neutral,neutral,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 08:23:43,5338.55,5398.4,5160.0,5203.0,2972026.0,"Buzzing Stocks: L&T, Dr Reddy’s Labs, JSPL And Others That Will Be In Focus Today",Check out the companies making the biggest headlines before the bell.,neutral,neutral,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 11:38:54,5338.55,5398.4,5160.0,5203.0,2972026.0,"Dr Reddy’s Labs To Announce Q4 Numbers Today, Here’s What Brokerages Expect",The company is expected to report double-digit growth in revenue on the back of the Wockhardt acquisition and good business in India and Europe but a drop in the US sales may dent profitability.,neutral,positive,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 12:34:57,5338.55,5398.4,5160.0,5203.0,2972026.0,Dr Reddy’s Labs Share Price Gains As Sputnik V Vaccine Is Launched In India,"One dose of the imported vaccine is priced at Rs 995.4 and the price may come down when local supply begins, the company has said.",neutral,negative,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 12:56:00,5338.55,5398.4,5160.0,5203.0,2972026.0,"Dr Reddy’s administers first dose of Sputnik V vaccine, imported doses at Rs 995/jab","The imported doses of the vaccine are presently priced at a maximum retail price of Rs 948, with 5 per cent GST per dose, with the possibility of a lower price point when local supply begins, Dr Reddy’s Laboratories added.",neutral,neutral,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 12:57:59,5338.55,5398.4,5160.0,5203.0,2972026.0,Dr Reddy Administers First Dose of Sputnik V Vaccine in India,"Drug firm Dr Reddy’s Laboratories on Friday said as part of a limited pilot, the soft launch of the Covid vaccine Sputnik V has commenced and the first dose of the vaccine was administered in Hyderabad.",neutral,neutral,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 12:58:00,5338.55,5398.4,5160.0,5203.0,2972026.0,Dr Reddy’s Laboratories consolidated net profit declines 28.65% in the March 2021 quarter,Sales rise 6.69% to Rs 4728.40 crore,negative,positive,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 13:02:58,5338.55,5398.4,5160.0,5203.0,2972026.0,"Dr Reddy’s Labs Q4 Profit Falls 27.6% On Muted US Business, Misses Estimates","In the financial year FY21, consolidated profit dropped 1.8 percent to Rs 1,914.9 crore and revenue grew by 8.7 percent to Rs 18,972.2 crore compared to the previous year.",neutral,negative,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 13:15:00,5338.55,5398.4,5160.0,5203.0,2972026.0,Dr Reddys Lab Q4 PAT skids 28% to Rs 554 cr,"On a consolidated basis, Dr Reddy’s Laboratories’ net profit dropped 28% to Rs 553.50 crore on 7% increase in revenues to Rs 4,728.40 crore in Q4 March 2021 over Q4 March 2020.",neutral,negative,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 13:16:00,5338.55,5398.4,5160.0,5203.0,2972026.0,Dr Reddy’s administers 1st dose of Sputnik V in Hyderabad; Russian vaccine to cost at Rs 995 per jab,Indian generic drug giant Dr Reddy’s Laboratories on Friday announced the soft launch of the Russian vaccine for Covid-19 Sputnik V in the Indian market. The Hyderabad headquartered pharmaceutical company has also announced that the first dose of the vaccine was administered in Hyderabad. Dr Reddy’s…,neutral,neutral,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 13:19:30,5338.55,5398.4,5160.0,5203.0,2972026.0,"Russian COVID-19 vaccine Sputnik V to cost Rs 995.40 per dose, reveals Dr Reddy’s Laboratories","Dr Reddy’s Laboratories on Friday (May 14, 2021) announced that Russian COVID-19 vaccine Sputnik V will cost ₹995.40 + 5% GST per dose in India and the price of vaccines produced in the country may be lower.",neutral,neutral,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 13:44:08,5338.55,5398.4,5160.0,5203.0,2972026.0,First dose of Sputnik V COVID-19 vaccine administered in Hyderabad; jabs set to cost Rs 948 plus 5% GST,"Dr Reddy’s Laboratories on Thursday announced that the first consignment of imported doses of the Sputnik V vaccine that landed in India on May 1 received regulatory clearance from the Central Drugs Laboratory, Kasauli, on May 13. As part of a limited pilot, the soft launch of the vaccine …",neutral,neutral,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 13:47:25,5338.55,5398.4,5160.0,5203.0,2972026.0,"Dr Reddy’s prices Sputnik V at ₹995 per dose, limited launch starts","Dr Reddy’s Laboratories has also commenced the soft launch of the Russian vaccine in India using the 150,000 shots it had procured on 1 May.The vaccine may be available at a lower price point when local supply begins, the pharmaceutical company said",neutral,neutral,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 13:50:58,5338.55,5398.4,5160.0,5203.0,2972026.0,Sputnik V: Twitterati upset with 5% GST levied on the vaccine; call it ‘loot’,"Dr Reddy’s Laboratories on Friday announced that the first consignment of imported doses of the Sputnik V vaccine that landed in India on May 1 received regulatory clearance from the Central Drugs Laboratory, Kasauli, on May 13.As part of a limited pilot, the soft launch of the vaccine has…",neutral,positive,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 14:13:24,5338.55,5398.4,5160.0,5203.0,2972026.0,Results: Dr Reddy’s profit declines 29% to Rs 557 crore in Q4,"Dr Reddy’s Laboratories reported 29 percent year-on-year decline in net profit to Rs 557 crore for the fourth quarter ended in March 30, 2021. The Hyderabad-based drug major had posted a net profit of Rs 781 crore in January-March period of 2019-20.For 2020-21 fiscal year, the compa…",negative,negative,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 14:49:39,5338.55,5398.4,5160.0,5203.0,2972026.0,Dr Reddy’s Q4 net down 28% at ₹554 cr,"Pharma major Dr Reddy’s Laboratories Ltd net profit decreased 28 per cent at ₹554 crore in the fourth quarter ended March 31, 2021 as against ₹764 crore in the corresponding quarter of the previous",negative,negative,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 18:51:00,5338.55,5398.4,5160.0,5203.0,2972026.0,Single dose vaccine in India soon? RDIF plans to bring Sputnik V Light,The double-dose Sputnik V was launched in the Indian market by Dr Reddy’s Laboratories on Friday. The vaccine is priced at Rs 995 per dose,positive,neutral,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 19:58:00,5338.55,5398.4,5160.0,5203.0,2972026.0,"Dr Reddy’s Q4 Results: Profit dips 28% to Rs 554 cr, misses estimates","Dr Reddy’s Laboratories on Friday reported a 28 per cent year-on-year decline in consolidated net profit to Rs 554 crore for the quarter ended March, sharply below analysts’ expectations. The drugmaker reported 7 per cent year-on-year growth in consolidated revenues to Rs 4,728 crore for the fourth …",negative,negative,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 23:03:00,5338.55,5398.4,5160.0,5203.0,2972026.0,Dr Reddy’s Laboratories consolidated net profit dips 29% to Rs 557 crore,"Dr Reddy’s Laboratories on Friday reported 29 per cent decline in consolidated net profit at Rs 557 crore for the fourth quarter ended March 31, 2021.",negative,negative,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-14 23:20:31,5338.55,5398.4,5160.0,5203.0,2972026.0,Russians are here: First dose of Sputnik administered in Hyderabad; presently priced at Rs 948,"The more the merrier. Drug firm Dr Reddy’s Laboratories on Friday said it has launched COVID vaccine Sputnik V in the Indian market with the first dose being administered in Hyderabad, as part of a pilot project. Other than the Pfizer and Moderna vaccines, Sputnik V is the only shot to show an ef…",neutral,neutral,-2.539078963388939,negative,-0.0257142857142926,neutral
2021-05-16 15:07:00,5250.0,5260.0,5145.0,5248.65,1363112.0,Second batch of Russia’s COVID-19 vaccine Sputnik V reaches Hyderabad,"Dr Reddy’s Laboratories on May 14 soft-launched imported COVID-19 vaccine Sputnik V vaccine which is priced at Rs948, with five per cent GST per dose (retail price).",neutral,neutral,-0.0257142857142926,neutral,-1.3468172581636029,negative
2021-05-17 00:51:14,5250.0,5260.0,5145.0,5248.65,1363112.0,"Second batch of 60,000 Sputnik V vaccine reaches Hyderabad","As many as 60,000 doses of the second batch of Russia’s Covid-19 vaccine Sputnik V on Sunday landed at Rajiv Gandhi International Airport here, Dr Reddy’s Laboratories said on Sunday.",neutral,neutral,-0.0257142857142926,neutral,-1.3468172581636029,negative
2021-05-17 10:32:50,5250.0,5260.0,5145.0,5248.65,1363112.0,Shilpa Medicare ties up with Dr Reddy’s to manufacture Sputnik V vaccine; share price up,"Drug firm Shilpa Medicare on Monday said its arm has entered into a definitive agreement with Dr Reddy’s Laboratories for manufacturing of Russian COVID-19 vaccine Sputnik V.“The company, via its wholly owned subsidiary Shilpa Biologicals Pvt Ltd (SBPL), has entered into a three-year defin…",positive,positive,-0.0257142857142926,neutral,-1.3468172581636029,negative
2021-05-17 10:33:17,5250.0,5260.0,5145.0,5248.65,1363112.0,"What Should Investors Do With Dr Reddy’s Labs Post Q4 Result: Buy, Sell Or Hold?","Consolidated revenue from operations grew by 6.7 percent year-on-year to Rs 4,728 crore in Q4FY21, supported by India and Europe businesses.",neutral,positive,-0.0257142857142926,neutral,-1.3468172581636029,negative
2021-05-17 10:41:00,5250.0,5260.0,5145.0,5248.65,1363112.0,Shilpa Medicare arm inks pact with Dr Reddy’s to manufacture Sputnik V vaccine,"“The company, via its wholly owned subsidiary Shilpa Biologicals Pvt Ltd (SBPL), has entered into a three year definitive agreement with Dr Reddy’s Laboratories for production-supply of the Sputnik V vaccine from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka,” Shilpa Me…",positive,positive,-0.0257142857142926,neutral,-1.3468172581636029,negative
2021-05-17 11:18:00,5250.0,5260.0,5145.0,5248.65,1363112.0,Shilpa Medicare arm inks pact with Dr Reddy’s to manufacture Sputnik V vax,Drug firm Shilpa Medicare on Monday said its arm has entered into a definitive agreement with Dr Reddy’s Laboratories for manufacturing of Russian Covid-19 vaccine Sputnik V,positive,positive,-0.0257142857142926,neutral,-1.3468172581636029,negative
2021-05-17 11:53:39,5250.0,5260.0,5145.0,5248.65,1363112.0,"Dr Reddy’s Q4 a mixed bag; Covid portfolio, Sputnik to drive forward prospects",Dr Reddy’s Laboratories Ltd’s (DRL) Q4 revenue growth remained soft with growth in various geographies being a mixed bag.On the positive side domestic sales grew 23 % y-o-y,positive,negative,-0.0257142857142926,neutral,-1.3468172581636029,negative
2021-05-17 12:57:00,5290.25,5304.9,5210.0,5219.0,907778.0,"DRDO’s anti-covid drug 2-DG launched; checkout efficacy, price, dosage",Anti-Covid oral drug has been developed by DRDO’s leading laboratory -- Institute of Nuclear Medicine and Allied Sciences in collaboration with Dr Reddy’s Laboratories,neutral,positive,-1.3468172581636029,negative,0.210124164278892,neutral
2021-05-17 16:16:00,5290.25,5304.9,5210.0,5219.0,907778.0,Shilpa Medicare jumps 12% after inking vaccine deal with DRL,"The company has entered into a three-year agreement with Dr Reddy’s Laboratories Limited (DRL) for the production of Sputnik V vaccine for coronavirus from its integrated biologics R&D cum manufacturing center at Dharwad, Karnataka.",positive,positive,-1.3468172581636029,negative,0.210124164278892,neutral
2021-05-17 16:21:00,5290.25,5304.9,5210.0,5219.0,907778.0,"COVID-19: Dr Reddy’s, Apollo Hospitals to start vaccination with Sputnik V",Dr Reddy’s Laboratories CEO - Branded Markets (India & Emerging Markets) MV Ramana said the two entities are working to scale up the pilot and take the vaccine to other cities.,neutral,neutral,-1.3468172581636029,negative,0.210124164278892,neutral
2021-05-17 16:57:10,5290.25,5304.9,5210.0,5219.0,907778.0,Apollo Hospitals begins pilot to administer SputnikV vaccines with Dr Reddy’s Labs,Domestic manufacturers of SputnikV to seek regulator nod,neutral,neutral,-1.3468172581636029,negative,0.210124164278892,neutral
2021-05-17 17:09:23,5290.25,5304.9,5210.0,5219.0,907778.0,"Apollo Hospitals, Dr Reddy’s Announce Covid-19 Vaccination Programme with Sputnik V",Apollo Hospitals and Dr Reddy’s Laboratories on Monday said they are collaborating to initiate a COVID-19 vaccination programme in the country with Sputnik V.,neutral,positive,-1.3468172581636029,negative,0.210124164278892,neutral
2021-05-17 17:29:00,5290.25,5304.9,5210.0,5219.0,907778.0,DRDO releases anti-Covid drug; reduces oxygen dependency in patients,"The oral drug, 2-deoxy-D-glucose (2-DG), will be produced by Dr Reddy’s Laboratories and is likely to reach hospitals in first week of June",positive,neutral,-1.3468172581636029,negative,0.210124164278892,neutral
2021-05-18 01:21:23,5290.25,5304.9,5210.0,5219.0,907778.0,Dr Reddy’s Laboratories rating – Add: A stable showing by the company,"Covid vaccine to provide significant upside to earnings; TP up to Rs 5,848; ‘Add’ retained",positive,positive,-1.3468172581636029,negative,0.210124164278892,neutral
2021-05-18 01:33:00,5290.25,5304.9,5210.0,5219.0,907778.0,"Apollo Hospitals, Dr Reddy’s announce vaccination drive with Sputnik V",Apollo Hospitals and Dr Reddy’s Laboratories on Monday said they are collaborating to initiate a COVID-19 vaccination programme in the country with Sputnik V.,neutral,positive,-1.3468172581636029,negative,0.210124164278892,neutral
2021-05-18 01:41:53,5290.25,5304.9,5210.0,5219.0,907778.0,Battling Coronavirus: Local anti-Covid drug 2-DG to hit markets in June,"The drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a laboratory under the Defence Research and Development Organisation (DRDO), in collaboration with pharma major Dr Reddy’s Laboratories (DRL).",neutral,neutral,-1.3468172581636029,negative,0.210124164278892,neutral
2021-05-18 09:20:06,5290.25,5304.9,5210.0,5219.0,907778.0,Coronavirus live updates | Villagers in tribal-dominated Dungarpur succeed in containing virus infection,"The first batch of the adjunct COVID therapy drug, 2-deoxy-D-glucose (2-DG) — developed by the Defence Research and Development Organisation (DRDO) along with Dr Reddy’s Laboratories (DRL), Hyderabad — was on May 17, 2021 released for emergency use.",neutral,neutral,-1.3468172581636029,negative,0.210124164278892,neutral
2021-05-18 18:02:14,5235.0,5264.0,5206.05,5246.0,917001.0,"DRDO’s Covid drug 2-DG expected to be in the market in June, says DRL","As has been reported earlier this anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been jointly developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), Defence Research and Development Organisation (DRDO), and Dr Reddy’s Laboratories (DRL), Hyderabad.",neutral,neutral,0.210124164278892,neutral,-0.1712654614652711,neutral
2021-05-19 21:27:30,5255.0,5286.0,5225.0,5246.0,773467.0,Dr Reddy’s shares important information on DRDO’s 2-DG Covid drug. Details here,"The 2-DG drug has been developed jointly by the Institute of Nuclear Medicine and Allied Sciences, a lab of the DRDO, in collaboration with Dr Reddy’s Laboratories, Hyderabad",neutral,positive,-0.1712654614652711,neutral,-0.6326103500761034,neutral
2021-05-19 22:08:02,5255.0,5286.0,5225.0,5246.0,773467.0,"Anti-Covid Oral Drug 2DG’s Price Yet to be Decided, Supply Likely to Begin by Mid-June: Dr Reddy’s","Dr Reddy’s Laboratories that has collaborated with INMAS, a lab of the Defence Research and Development Organisation (DRDO), to develop the anti-COVID drug 2-deoxy-D-glucose (2DG) shared a few key information about the same on Wednesday.",neutral,neutral,-0.1712654614652711,neutral,-0.6326103500761034,neutral
2021-05-20 23:22:00,5256.0,5269.5,5196.3,5222.75,710510.0,Prices of Sputnik V COVID-19 vaccine may drop after local manufacturing begins: Dr Reddy’s,"The pricing of the Sputnik V COVID-19 vaccine, currently capped at Rs 995 per dose, is expected to come down once local manufacturing of the vaccine begins, according to a company spokesperson from Dr Reddy’s Laboratories.",negative,negative,-0.6326103500761034,neutral,0.7324293353705188,neutral
2021-05-21 20:26:00,5256.0,5269.5,5196.3,5222.75,710510.0,Government mulling roping in 3-4 more firms to ramp up DRDO COVID-19 drug production,"2-DG has been developed by DRDO’s Institute of Nuclear Medicine and Allied Sciences (INMAS), in collaboration with Dr Reddy’s Laboratories, Hyderabad. Clinical trial results have shown that this molecule helps in the faster recovery of hospitalized patients and reduces supplemental oxygen dependence…",positive,positive,-0.6326103500761034,neutral,0.7324293353705188,neutral
2021-05-23 11:21:00,5236.0,5299.0,5226.7,5274.35,704911.0,"Dr Reddy’s developing new treatment options for COVID-19, says MD","“We are motivated to serve patients in every possible way and with utmost urgency. This is reflected in the multiple collaborations we have entered to develop and commercialise a wide range of preventive and curative options for COVID treatment,” Dr Reddy’s Laboratories Co-Chairman & Managing Direct…",neutral,neutral,0.7324293353705188,neutral,0.5217983136083557,neutral
2021-05-23 11:21:00,5236.0,5299.0,5226.7,5274.35,704911.0,Dr Reddy’s developing new Covid treatment options: MD,"“We are motivated to serve patients in every possible way and with utmost urgency. This is reflected in the multiple collaborations we have entered to develop and commercialise a wide range of preventive and curative options for COVID treatment,” Dr Reddy’s Laboratories Co-Chairman & Managing Direct…",neutral,neutral,0.7324293353705188,neutral,0.5217983136083557,neutral
2021-05-23 12:03:00,5236.0,5299.0,5226.7,5274.35,704911.0,"Dr Reddy’s developing new treatment options for Covid-19, says MD",Drug major Dr Reddy’s Laboratories is working on the development of new treatment options for Covid-19 patients which it aims to launch over the next few months,neutral,positive,0.7324293353705188,neutral,0.5217983136083557,neutral
2021-05-24 08:58:00,5236.0,5299.0,5226.7,5274.35,704911.0,"Stocks in the news: Grasim, SBI, JSW Steel, Dr Reddy’s Labs, India Cements and Natco Pharma","The country’s largest lender reported an 80.15 per cent jump in its standalone profit after tax (PAT) of Rs 6,451 crore in the three months to March 2021.",neutral,positive,0.7324293353705188,neutral,0.5217983136083557,neutral
2021-05-24 12:17:24,5289.4,5320.0,5255.0,5317.0,694098.0,"Dr Reddy’s lines up Rs 1,000 cr capex for current fiscal; positive about sustaining growth levels","Drug major Dr Reddy’s Laboratories has earmarked a Capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal and beyond, as per a top company official.The Hyderabad based firm invested about Rs 1,000 crore in the 2…",positive,positive,0.5217983136083557,neutral,-0.6578947368421052,neutral
2021-05-24 12:53:00,5289.4,5320.0,5255.0,5317.0,694098.0,"Dr Reddy’s lines up Rs 1,000 cr capex for current fiscal on growth outlook","Dr Reddy’s Laboratories has earmarked a Capex of around Rs 1,000 crore for the current fiscal as it remains positive about sustaining its growth trends in the current fiscal, top company official said",neutral,positive,0.5217983136083557,neutral,-0.6578947368421052,neutral
2021-05-24 13:48:00,5289.4,5320.0,5255.0,5317.0,694098.0,"Dr Reddy’s earmarks capex worth Rs 1,000 cr for 2021-22 on growth outlook","The Capex will be around the same numbers as the 2020-21 fiscal, maybe a bit higher if everything goes through, Dr Reddy’s Laboratories CEO Erez Israeli said",neutral,neutral,0.5217983136083557,neutral,-0.6578947368421052,neutral
2021-05-26 19:50:34,5278.75,5283.9,5230.15,5277.0,777110.0,"DRDO’s anti-Covid drug 2-DG: 2nd batch of 10,000 packets to be released tomorrow","The anti-COVID therapeutic application of the drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a leading laboratory of the DRDO, in collaboration with Dr Reddy″s Laboratories (DRL) in Hyderabad",neutral,positive,-0.0331517878285579,neutral,-1.496212121212121,negative
2021-05-28 09:03:00,5280.0,5280.0,5150.0,5201.0,873914.0,"If approved, Sputnik Light could become first single-dose vaccine to be launched in India",The two-dose Sputnik V had received the Indian drug regulator’s permission for restricted emergency use with certain conditions on April 12. Dr Reddy’s Laboratories is importing the vaccine for use in India.,positive,neutral,-1.496212121212121,negative,1.5784933870040323,positive
2021-05-28 21:05:56,5280.0,5280.0,5150.0,5201.0,873914.0,No Tie-ups with Residential Associations for Supply of Sputnik V Vaccine: Dr Reddy’s Clarifies,"Dr Reddy's Laboratories has not authorised any third party to supply the Sputnik V Covid-19 vaccine on its behalf in India and has initiated legal action against unscrupulous elements committing fraud in the name of the Russian vaccine, a statement said.",neutral,negative,-1.496212121212121,negative,1.5784933870040323,positive
2021-06-01 14:45:00,5306.25,5354.0,5283.0,5310.95,544308.0,Consignment of 3 million doses of Sputnik V vaccine from Russia land in Hyderabad,"Dr Reddy’s Laboratories is in a pact with Russian Direct Investment Fund to sell the first 125 million people doses (250 million vials) of Sputnik V in India. Dr Reddys which had earlier received over two lakh vaccines from RDIF, recently soft-launched Sputnik V and tied up with Apollo Hospitals for…",neutral,positive,0.0885747938751438,neutral,-0.5649717514124294,neutral
2021-06-01 14:58:02,5306.25,5354.0,5283.0,5310.95,544308.0,Sputnik V vaccine: Consignment of 30 lakh doses from Russia land in Hyderabad,"The Sputnik V vaccine requires specialised handling and storage, required to be kept at a temperature of -20 C.Dr Reddy’s Laboratories is in a pact with Russian Direct Investment Fund to sell the first 125 million people doses (250 million vials) of Sputnik V in India",neutral,neutral,0.0885747938751438,neutral,-0.5649717514124294,neutral
2021-06-03 11:01:33,5310.0,5340.0,5267.0,5280.0,565120.0,Sputnik V: Snowman Logistics in pact with Dr Reddy’s Laboratories,It can store up to 650 million doses and ramp-up to 1.05 billion doses at short notice.,neutral,neutral,-0.5649717514124294,neutral,-0.5754796452470974,neutral
2021-06-04 20:43:00,5282.55,5290.0,5242.0,5252.15,400684.0,Serum Institute gets DCGI’s nod to manufacture Covid jab Sputnik V in India,Russia’s Sputnik V vaccine is currently being manufactured by Dr Reddy’s Laboratories in India.,neutral,neutral,-0.5754796452470974,neutral,-0.80212887283786,neutral
2021-06-06 12:14:23,5261.0,5273.75,5212.7,5218.8,362586.0,Manipal Hospitals collaborates with Dr Reddy’s for Sputnik V vaccine,Manipal Hospitals said it has collaborated with Dr Reddy’s Laboratories to add the Sputnik V Covid-19 vaccine in its existing vaccine portfolio that consists of Covishield and Covaxin,positive,positive,-0.80212887283786,neutral,1.3477011494252944,positive
2021-06-06 12:44:39,5261.0,5273.75,5212.7,5218.8,362586.0,Manipal Hospitals Collaborates with Dr Reddy’s to Include Sputnik V in Its Vaccine Portfolio,Leading hospital chain Manipal Hospitals on Sunday said it has collaborated with Dr Reddy's Laboratories to add the Sputnik V COVID-19 vaccine in its existing vaccine portfolio that consists of Covishield and Covaxin.,neutral,positive,-0.80212887283786,neutral,1.3477011494252944,positive
2021-06-09 22:43:43,5232.5,5300.0,5232.5,5298.15,366682.0,Hyderabad-based firm signs agreement for production of 2-DG Covid drug,"Lee Pharma entered into the non-exclusive licensing agreement for the synthesis of 2-DG, recently developed by DRDO and Dr Reddy’s Laboratories.Lee Pharma will manufacture and commercialise the 2-DG sachets from their formulation facility located in Visakhapatnam",positive,positive,1.2546583850931607,positive,3.018867924528302,positive
2021-06-13 16:54:27,5453.0,5515.0,5370.0,5460.7,894914.0,"Russian made Sputnik V to be available at Delhi’s hospital from next week, check details",The first phase of the Sputnik V rollout by Apollo Hospitals and Dr Reddy`s Laboratories had started on a pilot basis on May 17 in Hyderabad and on May 18 in Vishakhapatnam.,neutral,neutral,0.1412066752246436,neutral,-1.187214611872146,negative
2021-06-13 17:55:00,5453.0,5515.0,5370.0,5460.7,894914.0,Russia’s Sputnik V likely to be available at Delhi’s Indraprastha Apollo Hospital from next week,"​​The first phase of the Sputnik V rollout by Apollo Hospitals and Dr Reddy’s Laboratories had started on a pilot basis on May 17 in Hyderabad and on May 18 in Vishakhapatnam. Besides Apollo Hospitals, the vaccine is also available in Hyderabad at Continental Hospitals.",neutral,neutral,0.1412066752246436,neutral,-1.187214611872146,negative
2021-06-13 19:36:00,5453.0,5515.0,5370.0,5460.7,894914.0,Sputnik V likely to be available at Delhi’s Apollo Hospital from June 15,The first phase of the Sputnik V rollout by Apollo Hospitals and Dr Reddy’s Laboratories had started on a pilot basis on May 17 in Hyderabad and on May 18 in Vishakhapatnam.,neutral,neutral,0.1412066752246436,neutral,-1.187214611872146,negative
2021-06-15 18:01:00,5410.0,5458.0,5340.3,5393.9,696122.0,"CSIR-IICT, Bengaluru pharma firm join hands to make Covid drug 2-DG","This drug, in the form of powder formulation, was earlier launched by Dr Reddy’s Laboratories in India",neutral,neutral,-0.2975970425138699,neutral,-2.099480216792142,negative
2021-06-16 08:56:00,5410.0,5458.0,5340.3,5393.9,696122.0,"Stocks to watch: ICICI Bank, Dish TV, Adani Ports, Jubilant Pharmova, Lupin",Dr Reddy’s Laboratories (DRL) on Tuesday said it has been asked to pay $46.25 million to Australia-based Hatchtech Pty Ltd as part of an asset purchase agreement between the two parties in 2015,neutral,neutral,-0.2975970425138699,neutral,-2.099480216792142,negative
2021-06-16 20:43:04,5406.1,5414.0,5248.55,5292.6,705411.0,DRDO’s 2DG found effective against all variants of COVID-19: Study,"Besides vaccines, the 2DG drug developed by the Defence Research and Development Organisation (DRDO) and Dr Reddy’s Laboratories, received approval for emergency use in moderate to severe cases of Covid-19 in May. A new study has claimed the anti-covid drug is effective against all variants of th…",positive,positive,-2.099480216792142,negative,-0.4581373471307688,neutral
2021-06-16 21:36:00,5406.1,5414.0,5248.55,5292.6,705411.0,"Sputnik V pilot in final leg; scaled up to other cities, says Dr Reddy’s",Dr Reddy’s Laboratories is in a pact with Russian Direct Investment Fund to sell the first 125 million people doses (250 million vials) of Sputnik V in India.,positive,positive,-2.099480216792142,negative,-0.4581373471307688,neutral
2021-06-18 10:01:00,5315.0,5345.0,5234.8,5290.65,695852.0,Fortis to offer Sputnik V vaccine,"The vaccine stock has been procured directly from Dr Reddy’s Laboratories according to government guidelines, the private hospital chain said.",neutral,neutral,-0.4581373471307688,neutral,0.4511848341232262,neutral
2021-06-22 10:11:01,5285.5,5320.0,5250.5,5308.55,425101.0,"Mirae Asset, With Rs 70,000 Cr In AUM, Raises Stake In Banks: ICICI, HDFC Bank Among Top 10 Holdings","In a period of pandemic-driven volatility, the AMC’s top stock holdings include companies like HDFC Bank, ICICI Bank, Infosys, RIL, Axis Bank, TCS, Maruti Suzuki, and Dr Reddy’s Laboratories; firm eyes under-penetrated sectors",neutral,neutral,0.4360987607605748,neutral,-0.6388575723412251,neutral
2021-06-22 10:11:01,5285.5,5320.0,5250.5,5308.55,425101.0,"Mirae Asset, With Rs 700 Billion In AUM, Raises Stake In Banks: ICICI, HDFC Bank Among Top 10 Holdings","In a period of pandemic-driven volatility, the AMC’s top stock holdings include companies like HDFC Bank, ICICI Bank, Infosys, RIL, Axis Bank, TCS, Maruti Suzuki, and Dr Reddy’s Laboratories; firm eyes under-penetrated sectors",neutral,neutral,0.4360987607605748,neutral,-0.6388575723412251,neutral
2021-06-22 11:26:00,5285.5,5320.0,5250.5,5308.55,425101.0,Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US,"Icosapent Ethyl Capsules, used to reduce triglyceride levels in adult patients have been launched by Dr. Reddy’s Laboratories in the US market.",neutral,neutral,0.4360987607605748,neutral,-0.6388575723412251,neutral
2021-06-22 14:48:00,5322.0,5349.95,5287.2,5288.0,410324.0,Dr Reddy’s Laboratories launches Icosapent Ethyl Capsules in US Market,Dr. Reddy’s Icosapent Ethyl is available in 1 gram capsules in bottle count size of 120’s count.,neutral,neutral,-0.6388575723412251,neutral,-0.3774297037176826,neutral
2021-06-27 13:27:34,5329.0,5419.95,5312.55,5404.8,592061.0,Roll-out of Sputnik V Covid vaccine delayed further in Delhi NCR hospitals,Indraprastha Apollo in Delhi earlier stated it would start administering the Sputnik V vaccine tentatively by June 25.Madhukar Rainbow Children’s Hospital officials also stated that they have not received Sputnik V doses from the vaccine’s marketing partner for the country Dr Reddy’s Laboratories,negative,neutral,1.4224057046350194,positive,0.6265015708741386,neutral
2021-06-27 17:30:00,5329.0,5419.95,5312.55,5404.8,592061.0,Sputnik V COVID-19 vaccine’s rollout in Delhi-NCR delayed again,"An official of Madhukar Rainbow Children’s Hospital said the facility has not yet received Sputnik V doses so far from Hyderabad-based Dr Reddy’s Laboratories, the marketing partner for the vaccine in the country",negative,neutral,1.4224057046350194,positive,0.6265015708741386,neutral
2021-06-28 07:11:23,5329.0,5419.95,5312.55,5404.8,592061.0,Fortis Memorial Research Institute in Gurugram begins Sputnik V vaccine trial run for general public,The Institute has started the trial run for the general public and has vaccinated over 470 people. The vaccination launch was driven in collaboration with Dr Reddy’s Laboratories.,neutral,positive,1.4224057046350194,positive,0.6265015708741386,neutral
2021-06-28 10:15:09,5329.0,5419.95,5312.55,5404.8,592061.0,Dr Reddy’s Labs Share Price Gains Over Launch Of COVID-19 Treatment Drug,"In the initial weeks, the Company will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India, the company said in an exchange filing.",neutral,positive,1.4224057046350194,positive,0.6265015708741386,neutral
2021-06-28 11:48:01,5329.0,5419.95,5312.55,5404.8,592061.0,Dr Reddy’s Laboratories announces commercial launch of 2-DG used in treatment of COVID-19,"Dr. Reddy’s Laboratories Limited on Monday announced the commercial launch of 2-deoxy-D-glucose (2-DG), an anti-COVID-19 drug.",neutral,positive,1.4224057046350194,positive,0.6265015708741386,neutral
2021-06-28 12:00:09,5411.0,5454.95,5380.0,5444.9,573548.0,Dr Reddy’s Laboratories announces commercial launch of anti-COVID 2-DG drug,"The Hyderabad based pharmaceutical company said that in the initial weeks, it will make the drug available in hospitals across metros and Tier 1 cities, and subsequently expand coverage to the rest of India.",neutral,positive,0.6265015708741386,neutral,-0.5929398786541644,neutral
2021-06-28 12:58:38,5411.0,5454.95,5380.0,5444.9,573548.0,Dr Reddys announces commercial launch of DRDO’s anti-covid drug 2-DG; Here are its price and availability,"The anti-Covid therapeutic application of 2-DG has been jointly developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), Defence Research and Development Organisation (DRDO), and Dr Reddy’s Laboratories.",neutral,positive,0.6265015708741386,neutral,-0.5929398786541644,neutral
2021-06-28 13:33:52,5411.0,5454.95,5380.0,5444.9,573548.0,"Dr Reddy’s Announces Commercial Launch of Anti-Covid Drug 2DG, to Cost Rs 990 Per Sachet","New Delhi: Dr Reddy's Laboratories on Monday announced the commercial launch of COVID-19 treatment drug, 2-deoxy-D-glucose (2-DG), at a maximum retail price of Rs 990 per sachet.",neutral,neutral,0.6265015708741386,neutral,-0.5929398786541644,neutral
2021-06-28 14:53:00,5411.0,5454.95,5380.0,5444.9,573548.0,Dr Reddy’s Laboratories announces commercial launch of Covid-19 drug 2-DG,The maximum retail price (MRP) of each sachet has been fixed at Rs 990,neutral,neutral,0.6265015708741386,neutral,-0.5929398786541644,neutral
2021-06-28 15:28:43,5411.0,5454.95,5380.0,5444.9,573548.0,Dr Reddy’s Labs announces commercial launch of 2-DG,MRP of each sachet fixed at ₹990; subsidised rate offered to government institutions,neutral,neutral,0.6265015708741386,neutral,-0.5929398786541644,neutral
2021-06-29 16:35:49,5439.0,5468.8,5405.0,5406.75,465713.0,Five Indian firms ink licensing deal with MSD for COVID-19 drug molnupiravir: Report,"MSD Pharmaceuticals Pvt Ltd, a wholly-owned subsidiary of Merck Sharp & Dohme (MSD), has signed non-exclusive voluntary licensing agreements with five established Indian generic manufacturers—Sun Pharmaceutical Industries, Cipla, Dr Reddy’s Laboratories, Emcure Pharmaceuticals and Hetero Labs—to …",positive,positive,-0.5929398786541644,neutral,2.69074824917066,positive
2021-06-29 16:50:07,5439.0,5468.8,5405.0,5406.75,465713.0,"Commercial Launch of Sputnik V Vaccine May be Postponed, Says Dr Reddy’s","The commercial launch of Sputnik V, India’s third Covid-19 vaccine after Covishield and Covaxin, may be deferred due to dependency on consignments imported from Russia and quality testing, said Hyderabad-based pharmaceutical company Dr Reddy’s Laboratories on Tuesday.",neutral,negative,-0.5929398786541644,neutral,2.69074824917066,positive
2021-06-29 17:49:00,5439.0,5468.8,5405.0,5406.75,465713.0,Five Indian drugmakers to jointly start trial of Merck & Co’s Covid-19 drug,The drugmakers include Cipla and Dr Reddy’s Laboratories,neutral,neutral,-0.5929398786541644,neutral,2.69074824917066,positive
2021-06-29 21:10:18,5439.0,5468.8,5405.0,5406.75,465713.0,What is Molnupiravir? All you need to know about oral anti-viral drug for treating COVID-19,"MSD Pharmaceuticals Pvt Ltd, a wholly-owned subsidiary of Merck Sharp & Dohme (MSD), has signed non-exclusive voluntary licensing agreements with five established Indian generic manufacturers—Sun Pharmaceutical Industries, Cipla, Dr Reddy’s Laboratories, Emcure Pharmaceuticals and Hetero Labs—to …",neutral,positive,-0.5929398786541644,neutral,2.69074824917066,positive
2021-06-30 08:54:00,5439.0,5468.8,5405.0,5406.75,465713.0,"Buy or Sell: Stock ideas by experts for June 30, 2021",ET Now spoke to various experts and here’s what they have to recommend for today’s trading session. Kunal Bothra has a buy/sell recommendation on Biocon and HDFC while Nooresh Merani has recommended IGL and Dr Reddy’s Labs for today’s trading session. Check out the targets and stoploss.,neutral,neutral,-0.5929398786541644,neutral,2.69074824917066,positive
2021-06-30 11:27:00,5439.0,5468.8,5405.0,5406.75,465713.0,Five drug makers collaborate for clinical trial of Molnupiravir,"Cipla, Dr Reddy’s Laboratories, Emcure Pharmaceuticals, Sun Pharmaceutical Industries & Torrent Pharmaceuticals will collaborate for the clinical trial of investigational oral anti-viral drug Molnupiravir for the treatment of mild COVID-19 in India.",neutral,positive,-0.5929398786541644,neutral,2.69074824917066,positive
2021-06-30 12:28:00,5426.0,5580.0,5412.4,5572.0,830267.0,"Cipla, Dr Reddy’s Labs: Tech charts show up to 11% rally in pharma stocks","After hitting a new all-time high of Rs 997 earlier today, the stock of Cipla is all set to rally towards Rs 1,100",positive,positive,2.69074824917066,positive,-0.3584229390681003,neutral
2021-07-01 07:14:00,5426.0,5580.0,5412.4,5572.0,830267.0,Dr Reddy’s Labs denied approval for final trial of Russian-made Sputnik Light,"“The subject expert committee (SEC), a body under the drug regulator, did not find any “scientific rationale” to conduct phase-3 trials and hence did not consider Dr Reddy’s application seeking to carry out trials in India,” sources say.",positive,neutral,2.69074824917066,positive,-0.3584229390681003,neutral
2021-07-01 11:28:46,5426.0,5580.0,5412.4,5572.0,830267.0,Indian drug regulatory body denies Dr Reddy’s permission for Phase 3 trial of Russian COVID-19 vaccine Sputnik light,"Dr Reddy’s Laboratories has been denied permission for conducting third phase trials in India for Russian COVID-19 vaccine Sputnik light. According to reports, the expert committee under the Indian drug regulatory body did not find any rationale behind conducting a fresh trial because the single …",neutral,neutral,2.69074824917066,positive,-0.3584229390681003,neutral
2021-07-01 16:28:05,5580.0,5600.0,5511.5,5560.0,568312.0,Dr Reddy’s Denied Permission to Conduct Phase 3 Trials of Russia’s Sputnik Light Vaccine,Dr Reddy’s Laboratories has been denied permission to undertake Phase 3 trials of Russia’s COVID-19 vaccine Sputnik Light in India.,neutral,neutral,-0.3584229390681003,neutral,-0.6276675872457946,neutral
2021-07-01 20:11:21,5580.0,5600.0,5511.5,5560.0,568312.0,Sputnik Light vaccine can submit Russian safety data for approval in India,"Earlier, the central government’s Subject Expert Committee (SEC) has denied permission to Dr Reddy’s Laboratories for conducting Phase 3 trials of Russia’s COVID-19 vaccine Sputnik Light in India",positive,neutral,-0.3584229390681003,neutral,-0.6276675872457946,neutral
2021-07-02 17:30:00,5580.0,5600.0,5511.5,5560.0,568312.0,"Stocks in news: Maruti Suzuki, BHEL, Tata Power, Hero MotoCorp and more","Stocks in news: Maruti Suzuki, BHEL, NCC, NMDC, Dr Reddy’s Labs and more",neutral,neutral,-0.3584229390681003,neutral,-0.6276675872457946,neutral
2021-07-04 23:32:25,5576.2,5596.0,5531.95,5541.2,296485.0,Dr Reddy’s expects biz growth to be volatile in current fiscal,"Dr Reddy’s Laboratories expects its business growth to be “volatile” in the current fiscal as the coronavirus pandemic continues to bring in disruptions and impact the markets across the globe. The Hyderabad-based drug major, however, noted that despite various challenges in the market, it…",negative,negative,-0.6276675872457946,neutral,0.0812303693274125,neutral
2021-07-06 21:51:55,5529.0,5614.6,5515.05,5553.9,537154.0,"Dr Reddy’s bullish on OTC products sale via Amazon, others in US","Dr Reddy’s Laboratories which also sells its Over the Counter (OTC) products through Amazon and other e-commerce channels in the US, is planning to double the portfolio on themarketplaceto over 50 products in the foreseeable future.Dr Reddy’s first began selling its OTC Habitrol brand nico…",neutral,positive,0.4503526858383005,neutral,-1.2689530685920611,negative
2021-07-08 17:10:00,5448.0,5520.25,5416.95,5465.95,459228.0,"Mankind Pharma gets DRDO nod to manufacture, market COVID drug 2-DG","2-DG was developed by the Defence Research and Development Establishment (DRDE), Gwalior. The clinical trials were conducted by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO, in association with Dr Reddy’s Laboratories, Mankind Pharma said in a statement.",neutral,neutral,0.3294787077826692,neutral,-0.2109129256895481,neutral
2021-07-12 23:57:27,5494.3,5534.0,5429.0,5440.0,369856.0,"Sputnik V: Commercial rollout of vaccine not put on hold, clarifies Dr Reddy’s","Neither the ongoing soft commercial launch nor work towards its ramp-up in India have been put on hold, Hyderabad-based pharma giant Dr Reddy’s Laboratories said in a statement",neutral,positive,-0.9882969623063936,negative,-0.7945412076290802,neutral
2021-07-13 10:17:33,5494.3,5534.0,5429.0,5440.0,369856.0,"Sputnik V soft launch not put on hold, Dr Reddy’s Laboratories issues statement",Dr Reddy’s Laboratories said that the nationwide soft launch of Sputnik V has reached over 50 cities and towns across the country.,neutral,neutral,-0.9882969623063936,negative,-0.7945412076290802,neutral
2021-07-13 10:33:00,5494.3,5534.0,5429.0,5440.0,369856.0,Sputnik V soft launched in over 50 cities in India: Dr Reddy’s Laboratories,"Dr Reddys Laboratories Ltd, which soft-launched Russia’s Covid-19 vaccine, Sputnik V here on May 14 has expanded the pilot project to over 50 other cities and towns in the country",neutral,positive,-0.9882969623063936,negative,-0.7945412076290802,neutral
2021-07-13 10:54:36,5494.3,5534.0,5429.0,5440.0,369856.0,Sputnik V: Vaccine reaches 50 cities; Dr. Reddy’s announces strengthening commercial rollout,"Dr Reddy’s Laboratories has partnerships with major hospitals and chains across India and all of these have administered the vaccine, including the ongoing commercial roll-outs.",positive,neutral,-0.9882969623063936,negative,-0.7945412076290802,neutral
2021-07-13 17:30:00,5437.1,5458.9,5367.5,5393.9,500677.0,"Stocks in news : Reliance Industries, Future Retail, Bharti Airtel, Dr Reddy’s and more","Stocks in news : Reliance Industries, Future Retail, Bharti Airtel, Dr Reddy’s Laboratories, FDC, NMDC and more",neutral,neutral,-0.7945412076290802,neutral,-0.0924214417744916,neutral
2021-07-15 13:52:53,5393.0,5450.0,5383.85,5405.05,436295.0,These pharma stocks are Centrum Broking’s top picks in the sector,"Its top stock picks in the pharma sector includes names like Dr Reddy’s Labs, Aurobindo Pharma and more",neutral,neutral,0.2234377897274277,neutral,0.5113004816598807,neutral
2021-07-27 11:39:00,5438.0,5444.95,4780.0,4851.85,5871892.0,"Dr Reddy’s Laboratories Q1 Profit Falls 1.5% To Rs 570.8 Crore, Revenue Increases 11.4%","Revenue from operations grew by 11.4 percent year-on-year to Rs 4,919.4 crore in Q1FY22",neutral,positive,-10.778778962853984,negative,-3.079087054281868,negative
2021-07-27 11:58:00,5438.0,5444.95,4780.0,4851.85,5871892.0,Dr Reddy’s Laboratories consolidated net profit declines 36.02% in the June 2021 quarter,Sales rise 11.36% to Rs 4919.40 crore,negative,positive,-10.778778962853984,negative,-3.079087054281868,negative
2021-07-27 11:59:05,5438.0,5444.95,4780.0,4851.85,5871892.0,Dr Reddy’s Laboratories Share Price Cracks Over 11% Post June Quarter Result,"The share touched a 52-week high of Rs 5,613.65 and a 52-week low of Rs 3,963.85 on 07 July, 2021 and 27 July, 2020, respectively.",neutral,negative,-10.778778962853984,negative,-3.079087054281868,negative
2021-07-27 14:27:00,4869.95,4874.85,4666.5,4720.0,3225469.0,D-Street Buzz: Nifty Pharma Falls More Than 4%; Dr Reddy’s Shares Fall 10%,"Shares of Dr Reddy’s Labs fell after the company posted a consolidated profit of Rs 570.8 crore for the quarter ended June 30, 2021, a 1.5 percent drop from the year-ago period",neutral,negative,-3.079087054281868,negative,-1.7052631578947368,negative
2021-07-27 15:05:08,4869.95,4874.85,4666.5,4720.0,3225469.0,"Nifty Pharma index slips 5%, records sharpest intra-day fall in 7 months","Alembic Pharma and Dr Reddy’s Labs plunged 12% and 11%, respectively in intra-day trade post their June quarter results",negative,negative,-3.079087054281868,negative,-1.7052631578947368,negative
2021-07-27 15:08:16,4869.95,4874.85,4666.5,4720.0,3225469.0,"Market LIVE Updates: Sensex sheds 350 pts, Nifty below 15,750; DRL down 10%","Stock Market LIVE Updates: The Sensex was at 52,559.49, down 292.78 points or 0.55%, while the Nifty was at 15,731.80, down 92.65 points or 0.59% at 2:47 pm. Dr Reddy’s Labs was trading lower after its Q1 earnings were below estimates",negative,negative,-3.079087054281868,negative,-1.7052631578947368,negative
2021-07-27 16:04:56,4869.95,4874.85,4666.5,4720.0,3225469.0,"Dr Reddy’s Laboratories Q1 profit falls 1.5%, revenue increases 11.4%","While the overall earnings fell short of expectations by market analysts, Dr. Reddy’s co-chairperson and managing director, GV Prasad, expressed confidence in improving margins in the upcoming quarters on the back of new launches.",negative,negative,-3.079087054281868,negative,-1.7052631578947368,negative
2021-07-27 17:34:22,4869.95,4874.85,4666.5,4720.0,3225469.0,Made in India Sputnik V to Be Available During September-October: Dr Reddy’s,"Dr Reddy’s Laboratories Ltd expects the locally manufactured Russia’s COVID-19 vaccine Sputnik V to be available from September-October period, a senior official of the city-based drug maker said on Tuesday.",neutral,neutral,-3.079087054281868,negative,-1.7052631578947368,negative
2021-07-27 19:37:28,4869.95,4874.85,4666.5,4720.0,3225469.0,Dr Reddy’s Labs Q1 net flat at ₹571 cr,Company in talks with RDIF to ramp up Sputnik V supply in India,neutral,positive,-3.079087054281868,negative,-1.7052631578947368,negative
2021-07-27 21:32:49,4869.95,4874.85,4666.5,4720.0,3225469.0,"Dr Reddy’s Labs: Quarter marked by strong launches, pricing erosion, weak margins and investigations",2.5 lakh doses of Sputnik V administered in India so far,negative,neutral,-3.079087054281868,negative,-1.7052631578947368,negative
2021-07-27 23:51:39,4869.95,4874.85,4666.5,4720.0,3225469.0,Dr Reddy’s profit drops 36% to Rs 380.4 cr in June quarter,"Dr Reddy’s Laboratories on Tuesday reported 36 percent decline in consolidated net profit at Rs 380.4 crore for the quarter ended June 30, 2021, on account of higher expenses.The pharma major had posted a net profit of Rs 594.6 crore in the corresponding period a year ago.Total inco…",negative,negative,-3.079087054281868,negative,-1.7052631578947368,negative
2021-07-28 09:37:16,4869.95,4874.85,4666.5,4720.0,3225469.0,"What Should Investors Do With Dr Reddy’s Labs After Q1 Results: Buy, Sell Or Hold?","Sputnik V supply from Russia has been limited. The company will likely miss the golden period of vaccine supply shortage in India, said Credit Suisse.",neutral,negative,-3.079087054281868,negative,-1.7052631578947368,negative
2021-07-28 17:30:00,4750.0,4765.0,4660.0,4669.0,1082972.0,"Stock Market Updates: Sensex falls 273 points, Nifty at 15,746; DRL slips 10%","Dr Reddy’s Laboratories (DRL) was the top loser in the Sensex pack, shedding over 10 per cent, followed by Axis Bank, Sun Pharma, Kotak Bank and HDFC",neutral,negative,-1.7052631578947368,negative,0.5549626467449306,neutral
2021-07-28 18:50:12,4750.0,4765.0,4660.0,4669.0,1082972.0,"Cashless Doctor’s Visit, Lab Tests, Medicine Deliveries: Check this New Service","SVAAS Wellness Limited, which is a wholly-owned subsidiary of ICICI Lombard General Insurance Company Limited and Dr Reddy’s Laboratories Limited, announced the rolling out of a new partnership programme.",neutral,neutral,-1.7052631578947368,negative,0.5549626467449306,neutral
2021-07-30 12:09:00,4685.0,4805.0,4677.6,4711.0,1371142.0,India’s worst-performing stock in July may rebound if history is any guide,Shares of pharma firm Dr Reddy’s Labs have rallied about 15% after losing steam,positive,positive,0.5549626467449306,neutral,-0.7596539354294155,neutral
2021-08-02 11:27:51,4739.0,4750.5,4687.6,4703.0,754845.0,Hold Dr Reddy’s Laboratories: Target Of Rs 5250: ICICI Direct,"ICICI Direct recommended hold rating on Dr Reddy’s Laboratories with a target price of Rs 5250 in its research report dated July 28, 2021.",neutral,positive,-0.7596539354294155,neutral,-0.1670755435242288,neutral
2021-08-04 08:42:00,4725.6,4810.0,4725.6,4769.35,1102559.0,Dr Reddy’s re-launches Naproxen Sodium OTC Tablets in US market,"Dr Reddy’s Laboratories announced the re-launch of over-the-counter Naproxen Sodium Tablets USP, 220 mg, the store-brand equivalent of Aleve, in the US market, as approved by the USFDA.",neutral,positive,0.9258083629592008,positive,-0.1877346683354192,neutral
2021-08-04 21:31:00,4794.0,4809.0,4742.0,4785.0,593857.0,"Dr Reddy’s to sell US, Canada territory rights for migraine drug to BDSI","Drug firm Dr Reddy’s Laboratories on Wednesday said it has entered into a definitive agreement with BioDelivery Sciences International, Inc., to sell its US and Canada territory rights",positive,positive,-0.1877346683354192,neutral,-0.6127042347449074,neutral
2021-08-05 14:23:52,4798.4,4806.25,4756.3,4769.0,399197.0,"Mansukh Mandaviya Holds Meeting with Dr Reddy’s Lab Chairman on Sputnik V Production, Supply",Union Health Minister Mansukh Mandaviya on Thursday said he has held a meeting with Dr Reddy's Laboratories Chairman Satish Reddy regarding the production and supply of COVID-19 vaccine Sputnik V.,neutral,neutral,-0.6127042347449074,neutral,0.6882168925964547,neutral
2021-08-05 15:54:06,4798.4,4806.25,4756.3,4769.0,399197.0,Sputnik V Covid jab in India: Panacea Biotec to make 25 mn doses,"After production, Panacea will then supply the entire dose to drugmaker Dr Reddy’s Laboratories for distribution in the country, it said in a regulatory filing",neutral,neutral,-0.6127042347449074,neutral,0.6882168925964547,neutral
2021-08-05 18:42:14,4798.4,4806.25,4756.3,4769.0,399197.0,SII CEO Adar Poonawalla expected to meet Union Health Minister Mansukh Mandaviya tomorrow,Serum Institute of India CEO-owner Adar Poonawalla is expected to meet Union Health Minister Mansukh Mandaviya tomorrow in Delhi. The expected meet comes after the union health minister toay met met Dr Reddy’s Laboratories Ltd Chairperson K. Satish Reddy in New Delhi to discuss the availability o…,neutral,neutral,-0.6127042347449074,neutral,0.6882168925964547,neutral
2021-08-06 16:20:35,4798.4,4806.25,4756.3,4769.0,399197.0,Mansukh Mandaviya Holds Meeting With Biological-E MD On Progress Of COVID Vaccine,The health minister on Thursday had also held a meeting with Dr Reddy’s Laboratories Chairman Satish Reddy regarding the production and supply of COVID-19 vaccine Sputnik V.,neutral,neutral,-0.6127042347449074,neutral,0.6882168925964547,neutral
2021-08-19 17:03:15,4659.9,4659.9,4508.0,4540.25,825731.0,LIC bought shares of these companies in April-June quarter; stocks trade with losses this quarter,"LIC’s largest investments during the previous quarter include Dr Reddy’s Laboratories, Adani Enterprises, Tech Mahindra, Union Bank, Apollo Hospitals, Tata Consumer Products, and Lupin.",neutral,neutral,-2.5676516663447635,negative,-1.9352033050663189,negative
2021-08-29 15:39:00,4619.0,4700.0,4578.05,4680.2,626882.0,"Dr Reddy’s Laboratories, Zydus Pharma recall products in US market","Dr Reddy’s Laboratories, Inc, the US arm of Dr Reddy’s Laboratories, is recalling 37,560 bottles of Tizanidine HCl tablets, USP 4 mg",negative,negative,1.3249621130114704,positive,0.6829987815045369,neutral
2021-08-30 08:05:00,4619.0,4700.0,4578.05,4680.2,626882.0,"Nifty Pharma picks speed to advance 2%; Divis Lab, Biocon, Sun Pharma lift performance",Dr Reddy’s Laboratories (up 1.73%) and Torrent Pharmaceuticals (up 1.564%) were also bullish. Lupin and Cipla advanced over 1.2%.,positive,positive,1.3249621130114704,positive,0.6829987815045369,neutral
2021-08-31 15:02:52,4739.0,4784.45,4687.0,4758.4,561574.0,Dr Reddy’s Launches Generic Stomach Ulcer Drug In US Market,"The company has launched Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules USP, 5 mg/2.5 mg in the US market, Dr Reddy’s Laboratories said in a regulatory filing.",neutral,neutral,0.4093690652036218,neutral,0.8033672833090758,neutral
2021-08-31 15:39:00,4739.0,4784.45,4687.0,4758.4,561574.0,Dr Reddy’s launches generic stomach ulcer drug in US market,"The company has launched Chlordiazepoxide Hydrochloride and Clidinium Bromide capsules USP, 5 mg/2.5 mg in the US market, Dr Reddy’s Laboratories said in a regulatory filing.",neutral,neutral,0.4093690652036218,neutral,0.8033672833090758,neutral
2021-09-02 09:54:55,4811.0,4904.4,4810.0,4849.65,1249359.0,Dr Reddy’s Laboratories Shares Rise 3% On Drug Launch In Canada,"The share touched a 52-week high of Rs 5,613.65 and a 52-week low of Rs 4,135.90 on 07 July, 2021 and 19 March, 2021, respectively.",neutral,negative,0.8033672833090758,neutral,0.4870595955867273,neutral
2021-09-02 22:23:00,4876.2,4909.25,4862.3,4899.95,428704.0,"Dr Reddy’s, Natco Pharma launch generic cancer drug in Canada",Dr Reddy’s Laboratories and Natco Pharma on Thursday said they have launched generic capsules used in the treatment of multiple myeloma and myelodysplastic syndrome patients in the Canadian market.,neutral,positive,0.4870595955867273,neutral,-0.7307692307692382,neutral
2021-09-06 07:29:45,4940.0,4943.3,4871.45,4903.9,613103.0,"Buzzing Stocks: RIL, ICICI Lombard, Dr Reddy’s Labs And Other Stocks In News Today",Stocks In the News: Check out the companies making the biggest headlines before the opening bell,neutral,neutral,-0.7307692307692382,neutral,-0.5645981688708036,neutral
2021-09-06 09:21:00,4940.0,4943.3,4871.45,4903.9,613103.0,Dr Reddys Lab gains on deal with Citius Pharma for anti-cancer agent E7777,"Dr.Reddy’s Laboratories rose 0.71% to Rs 4934 after the company signed a deal with Citius Pharmaceuticals, Inc. to sell its rights to anti-cancer agent E7777 (denileukin diftitox).",positive,positive,-0.7307692307692382,neutral,-0.5645981688708036,neutral
2021-09-06 14:07:22,4915.0,4925.95,4855.55,4887.25,419495.0,Why stock market experts are bullish on Dr. Reddy’s shares? Key levels to watch,Dr Reddy’s Laboratories has sold out its rights of anti-cancer agent to a US-based Citius Pharmaceuticals,positive,neutral,-0.5645981688708036,neutral,-0.2807731434384574,neutral
2021-09-07 11:17:21,4915.0,4925.95,4855.55,4887.25,419495.0,Panacea Biotec up 9% on first shipment of second component of Sputnik V,The batch will be distributed in India through Dr Reddy’s Laboratories,positive,neutral,-0.5645981688708036,neutral,-0.2807731434384574,neutral
2021-09-07 13:03:05,4915.0,4940.0,4861.3,4901.2,498871.0,Buy Dr Reddy’s Laboratories: Target Of Rs 5900: Sharekhan,"Sharekhan is bullish on Dr Reddy’s Laboratories has recommended buy rating on the stock with a target price of Rs 5900 in its research report dated September 06, 2021.",neutral,positive,-0.2807731434384574,neutral,0.5547594677584516,neutral
2021-09-07 16:51:00,4915.0,4940.0,4861.3,4901.2,498871.0,Panacea Biotech and RDIF supply first shipment of the second component of Sputnik V vaccine in India; Stock hits 10% upper circuit,The first batch will be distributed in India through a partner of RDIF and Panacea Biotec – Dr Reddy’s Laboratories.,neutral,neutral,-0.2807731434384574,neutral,0.5547594677584516,neutral
2021-09-07 17:30:00,4915.0,4940.0,4861.3,4901.2,498871.0,Panacea Biotec supplies first shipment of Sputnik V component II developed in India,"The batch will be distributed in India through Dr Reddy’s Laboratories. To date, Sputnik V has been authorised in 70 countries",neutral,neutral,-0.2807731434384574,neutral,0.5547594677584516,neutral
2021-09-07 21:12:39,4915.0,4940.0,4861.3,4901.2,498871.0,Dr Reddy’s starts supply of Sputnik V first vaccine doses; dosage gap 21 days,"Dr Reddy’s Laboratories said that the Russian vaccine, which is administered in two doses with a 21-day gap, should be taken from the same hospital",neutral,neutral,-0.2807731434384574,neutral,0.5547594677584516,neutral
2021-09-07 21:33:07,4915.0,4940.0,4861.3,4901.2,498871.0,Panacea Biotec supplies second component of Sputnik vaccine,To be distributed in India through Dr Reddy’s Laboratories,neutral,neutral,-0.2807731434384574,neutral,0.5547594677584516,neutral
2021-09-07 22:12:26,4915.0,4940.0,4861.3,4901.2,498871.0,Covid-19 Vaccine: Dr Reddy’s Starts Supply of Sputnik V First Doses,Dr Reddy’s Laboratories on Tuesday said it initiated supply of the first dose component of Russian Covid-19 vaccine Sputnik V to partner hospitals all over the country.,neutral,positive,-0.2807731434384574,neutral,0.5547594677584516,neutral
2021-09-15 21:50:00,4981.0,4996.5,4916.55,4919.1,295785.0,Dr Reddy’s gets nod for bridging trials of Sputnik Light vaccine,"RDIF, in partnership with Dr Reddy’s Labs, to distribute first 250 million doses of Sputnik in India",neutral,positive,-1.2427223449106533,negative,-1.0115548347861267,negative
2021-09-23 17:30:00,4806.0,4821.1,4778.05,4799.0,251139.0,How Sensex stocks have performed this year so far,"While Tata Steel, Bajaj Finserv and SBI are the best performers, Maruti Suzuki India and Dr Reddy’s Labs are in the red even as Sensex surged over 23 per cent",positive,positive,-0.1456512692467748,neutral,0.0145915410751843,neutral
2021-09-29 17:46:17,4889.9,4985.0,4865.45,4886.0,774727.0,"Price, Storage, Govt’s Amped Vax Drive: Why Sputnik V Didn’t Turn Out to be a Shot in the Arm For India","Russia’s Sputnik V Covid-19 vaccine, distributed by pharma giant Dr Reddy’s Laboratories, has not seen many takers in India since its soft launch in May this year, a time when India faced a double whammy of surge in cases and supply shortage of coronavirus jabs.",neutral,negative,-0.0797562322337805,neutral,1.8194930970533727,positive
2021-10-07 12:41:41,4906.65,4946.65,4821.0,4847.8,347129.0,KRChoksey Picks These 6 Stocks For An Upside Of 6-33%,"ITC, Dr Reddy’s Laboratories, Tata Motors and HDFC AMC among the picks for October. Read on for target prices",neutral,neutral,-1.199392660980495,negative,0.6652977412730932,neutral
2021-10-11 12:03:00,4900.0,4957.0,4856.0,4913.15,284844.0,22 Nifty stocks still trade at discount to historical valuations. Worth a look?,"Pharma names such as Sun Pharma, Dr Reddy’s Labs and Cipla, refiner IOC and utilities Power Grid and NTPC are trading at up to 26 per cent discounts to their 10-year averages.",neutral,neutral,0.268367346938768,neutral,0.3218578121817108,neutral
2021-10-14 17:30:00,4924.0,5009.65,4914.05,4950.0,291481.0,Dr Reddy’s becomes the first Indian company to launch an anti-cancer drug in China,Hyderabad-based Dr Reddy’s Laboratories has become the first Indian pharmaceutical company to launch an anti-cancer drug in the Chinese market.,neutral,neutral,0.5280259951259139,neutral,-1.5500505561172828,negative
2021-10-18 10:40:00,4945.0,4974.95,4865.65,4868.35,329421.0,Dr Reddy’s Labs launches copy of BI drug; move may lead to legal battle,"Under its brand Vicra, Dr. Reddy’s is expected to sell the drug in India at less than a third of the price charged by Boehringer Ingelheim. According to sources the 10 mg variant of Dr. Reddy’s brand may cost ₹15 per tablet against ₹51 of the innovator’s brand.",negative,neutral,-1.5500505561172828,negative,-2.2038735983690185,negative
2021-10-18 19:50:00,4905.0,4920.0,4790.0,4796.9,536871.0,"MSN Labs launches patented diabetes pill Jardiance after DRL, heats up potential legal battle","Earlier, ET reported that Dr Reddy’s Labs has launched copies of Jardiance. It has a valid patent in India until 2025.",positive,neutral,-2.2038735983690185,negative,-1.062267628956166,negative
2021-10-19 09:48:00,4905.0,4920.0,4790.0,4796.9,536871.0,Dr Reddy’s Laboratories gets a USFDA nod on Lenalidomide capsules,"Dr Reddy’s Laboratories received the final approval of its Abbreviated New Drug Application for Lenalidomide capsules (in 2.5 mg and 20 mg) and tentative approval (for 5 mg, 10 mg, 15 mg and 25 mg) from the United States Food and Drug",neutral,positive,-2.2038735983690185,negative,-1.062267628956166,negative
2021-10-19 16:04:00,4801.05,4844.45,4718.0,4750.05,315626.0,Dr Reddy’s Lab receives USFDA approval to market Lenalidomide capsule,Dr Reddy’s Laboratories on Tuesday said it has received approval from the US health regulator to market Lenalidomide capsules,positive,positive,-1.062267628956166,negative,-2.489539748953975,negative
2021-10-29 08:23:24,4593.0,4917.85,4526.05,4629.6,1941744.0,"Indian stock markets may stay under pressure; Zee, Vedanta, IRCTC in focus","Adani Transmission, Vedanta, BPCL, Dr Reddy’s Laboratories, IRCTC, GAIL (India), JSW Energy, UPL, Cadila Healthcare, Bandhan Bank, SAIL, Adani Power are among the companies scheduled to release their Q2 earnings today",negative,neutral,0.7968647942521306,neutral,2.56136606189968,positive
2021-10-29 08:53:00,4593.0,4917.85,4526.05,4629.6,1941744.0,"NTPC, IRCTC, InterGlobe Aviation, DLF in focus","Among key corporate earnings, BPCL, Adani Power, Dr Reddy’s Labs, Shree Cement, UPL, Vedanta, Adani Transmission, Apollo Tyres, Bandhan Bank, Bharat Electronics, Cadila Healthcare, GAIL (India), Glaxosmithkline Pharmaceuticals, Oberoi Realty, among",neutral,neutral,0.7968647942521306,neutral,2.56136606189968,positive
2021-10-29 14:43:00,4593.0,4917.85,4526.05,4629.6,1941744.0,Dr Reddy’s Lab jumps after Q2 PAT climbs 30% YoY,Dr Reddy’s Laboratories rose 5.14% to Rs 4808.25 after the company’s consolidated net profit rose 30% to Rs 992 crore on 18% increase in net sales to Rs 5763.20 crore in Q2 September 2021 over Q2 September 2020.,positive,positive,0.7968647942521306,neutral,2.56136606189968,positive
2021-10-29 14:59:56,4593.0,4917.85,4526.05,4629.6,1941744.0,Dr Reddy’s Laboratories Q2 net profit up 30% at ₹992 crore,"The total revenue of the Hyderabad-based company increased 18 per cent at ₹5,763 crore",positive,positive,0.7968647942521306,neutral,2.56136606189968,positive
2021-10-29 16:20:00,4593.0,4917.85,4526.05,4629.6,1941744.0,Dr Reddy’s Laboratories consolidated net profit rises 29.02% in the September 2021 quarter,Sales rise 17.70% to Rs 5763.20 crore,positive,positive,0.7968647942521306,neutral,2.56136606189968,positive
2021-10-29 23:18:00,4593.0,4917.85,4526.05,4629.6,1941744.0,Dr Reddy’s Laboratories working on enhancing Covid-19 portfolio,"As for MSD’s drug Molnupiravir, which is currently undergoing clinical trial in India, the company said it has already shared interim data with the drug regulator",positive,neutral,0.7968647942521306,neutral,2.56136606189968,positive
2021-11-01 00:51:43,4685.0,4834.95,4629.05,4805.0,675160.0,Dr Reddy’s Labs is firing on all cylinders,"Dr Reddy’s reported a revenue growth of 17% sequentially and 18% year-on-year during Q2.The firm’s domestic revenues, which contributed a fifth of overall revenues, grew 25% y-o-y",positive,positive,2.56136606189968,positive,-1.185453712095181,negative
2021-11-01 08:59:15,4685.0,4834.95,4629.05,4805.0,675160.0,"Trade Spotlight | What Should Investors Do With Canara Bank, InterGlobe Aviation, Dr Reddy’s Labs, And Ujjivan Financial Services?","Here’s what Mehul Kothari of Anand Rathi Shares & Stock Brokers, recommends investors should do with these stocks when the market resumes trading today.",neutral,neutral,2.56136606189968,positive,-1.185453712095181,negative
2021-11-01 10:11:03,4685.0,4834.95,4629.05,4805.0,675160.0,"What Should Investors Do With Dr Reddy’s Laboratories Post Q2 Results; Buy, Sell Or Hold?","The revenues came in higher by 18% at Rs 5,763 crore for the quarter, compared to Rs 4,897 crore in the same period last year.",neutral,positive,2.56136606189968,positive,-1.185453712095181,negative
2021-11-03 13:35:58,4775.0,4788.65,4754.0,4765.6,20626.0,Buy Dr Reddy’s Labs; Target Of Rs 5470: Motilal Oswal,"Motilal Oswal is bullish on Dr Reddy’s Labs recommended buy rating on the stock with a target price of Rs 5470 in its research report dated October 30, 2021.",neutral,positive,-0.1968586387434478,neutral,0.7352941176470588,neutral
2021-11-10 10:08:59,4784.1,4849.95,4774.0,4828.0,341771.0,Geojit Bets On These Large Caps For An Upside Upto 38%,"Gail India, Dr Reddy’s Laboratories, HDFC, Vedanta, UPL, Axis Bank, IndusInd Bank and Kotak Mahindra Bank are among the largecap stocks, in which broking house Geojit expects up to 38 percent upside.",neutral,neutral,0.9176229593862928,positive,-0.3694887186917898,neutral
2021-11-18 07:15:00,4759.8,4767.7,4651.1,4659.95,233060.0,Panel to meet today to take up applications seeking nod for Molnupiravir,"The firms whose applications that will be taken up are Dr Reddy’s Laboratories which has filed for approval in a consortium with five other companies and MSD, Hetero Labs, Natco Pharma, Aurobindo Pharma, Optimus Pharma, Strides Pharma, MSN Pharma and BDR Pharmaceuticals.",neutral,positive,-2.097777217530156,negative,-1.6347870713896189,negative
2021-11-24 22:25:34,4614.0,4696.0,4585.0,4599.0,544576.0,Sputnik Light Covid vaccine to be launched in India by Dec: RDIF CEO,The Hyderabad-based Dr Reddy’s Laboratories is the sole distributor of Sputnik V under an agreement with the RDIF,neutral,neutral,-0.3250975292587776,neutral,3.558951965065502,positive
2021-12-06 15:26:10,4520.0,4550.0,4441.3,4528.0,531469.0,Hold Dr Reddy’s Labs; Target Of Rs 5105: Edelweiss Securities,"Edelweiss Securities recommended hold rating on Dr Reddy’s Labs with a target price of Rs 5105 in its research report dated December 03, 2021.",neutral,positive,0.1769911504424778,neutral,0.9597437738141216,positive
2021-12-07 07:59:53,4520.0,4550.0,4441.3,4528.0,531469.0,KR Choksey Bullish On These 6 Stocks For Upside Of 12-37%,"ICICI Bank, UltraTech Cement, State Bank of India, UltraTech Cement, Devyani International and Dr Reddy’s Laboratories are among the top six picks for the month of December 2021 with an upside of 12-37 percent.",neutral,neutral,0.1769911504424778,neutral,0.9597437738141216,positive
2021-12-09 09:20:00,4600.0,4617.95,4565.35,4604.45,225172.0,"Dr Reddy’s Laboratories, Prestige BioPharma to commercialize Trastuzumab biosimilar",Dr Reddy’s Laboratories and Prestige BioPharma entered into a binding agreement for an exclusive partnership for the supply and commercialization of the latter’s proposed Trastuzumab biosimilar in select countries in Latin America and Southeast,neutral,positive,0.0967391304347786,neutral,-0.5466377440347032,neutral
2021-12-09 12:18:00,4610.0,4619.5,4573.5,4584.8,160031.0,Dr Reddy’s launches Valsartan Tablets in the U.S. market,"Dr Reddy’s Laboratories said that it has launched Valsartan Tablets, USP, a therapeutic equivalent generic version of Diovan (valsartan) Tablets approved by the U.S. Food and Drug Administration (USFDA) in the U.S. market.",neutral,positive,-0.5466377440347032,neutral,-1.731509191962377,negative
2021-12-09 19:10:14,4610.0,4619.5,4573.5,4584.8,160031.0,COVID-19: Dr Reddy’s Laboratories seeks DCGI’s nod for Phase III trial of Sputnik Light as booster dose,"Recently, Serum Institute of India sought approval for Covishield as a booster dose citing adequate stock and a demand for a booster shot due to the emergence of new variants.",neutral,positive,-0.5466377440347032,neutral,-1.731509191962377,negative
2021-12-09 20:03:40,4610.0,4619.5,4573.5,4584.8,160031.0,Dr Reddy’s Laboratories Seeks DCGI’s Nod For Phase-3 Trial Of Sputnik Light As Booster Dose,"Stating the Sputnik Light is the Component 1 of the Gam-COVID-Vac Combined Vector Vaccine (Sputnik V), P Madhavi, the Director-Regulatory Affairs at Dr Reddy’s Laboratories, proposed to use batches of the vaccine manufactured at Hetero Biopharma Limited, Telangana, and at its loan license facility a…",neutral,neutral,-0.5466377440347032,neutral,-1.731509191962377,negative
2021-12-10 07:28:37,4610.0,4619.5,4573.5,4584.8,160031.0,"Buzzing Stocks: Tata Motors, IndusInd Bank, Dr Reddy’s Labs And Other Stocks In News Today",Stocks In the News: Check out the companies making the biggest headlines before the opening bell.,neutral,neutral,-0.5466377440347032,neutral,-1.731509191962377,negative
2021-12-10 08:14:57,4610.0,4619.5,4573.5,4584.8,160031.0,"India stock markets seen volatile; Paytm, Dr Reddy’s in focus",Dr Reddy’s Laboratories has sought permission from India’s drug regulator to conduct a phase-3 clinical trial to evaluate the efficacy and safety of Sputnik Light vaccine as a booster dose against covid-19 in India,negative,positive,-0.5466377440347032,neutral,-1.731509191962377,negative
2021-12-22 09:05:00,4640.0,4679.3,4610.0,4641.0,213013.0,"Here’s why HDFC Securities is bullish on HCL Tech, Dr Reddy’s Labs","Nifty should be held long with the stoploss of 16,650.",positive,neutral,0.021551724137931,neutral,0.426856666024773,neutral
2021-12-24 11:54:25,4725.0,4730.0,4611.0,4624.0,250243.0,Covid-19: How will Pfizer’s oral antiviral treatment drug Paxlovid come to India?,"Indian giants Sun Pharmaceutical Industries, Optimus Pharma, and Dr Reddy’s Laboratories are exploring the possibility of manufacturing the pill, reports suggest.",neutral,neutral,-2.137566137566137,negative,2.3766787050452978,positive
2021-12-28 18:14:00,4743.8,4848.15,4743.8,4822.0,503959.0,Dr Reddy’s Laboratories to introduce Molnupiravir to treat Covid-19 shortly,The Hyderabad-based firm said it will introduce the drug under the brand name Molflu in India,neutral,neutral,1.6484674733336104,positive,1.4275362318840543,positive
2021-12-28 18:23:00,4743.8,4848.15,4743.8,4822.0,503959.0,Dr Reddy’s Laboratories to introduce Molnupiravir to treat COVID-19 shortly,"​​The drug firm said it is able to manufacture the active pharmaceutical ingredient (API) as well as the formulation for Molnupiravir, and has made adequate capacity preparations to ensure that it is able to help patients in India as well as in patient populations in need around the world.",neutral,positive,1.6484674733336104,positive,1.4275362318840543,positive
2021-12-28 19:23:29,4743.8,4848.15,4743.8,4822.0,503959.0,Dr Reddy’s Laboratories to Introduce Molnupiravir to Treat Covid-19 Shortly,Molnupiravir is an oral antiviral that inhibits the replication of multiple RNA viruses including SARS-CoV-2.,neutral,neutral,1.6484674733336104,positive,1.4275362318840543,positive
2022-01-05 05:30:00,4880.0,4904.6,4757.05,4790.0,533974.0,"Stocks in Focus on Jan 5: Airtel, GAIL, Dr Reddy’s Labs & More","Stocks in Focus on Jan 5: Airtel, GAIL, Dr Reddy’s Labs & More",neutral,neutral,-1.8442622950819672,negative,-1.17735470941883,negative
2022-01-05 11:21:06,4880.0,4904.6,4757.05,4790.0,533974.0,Dr Reddy’s Laboratories to launch Molflu at Rs 35 per capsule,"The total course of 40 capsules over 5 days would cost Rs 1,400 with 10 capsules per strip.",neutral,neutral,-1.8442622950819672,negative,-1.17735470941883,negative
2022-01-05 19:18:23,4790.4,4836.05,4728.3,4734.0,380730.0,Centre says Covid antiviral drug Molnupiravir has ‘major safety concerns’,"Hyderabad-based Dr Reddy’s Laboratories Ltd plans to launch its generic version of the Merck drug, called molnupiravir, from early next week",negative,neutral,-1.17735470941883,negative,-1.3198586839153323,negative
2022-01-21 14:34:00,4561.25,4570.0,4435.0,4501.5,556472.0,"Viral vaccines, vector platforms may become new growth areas: DRL chief","In a Q&A, the chairman of Dr Reddy’s Laboratories dwells, among other things, on the draft R&D policy and the first-ever Global Innovation Summit of the pharma sector held last November",neutral,neutral,-1.3099479309399835,negative,-3.029357348253506,negative
2022-01-28 07:42:00,4248.8,4380.0,4175.45,4224.0,1301370.0,"Stocks in the news: Lupin, BHEL, Canara Bank, RBL Bank, L&T and PNB","Kotak Mahindra Bank, L&T, Vedanta, Britannia, Dr Reddy’s Labs, Marico, Info Edge, Bharat Electronics, Au SFB and Oberoi Realty are among the companies that will announce their December quarter results today.",neutral,neutral,-0.5836942195443462,neutral,1.1000129413287216,positive
2022-01-28 15:01:36,4248.8,4380.0,4175.45,4224.0,1301370.0,Q3 results: Dr Reddy’s Laboratories net profit jumps 3468 per cent,Consolidated revenues increased by 8 per cent at ₹5320 crore in Q3 FY22,positive,positive,-0.5836942195443462,neutral,1.1000129413287216,positive
2022-01-28 17:30:00,4248.8,4380.0,4175.45,4224.0,1301370.0,Dr Reddy’s Q3 net profit rises multi-fold to Rs 707 cr,"Revenues stood at Rs 5,319.7 crore during the third quarter as compared with Rs 4,929.6 crore in the same period of 2020-21, Dr Reddy’s Laboratories said.",positive,positive,-0.5836942195443462,neutral,1.1000129413287216,positive
2022-01-28 20:52:32,4248.8,4380.0,4175.45,4224.0,1301370.0,Dr Reddy’s Laboratories to seek WHO pre-qualification on molnupiravir,Poised to submit data to Indian regulator on Sputnik vaccine for adolescents,neutral,neutral,-0.5836942195443462,neutral,1.1000129413287216,positive
2022-02-01 21:52:07,4325.0,4429.75,4315.1,4418.5,304376.0,Buy Dr Reddy’s Labs; Target Of Rs 5160: Motilal Oswal,"Motilal Oswal is bullish on Dr Reddy’s Labs recommended buy rating on the stock with a target price of Rs 5160 in its research report dated January 29, 2022.",neutral,positive,2.161849710982659,positive,-1.199637845178814,negative
2022-02-02 10:08:14,4325.0,4429.75,4315.1,4418.5,304376.0,"Union Budget 2022 | ‘Make in India’ to ‘Discover and Make in India’: Satish Reddy, chairman, Dr Reddy’s Laboratories",The vaccination campaign has been and continues to be the biggest focus for the country at present.,neutral,neutral,2.161849710982659,positive,-1.199637845178814,negative
2022-02-04 00:24:00,4404.55,4406.5,4337.0,4345.0,245837.0,Dr Reddy’s Laboratories inks agreement to acquire Nimbus Health GmbH,Dr Reddy’s Laboratories on Thursday said it has inked a pact to acquire Germany-based Nimbus Health GmbH.,positive,positive,-1.3520109886367548,negative,-0.4884259259259343,neutral
2022-02-04 09:18:00,4404.55,4406.5,4337.0,4345.0,245837.0,Dr Reddy’s to acquire German medical cannabis firm,Dr.Reddy’s Laboratories said that it has entered into a definitive agreement to acquire German medical cannabis firm Nimbus Health GmbH.,neutral,positive,-1.3520109886367548,negative,-0.4884259259259343,neutral
2022-02-06 12:19:00,4320.0,4350.0,4250.05,4298.9,255105.0,Submitted proposal to DCGI to test Sputnik Light as Covid booster dose: Dr Reddy’s,"“As regards to Sputnik, we are now ready with capacities in India. We are working actively with the Government of India for registering Sputnik Light as a vaccine and as a booster dose of Sputnik V,” Dr Reddy’s Laboratories CEO Erez Israeli said in an analyst call.",neutral,positive,-0.4884259259259343,neutral,0.1148758412624696,neutral
2022-02-06 21:27:17,4320.0,4350.0,4250.05,4298.9,255105.0,Single-dose Sputnik Light Vaccine Gets DCGI Nod for Emergency Use to ‘Strengthen Fight Against Covid’,The approval comes after Dr Reddy’s Laboratories said it has submitted a proposal to the DCGI to register Sputnik Light vaccine as a booster dose against Covid-19.,neutral,positive,-0.4884259259259343,neutral,0.1148758412624696,neutral
2022-02-07 10:00:00,4320.0,4350.0,4250.05,4298.9,255105.0,Dr Reddy’s Lab spurts after DGCI nod for single-shot Sputnik Light vaccine,"Dr Reddy’s Laboratories jumped 5.74% to Rs 4,600 after the company announced that the Drugs Controller General of India (DCGI) has granted approval to the single-shot Sputnik Light vaccine for restricted use in emergency situation in India.",neutral,positive,-0.4884259259259343,neutral,0.1148758412624696,neutral
2022-02-08 23:18:00,4322.2,4395.0,4311.5,4364.0,198624.0,Covid-19 vaccine: Hospitals see no immediate rush for Sputnik Light,"Dr Reddy’s Laboratories, marketing partner of the Russian Direct Investment Fund for the Sputnik V and Sputnik Light vaccines, has sought government approval for use of Sputnik Light as a booster shot",neutral,positive,0.967100087918194,positive,-0.5188141391106044,neutral
2022-02-09 19:23:00,4385.0,4388.75,4333.7,4362.25,237194.0,Dr Reddy’s Laboratories launches generic drug in the US market,"Dr Reddy’s Laboratories said it has launched vasopressin injection, which is used to control frequent urination, increased thirst, and loss of water caused by diabetes, in the American market.",neutral,neutral,-0.5188141391106044,neutral,0.3247506379030387,neutral
2022-02-11 17:30:00,4311.0,4349.55,4280.15,4325.0,336750.0,"Stocks in news: Hero MotoCorp, Zomato, Trent, Tata Chemicals and more","Stocks in news: Hero MotoCorp, Zomato, Dr Reddy’s Laboratories, Torrent Power, Trent, Tata Chemicals, Rashtriya Chemicals and more",neutral,neutral,0.3247506379030387,neutral,-1.1152941176470503,negative
2022-02-11 22:29:00,4311.0,4349.55,4280.15,4325.0,336750.0,Dr Reddy’s Laboratories inks exclusive sales pact with Novartis India,"Dr Reddy’s Laboratories has entered into an exclusive sales and distribution agreement with Novartis India Ltd (NIL), a statement said",positive,positive,0.3247506379030387,neutral,-1.1152941176470503,negative
2022-02-14 08:07:34,4250.0,4266.6,4166.75,4202.6,447551.0,"Buzzing Stocks | Dr Reddy’s Labs, Ashok Leyland, TVS Motor Company and others in news today",Stocks In the News: Check out the companies making headlines before the opening bell.,neutral,neutral,-1.1152941176470503,negative,1.3226263580538498,positive
2022-02-15 08:15:11,4234.0,4294.45,4188.6,4290.0,357695.0,"Stocks to Watch Today: RIL, Future Retail, Cipla, and Others","Stocks to watch: Shares of firms like RIL, Future Retail, Dr Reddy’s Labs, Adani Wilmar will be in focus in Tuesday’s trade Today’s biggest stock Gainers Market News at news18.com",neutral,neutral,1.3226263580538498,positive,0.9350163627863488,positive
2022-02-16 08:16:00,4278.0,4372.8,4243.55,4318.0,380104.0,"Sensex ends choppy day 145 pts down; Vedant Fashions up 9%, SBI falls 2%","Among individual stocks, Bharti Airtel, M&M, HDFC, Kotak Bank, Nestle India, and Dr Reddy’s Labs were the only Sensex gainers today",positive,neutral,0.9350163627863488,positive,-0.529736982118477,neutral
2022-02-16 12:54:59,4322.9,4335.25,4293.2,4300.0,228718.0,Mankind Pharma to acquire two brands from Dr Reddy’s Laboratories,"As per the terms of the definitive agreement executed between the companies, Mankind Pharma will take over the manufacturing, marketing and distribution of both the products in India.",neutral,neutral,-0.529736982118477,neutral,0.9357476635514062,positive
2022-02-16 13:10:00,4322.9,4335.25,4293.2,4300.0,228718.0,Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy’s Laboratories,"Mankind Pharma said the market for Combihale is valued at Rs 900 crore growing at 14 per cent. The acquisition of the product is expected to strengthen the company’s presence in the inhalation respiratory market segment, Mankind Pharma said in a statement. The total market for Daffy is valued at Rs …",neutral,positive,-0.529736982118477,neutral,0.9357476635514062,positive
2022-02-16 17:30:00,4322.9,4335.25,4293.2,4300.0,228718.0,Mankind Pharma to acquire Combihale and Daffy brands from Dr Reddy’s Labs,"The acquisition of the product is expected to strengthen the company’s presence in the inhalation respiratory market segment, Mankind Pharma said.",neutral,positive,-0.529736982118477,neutral,0.9357476635514062,positive
2022-02-21 09:45:00,4376.0,4416.65,4282.6,4299.0,584625.0,Dr Reddy’s Laboratories gains 2% on selling of two anti-bacterial brands,"The share touched a 52-week high of Rs 5,613.65 and a 52-week low of Rs 4,135.90 on 07 July, 2021 and 19 March, 2021.",positive,negative,-1.7595978062157225,negative,0.4546593634768955,neutral
2022-02-24 06:28:00,4050.0,4149.0,4049.95,4083.0,689828.0,Risk-reward ratio is favourable in select pharma companies: CLSA,"CLSA sees a favourable risk-to-reward ratio in shares of Dr Reddy’s Laboratories, Cadila Healthcare and Torrent Pharma. The brokerage has upgraded Torrent Pharma to ‘buy’ from ‘outperform’ with an unchanged target price of ₹3,550.",positive,positive,0.8148148148148148,neutral,1.6042780748663104,positive
2022-03-02 12:05:00,3879.0,3894.25,3700.0,3735.65,1332751.0,"Sensex gyrates 1,227pts, ends 779pts down; Maruti dips 6%, Coal India up 9%","Closing Bell: The benchmarks were bogged down by Maruti Suzuki, Dr Reddy’s Labs, Bajaj Auto, Hero MotoCorp, ICICI Bank, HDFC twins, Eicher Motors, and Sun Pharma",neutral,negative,-3.695540087651454,negative,3.1266846361185987,positive
2022-03-08 08:09:00,3750.0,3886.95,3737.85,3875.3,783534.0,"Sensex leaps 1,163 pts from the day’s low, ends 581 pts up; Nifty tops 16K","CLOSING BELL: The winners included Indian Oil Corporation, Sun Pharma, Tata Consumer Products, TCS, Cipla, Shree Cement, NTPC, Tech M, Dr Reddy’s Labs, Wipro, Ultratech Cement, and Infosys",neutral,neutral,3.3413333333333384,positive,0.7304882737408689,neutral
2022-03-11 15:04:34,3893.0,3996.0,3873.0,3964.0,1112401.0,"D-Street Buzz: Pharma stocks outperform; Sun Pharma, Cipla hit fresh highs","Cipla, Laurus Labs and Sun Pharma which gained over 3 percent each followed by Torrent Pharma, Dr Reddy’s Labs and Aurobindo Pharma.",positive,positive,1.8237862830721807,positive,-0.1514768997727846,neutral
2022-03-24 06:52:00,4113.0,4348.55,4101.45,4322.05,1737481.0,"Indian firms in a huddle with auditors, valuers over Russian investments as fiscal end draws near","Companies including Dr Reddy’s Laboratories, Sun Pharmaceuticals, ONGC, BPCL and Indian Oil have investments in Russia. Their income projections have become next to impossible.",neutral,neutral,5.082664721614398,positive,0.5315461058470071,neutral
2022-03-24 11:50:00,4113.0,4348.55,4101.45,4322.05,1737481.0,"Sensex gyrates 690 pts, ends 89 pts down; metal, pharma rally, banks slide","CLOSING BELL: Dr Reddy’s Labs (up nearly 5 per cent) was the top Nifty gainer today, followed by Coal India, Hindalco, Cipla, NTPC, JSW Steel, Tech M, and RIL",negative,positive,5.082664721614398,positive,0.5315461058470071,neutral
2022-03-31 08:09:00,4353.0,4387.5,4280.1,4293.0,611013.0,"RIL, HDFC Bk drag Sensex 115pts, Nifty holds 17,450; indices up 19% in FY22","CLOSING BELL: Hindalco tumbled 5 per cent, followed by Divis Labs, Apollo Hospitals, RIL, Wipro, Eicher Motors, Dr Reddy’s Labs, and Cipla",positive,negative,-1.3783597518952446,negative,-0.3958090803259604,neutral
2022-04-04 05:30:00,4340.0,4340.0,4270.0,4314.0,258519.0,"Stocks Under Focus on April 4: Dr Reddy’s Labs, HDFC Bank, Auto Companies & More","Stocks Under Focus on April 4: Dr Reddy’s Labs, HDFC Bank, Auto Companies & More",neutral,neutral,-0.599078341013825,neutral,-0.4966696628177481,neutral
2022-04-04 07:08:38,4340.0,4340.0,4270.0,4314.0,258519.0,"Buzzing Stocks | Wipro, TVS Motor, Dr Reddy’s Labs, others in news today",Stocks In the News: Check out the companies making headlines before the opening bell.,neutral,neutral,-0.599078341013825,neutral,-0.4966696628177481,neutral
2022-04-11 22:42:00,4376.0,4408.1,4328.65,4362.4,370258.0,"Torrent Pharma, JB Chemicals in final race to acquire Curatio Healthcare","Dr Reddy’s Laboratories is also understood to have made to the penultimate round of bidding process, people with direct knowledge of the matter told ET. The transaction will see the exit of existing investors such as ChrysCapital and Sequoia Capital. Promoters are expected to stay on with a minority…",positive,neutral,-0.310786106032915,neutral,-1.1261778901401975,negative
2022-04-13 08:15:00,4351.0,4362.35,4290.6,4302.0,368428.0,"Sensex slips for 3rd day, ends 237 pts down; HDFC duo top drags, ITC up 2%","CLOSING BELL: HDFC, HDFC Bank, Maruti Suzuki, Dr Reddy’s Labs, Tata Motors, PowerGrid, Asian Paints, Bajaj Finserv, Kotak Bank, Titan, Cipla, and Eicher Motors were the top laggards on the Nifty index",neutral,neutral,-1.1261778901401975,negative,-0.0935672514619883,neutral
2022-04-22 08:04:00,4296.95,4299.0,4167.0,4192.0,389877.0,"Sensex drops 715 pts, Nifty holds 17150 in broad-based sell-off; banks sink","CLOSING BELL: SBI, HUL, IndusInd Bank, Axis Bank, Dr Reddy’s Labs, Bajaj Finserv, and ICICI Bank fell in the range of 2-3 per cent",neutral,negative,-2.442430095765597,negative,-0.6397590361445827,neutral
2022-04-26 17:30:00,4154.55,4163.7,4072.55,4075.95,197765.0,"Taking Stock | Sensex down 575 points, Nifty below 17,700 ahead of RBI policy","Adani Ports, Titan Company, HDFC, Power Grid Corp and ONGC were among the top Nifty losers. Axis Bank, Divi’s Labs, HUL, Dr Reddy’s Laboratories and ICICI Bank gained the most",negative,positive,-1.8919016499982035,negative,0.3914634146341507,neutral
2022-05-19 14:50:00,3975.0,4299.1,3975.0,4228.0,2478179.0,"Dr Reddy’s Labs Q4 PAT falls 76% on pricing pressure, low export benefit","Dr Reddy’s Q4 results: The revenue was up 15% to Rs 5,437 crore for the quarter under review",negative,positive,6.364779874213837,positive,0.4671577510531513,neutral
2022-05-20 08:47:00,3975.0,4299.1,3975.0,4228.0,2478179.0,"Sensex soars 1,534 pts; Nifty tops 16,250; Dr Reddy’s surges 8%, RIL 6%","CLOSING BELL: Dr Reddy’s Labs, JSW Steel, Nestle India, Tata Motors, Tata Steel, Cipla, Adani Ports, L&T, RIL, Axis Bank, and SBI led from the front, rallying over 3.5 per cent each",positive,positive,6.364779874213837,positive,0.4671577510531513,neutral
2022-05-20 15:54:53,3975.0,4299.1,3975.0,4228.0,2478179.0,"Sensex jumps over 1,500 points to make massive comeback; Nifty ends above 16,250","The Sensex has recovered a major part of the losses suffered on Thursday amid the global meltdown. Dr Reddy’s Laboratories surged 7.71 per cent to ₹4230.75, Nestle India soared 4.96 per cent to ₹16899.30, and Hindustan Unilever jumped 3.29 per cent to ₹2338.05.",positive,positive,6.364779874213837,positive,0.4671577510531513,neutral
2022-05-26 22:34:21,4320.0,4409.0,4268.95,4393.0,433825.0,Torrent Pharma acquires 4 brands from Dr Reddy’s Laboratories,The acquisition will strengthen Torrent’s positioning in gynaecology and urology therapy,neutral,positive,1.6898148148148149,positive,-0.9014532243415035,negative
2022-06-09 15:34:49,4322.9,4364.0,4281.8,4340.5,418556.0,"Sensex snaps 4-day losing run, rises 428 pts; Nifty holds 16,450; RIL up 3%","CLOSING BELL: Dr Reddy’s Labs, Reliance Industries, Bharti Airtel, Sun Pharma, Tech M, and Infosys were the top large-cap gainers",positive,neutral,0.4071340997941281,neutral,-1.3416608836456163,negative
2022-06-09 22:07:16,4322.9,4364.0,4281.8,4340.5,418556.0,Dr Reddy’s subsidiary inks pact with US-based Olema Pharmaceuticals,"Dr Reddy’s Laboratories on Thursday said its subsidiary has inked a pact with US-based Olema Pharmaceuticals Inc to research, develop and commercialise novel small molecule inhibitors of a target",positive,positive,0.4071340997941281,neutral,-1.3416608836456163,negative
2022-06-10 07:01:28,4322.9,4364.0,4281.8,4340.5,418556.0,"Stocks to Watch Today | Bajaj Auto, Dr Reddy’s Labs, Escorts and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,0.4071340997941281,neutral,-1.3416608836456163,negative
2022-06-10 07:43:52,4322.9,4364.0,4281.8,4340.5,418556.0,Dr Reddy’s arm inks pact with US-based Olema Pharmaceuticals,"Olema and Aurigene Discovery Technologies, a wholly-owned unit of Dr Reddy’s Laboratories, have inked an exclusive global licence agreement in this regard.",positive,positive,0.4071340997941281,neutral,-1.3416608836456163,negative
2022-06-10 08:31:04,4322.9,4364.0,4281.8,4340.5,418556.0,"Stocks that will see action on June 10, 2022","Buzzing stocks: IIFL Finance Limited, Dr Reddy’s Laboratories, Welspun Enterprises, HFCL, Bajaj Auto, Shriram Transport Finance Company, KPI Green Energy",neutral,neutral,0.4071340997941281,neutral,-1.3416608836456163,negative
2022-06-14 14:20:06,4306.7,4349.1,4287.05,4326.0,316676.0,Dr Reddy’s Laboratories launches Sorafenib tablets in UK market,"“We are pleased to launch this important generic product, illustrating our continued commitment to bring affordable generic medicines to market for patients,” Dr Reddy’s Laboratories Inc North America Generics CEO Marc Kikuchi said in a statement.",neutral,positive,0.4481389462929895,neutral,-1.4482758620689655,negative
2022-06-22 19:04:54,4295.0,4307.7,4255.0,4283.4,334671.0,Broker’s Call: Dr Reddy’s Laboratories (Buy),Prabhudas Lilladher,neutral,neutral,-0.2700814901047814,neutral,-0.3701989819527996,neutral
2022-06-22 22:47:29,4295.0,4307.7,4255.0,4283.4,334671.0,Trade setup for Thursday: Top 15 things to know before Opening Bell,"Based on the open interest future percentage, a short build-up was seen in 122 stocks including Sun TV Network, Hindustan Copper, Dr Reddy’s Laboratories, Nifty, and Chambal Fertilizers",neutral,positive,-0.2700814901047814,neutral,-0.3701989819527996,neutral
2022-06-24 15:54:00,4322.0,4372.55,4292.0,4306.0,302860.0,Dr Reddy’s Laboratories planning mergers and acquisitions to climb up ladder,"​​​India contributed about a fifth or ₹4,196 crore of the company’s overall sales of ₹21,439 crore in 2021-22, but domestic business has clocked 17% compound annual growth rate in the past four financial years, well above the sector average of 9-10%.",neutral,positive,-0.3701989819527996,neutral,-1.814834596633984,negative
2022-06-24 17:30:00,4322.0,4372.55,4292.0,4306.0,302860.0,"Dr Reddy’s Lab inks settlement pact with Indivior, Aquestive","The said agreement resolves all claims between the parties relating to the company’s products and also covers Indivior’s and Aquestive’s patent infringement allegations, Dr Reddy’s Laboratories said in a regulatory filing.",neutral,positive,-0.3701989819527996,neutral,-1.814834596633984,negative
2022-06-27 06:47:43,4399.85,4399.85,4305.85,4320.0,329646.0,"Stocks to Watch today | Dr Reddy’s Laboratories, Axis Bank, Zomato and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,-1.814834596633984,negative,1.056765028584628,positive
2022-06-27 08:02:55,4399.85,4399.85,4305.85,4320.0,329646.0,"Stocks to Watch Today: Zomato, Axis Bank, Dr Reddy’s Laboratories, and Others","Stocks to watch today: Shares of firms like Zomato, Axis Bank, Dr Reddy’s Laboratories, and others will be in focus in Monday’s trade",neutral,neutral,-1.814834596633984,negative,1.056765028584628,positive
2022-06-27 17:30:00,4329.25,4380.0,4312.0,4375.0,282290.0,"Stocks in news: Zomato, Federal Bank, Tata Power, Axis Bank and more","Stocks in news: Zomato, Federal Bank, Dr Reddy’s Laboratories, Tata Power, Axis Bank and more",neutral,neutral,1.056765028584628,positive,0.2042643042390497,neutral
2022-06-28 15:41:43,4357.1,4408.75,4334.4,4366.0,380946.0,"Sensex finishes day marginally higher at 53,177, Nifty ends at 15,850","In the Sensex pack, Mahindra & Mahindra, Reliance Industries, Dr Reddy’s Laboratories, Tech Mahindra, Tata Steel and Larsen & Toubro were among the gainers.",positive,neutral,0.2042643042390497,neutral,0.0022884604382484,neutral
2022-06-28 16:05:30,4357.1,4408.75,4334.4,4366.0,380946.0,"Sensex, Nifty end flat after volatile session; metal, energy stocks shine","CLOSING BELL: M&M, Tech M, Dr Reddy’s Labs, Reliance Industries, HCL Tech, and Tata Steel were the top gainers on the 30-pack index",neutral,positive,0.2042643042390497,neutral,0.0022884604382484,neutral
2022-06-30 13:20:31,4385.0,4395.0,4290.05,4385.0,304150.0,JB Chem gets board approval to acquire Dr Reddy’s 4 brands for Rs 98 cr,JB Chemicals & Pharmaceuticals on Thursday said its board has approved a proposal to acquire four paediatric brands from Dr Reddy’s Laboratories for about Rs 98 crore,positive,positive,0.0,neutral,-0.5066367116755774,neutral
2022-06-30 17:30:00,4385.0,4395.0,4290.05,4385.0,304150.0,"Dr Reddy’s Laboratories settles patent litigation with Indivior Inc, Aquestive Therapeutics","On June 28, 2022, a US Court dismissed all claims and counterclaims pending in the case with prejudice, pursuant to a joint stipulation of dismissal filed by the parties, the Hyderabad-based drug major said in a statement.",neutral,positive,0.0,neutral,-0.5066367116755774,neutral
2022-07-01 20:35:48,4385.0,4395.0,4290.05,4385.0,304150.0,JB Pharma acquires four brands from Dr Reddy’s Laboratories for ₹98.3 crore,This is the company’s third acquisition in one financial year,neutral,neutral,0.0,neutral,-0.5066367116755774,neutral
2022-07-07 17:30:00,4330.0,4414.95,4304.4,4400.0,415467.0,Andhra plant gets two observations from USFDA: Dr Reddy’s Laboratories,"The inspection was conducted from June 30, 2022 to July 7, 2022.",neutral,neutral,1.6166281755196306,positive,2.668326045008743,positive
2022-07-07 20:52:00,4330.0,4414.95,4304.4,4400.0,415467.0,Dr Reddy’s Laboratories says its Andhra plant gets two observations from USFDA,"The US Food and Drug Administration (USFDA) completed a pre-approval inspection at the company’s formulations manufacturing facility FTO 11 in Srikakulam, Andhra Pradesh on Thursday, Dr Reddy’s said in a regulatory filing. The inspection was conducted from June 30, 2022 to July 7, 2022.",neutral,positive,1.6166281755196306,positive,2.668326045008743,positive
2022-07-07 21:10:33,4330.0,4414.95,4304.4,4400.0,415467.0,Dr Reddy’s Laboratories gets Form 483 from USFDA: This is what it means,Dr Reddy’s Laboratories has said that its Andhra Pradesh plant got two observations from USFDA.,neutral,neutral,1.6166281755196306,positive,2.668326045008743,positive
2022-07-08 01:26:15,4330.0,4414.95,4304.4,4400.0,415467.0,Dr Reddy’s Lab says its Andhra plant gets two observations from USFDA,Dr Reddy’s Laboratories Ltd on Thursday said the US health regulator has issued Form 483 with two observations after inspecting its manufacturing facility located at Srikakulam in Andhra Pradesh.,neutral,neutral,1.6166281755196306,positive,2.668326045008743,positive
2022-07-08 15:41:05,4330.0,4414.95,4304.4,4400.0,415467.0,"Sensex up 303 pts, Nifty tops 16,200; banks, FMCG shine; metals sole losers","CLOSING BELL: L&T, PowerGrid, NTPC, ICICI Bank, DR Reddy’s Labs, Axis Bank, Bharti Airtel, and Nestle India were the top large-cap gainers",neutral,neutral,1.6166281755196306,positive,2.668326045008743,positive
2022-07-08 17:30:00,4330.0,4414.95,4304.4,4400.0,415467.0,"Stocks in news: TCS, Tata Power, Adani Ports, M&M and more","Stocks in news: TCS, Tata Power, Adani Ports, M&M, Dr Reddy’s Laboratories, Shriram City Union Finance, Kalpataru Power Transmission and more",neutral,neutral,1.6166281755196306,positive,2.668326045008743,positive
2022-07-08 19:00:53,4330.0,4414.95,4304.4,4400.0,415467.0,"Stocks to Watch Today: TCS, Tata Motors, Vedanta, Dr Reddy’s Labs, and Others","Stocks to watch today: Shares of firms like TCS, Tata Motors, Vedanta, and others will be in focus in Friday’s trade",neutral,neutral,1.6166281755196306,positive,2.668326045008743,positive
2022-07-08 22:00:00,4330.0,4414.95,4304.4,4400.0,415467.0,Dr Reddy’s Laboratories launches generic version of fesoterodine fumarate tablets in US,"The company’s fesoterodine fumarate extended-release tablets are available in 4 mg and 8 mg tablets, each in bottle count sizes of 30. These are the therapeutic generic equivalent of Toviaz, it added. Citing IQVIA data, Dr Reddy’s said the Toviaz brand had US sales of approximately USD 211 million f…",neutral,neutral,1.6166281755196306,positive,2.668326045008743,positive
2022-07-11 17:30:00,4470.1,4539.0,4426.0,4465.1,414659.0,"Stocks in news: Tata Motors, TCS, Avenue Supermarts, Dr Reddy’s Labs and more","Stocks in news: Tata Motors, Aurobindo Pharma, TCS, M&M, Avenue Supermarts, Dr Reddy’s Laboratories and more",neutral,neutral,-0.1118543209324176,neutral,0.1223717877405718,neutral
2022-07-26 16:48:34,4207.95,4300.0,4163.0,4285.0,372203.0,"Taking Stock | Second day of selling pulls market down, all eyes on Fed meeting","Infosys, HUL, Axis Bank, Dr Reddy’s Laboratories and Bajaj Auto were among the top Nifty losers, while gainers included Bajaj Finserv, JSW Steel, Grasim Industries, Bharti Airtel and Coal India",neutral,neutral,1.831057878539436,positive,-1.3444598980064904,negative
2022-07-27 14:10:11,4314.0,4314.9,4195.0,4256.0,565614.0,"Dr Reddy’s Q1 revenue may grow up to 10% YoY, margins may expand: Analysts","Dr Reddy’s Labs Q1 results preview: Analysts said that despite pricing pressures in the US, the company is likely to have recorded steady growth in this segment due to a ramp-up of new products.",positive,positive,-1.3444598980064904,negative,-2.198209397673886,negative
2022-07-28 06:35:37,4314.0,4314.9,4195.0,4256.0,565614.0,"Stocks to Watch Today | Tata Motors, Dr Reddy’s Labs, Biocon and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,-1.3444598980064904,negative,-2.198209397673886,negative
2022-07-29 07:01:57,4182.95,4182.95,4055.6,4091.0,1952153.0,"Stocks to Watch Today | HDFC, Vedanta, Dr Reddy’s Labs and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,-2.198209397673886,negative,-0.6920624184743356,neutral
2022-07-29 07:44:05,4182.95,4182.95,4055.6,4091.0,1952153.0,"Stocks to Watch Today: Vedanta, DRL, Sun Pharma, Indian Oil, Ashok Leyland, and Others","Stocks to watch today: Shares of firms like Vedanta, Dr Reddy’s Laboratories, Sun Pharma, Indian Oil, Ashok Leyland, and others will be in focus in Friday’s trade",neutral,neutral,-2.198209397673886,negative,-0.6920624184743356,neutral
2022-07-29 11:14:00,4182.95,4182.95,4055.6,4091.0,1952153.0,Dr Reddy’s Labs net profit doubles in Q1: What should investors do?,"Share of the pharma major fell about 4 per cent in the first one hour of the trade on Friday. Experts see concerns over the US business, as well as, pressure on operating performance as key drags. Despite near-term headwinds, most brokerage firms maintained their rating and target prices but slashed…",positive,negative,-2.198209397673886,negative,-0.6920624184743356,neutral
2022-07-29 16:53:25,4182.95,4182.95,4055.6,4091.0,1952153.0,Gainers & Losers: 10 stocks that moved the most on July 29,"SBI Life Insurance, Tata Steel, Sun Pharma, HDFC Life and Hindalco Industries were among the major gainers on the Nifty, while losers were Dr Reddy’s Labs, Kotak Mahindra Bank, SBI, Divis Labs and Axis Bank.",neutral,positive,-2.198209397673886,negative,-0.6920624184743356,neutral
2022-08-08 15:34:49,4156.85,4234.0,4156.85,4220.0,407281.0,"Sensex soars 465 pts, Nifty tops 17,500; all except PSBs rally; SBI dips 2%","CLOSING BELL: Coal India, M&M, Bajaj Finserv, HDFC Bank, Hindalco, Axis Bank, NTPC, L&T, HDFC, Dr Reddy’s Labs, RIL, IndusInd Bank, and Apollo Hospitals were the top gainers on the 50-pack index today",neutral,positive,1.5191791861625903,positive,-0.0848336318220464,neutral
2022-08-15 10:57:47,4275.0,4319.0,4262.8,4300.0,262439.0,"Pharma@75: More innovation hubs need to come up in the country, says Satish Reddy",Chairman of Dr Reddy’s Laboratories says the pandemic has taught us to be resilient,neutral,positive,0.5847953216374269,neutral,-0.1146377331835667,neutral
2022-08-17 00:51:00,4317.95,4329.9,4291.75,4313.0,432805.0,Pharma Inc sets sights on monkeypox vax,"Pune-based Serum Institute of India , Reliance Life Sciences, Dr Reddy’s Laboratories, Biological E and two state-owned units - Mumbai-based Haffkine Institute and Indian Immunologicals Ltd - are among those that have come forward to join hands with the Indian Council of Medical Research (ICMR) to d…",neutral,neutral,-0.1146377331835667,neutral,-0.3773584905660377,neutral
2022-08-17 10:27:00,4317.95,4329.9,4291.75,4313.0,432805.0,At least 8 Indian companies working to develop monkeypox vaccine: Report,"Among the companies that are working with ICMR are Serum Institute of India (SII), Reliance Life Sciences, Dr Reddy’s Laboratories, and Biological E",neutral,neutral,-0.1146377331835667,neutral,-0.3773584905660377,neutral
2022-08-18 15:31:04,4232.0,4247.1,4185.0,4188.0,385158.0,Dr.Reddy’s Lab declines on profit selling,"Dr.Reddy’s Laboratories shed 1.90% to Rs 4,237.65 on profit booking after rising in the past nine trading sessions.",negative,negative,-1.0396975425330812,negative,0.1655033460459004,neutral
2022-08-19 23:09:50,4232.0,4247.1,4185.0,4188.0,385158.0,US ranitidine litigation unlikely to impact Indian pharma: Analysts,"Sun Pharmaceuticals, Dr Reddy’s Laboratories, Perrigo and Teva have agreed to a combined settlement of $5 mn with cancer patient Joseph Bayer",neutral,positive,-1.0396975425330812,negative,0.1655033460459004,neutral
2022-08-26 06:46:47,4273.0,4275.0,4212.15,4223.7,161783.0,"Stocks to Watch Today | Dr Reddy’s Laboratories, Syrma SGS Technology, Eicher Motors, and others in news today",Stocks to Watch: Check out the companies making headlines before the opening bell.,neutral,neutral,-1.1537561432249048,negative,0.9892086330935252,positive
2022-08-26 07:52:08,4273.0,4275.0,4212.15,4223.7,161783.0,"Stocks to Watch Today: HDFC Bank, Eicher Motors, Dr Reddy’s Laboratories, and Others","Stocks to watch today: Shares of firms like HDFC Bank, Eicher Motors, Dr Reddy’s Laboratories, and others will be in focus in Friday’s trade",neutral,neutral,-1.1537561432249048,negative,0.9892086330935252,positive
2022-08-26 17:30:00,4273.0,4275.0,4212.15,4223.7,161783.0,"Stocks in news: Syrma SGS, HDFC Bank, Dr Reddy’s Laboratories, ICICI Prudential and more","Stocks in news: Syrma SGS, HDFC Bank, Dr Reddy’s Laboratories, ICICI Prudential, Inox Wind Energy, PVR and more",neutral,neutral,-1.1537561432249048,negative,0.9892086330935252,positive
2022-09-22 22:49:35,4163.0,4214.75,4129.5,4141.0,331507.0,Trade setup for Friday: Top 15 things to know before the opening bell,"Based on the open interest future percentage, there were 46 stocks including Metropolis Healthcare, Berger Paints, Dabur India, Dr Reddy’s Laboratories, and Escorts in which a short-covering was seen",neutral,neutral,-0.5284650492433342,neutral,0.1893571567294664,neutral
2022-09-29 15:47:44,4382.55,4405.0,4272.05,4324.85,631939.0,"F&O expiry: Nifty holds 16,800, Sensex dips 188 pts day ahead of RBI policy","CLOSING BELL: ITC, Dr Reddy’s Labs, Tata Steel, Sun Pharma, M&M, NTPC, and Nestle India were the top large-cap winners, while Asian Paints, Tech M, Wipro, TCS, Titan, Kotak Bank sank",neutral,neutral,-1.3165850931535252,negative,2.282734646581692,positive
2022-10-03 17:48:00,4446.0,4449.9,4376.05,4414.0,307530.0,LIC increases its stake in Dr Reddy’s Laboratories to 7.7%,"Between June 15, 2022 and September 30, 2022 LIC purchased 33,86,486 shares of DRL, aggregating 2.034 per cent stake from the open market, it added.",positive,positive,-0.7197480881691408,neutral,-0.8126599114076754,neutral
2022-10-03 17:52:02,4446.0,4449.9,4376.05,4414.0,307530.0,LIC increases its stake in Dr Reddy’s Laboratories to 7.7% from 5.65%,Dr Reddy’s Laboratories Ltd said Life Insurance Corporation of India has increased its stake to 7.7% in the pharmaceutical firm through purchase of 33.86 lakh shares,positive,positive,-0.7197480881691408,neutral,-0.8126599114076754,neutral
2022-10-04 12:31:11,4446.0,4449.9,4376.05,4414.0,307530.0,LIC buys over 2% stake in Dr Reddy’s Labs,The state-run insurance major on Monday (3 October 2022) announced that it acquired 2.03% stake in the drug major.,neutral,positive,-0.7197480881691408,neutral,-0.8126599114076754,neutral
2022-10-11 16:24:00,4300.0,4310.0,4215.05,4238.15,293686.0,"India facilities of Cipla, Dr Reddy’s Labs, Mondelez join WEF’s Global Lighthouse Network","The World Economic Forum on Tuesday announced the addition of 11 factories and industrial sites, including three from India, to its Global Lighthouse Network. From India, the additions are pharma major Cipla’s Indore facility, Dr Reddy’s Laboratories’ Hyderabad facility and the Mondelez facility in …",neutral,positive,-1.4383720930232644,negative,0.448240567536093,neutral
2022-10-12 00:11:22,4300.0,4310.0,4215.05,4238.15,293686.0,"India facilities of Cipla, Dr Reddy’s Labs, join Global Lighthouse Network","The World Economic Forum on Tuesday announced the addition of 11 factories and industrial sites, including three from India, to its Global Lighthouse Network.",neutral,positive,-1.4383720930232644,negative,0.448240567536093,neutral
2022-10-13 17:30:00,4305.0,4340.0,4263.05,4304.3,248521.0,"HCL Tech, Sun Pharma, Wipro and SBI among top gainers & losers as market ends lower","Top Gainers and Losers of the day (October 13): HCL Tech, Sun Pharma, Wipro, SBI, L&T, ICICI Bank, Dr Reddy’s Labs, Reliance Industries and more",neutral,neutral,-0.0162601626016217,neutral,0.8130081300813009,neutral
2022-10-23 11:14:00,4364.8,4384.0,4355.0,4384.0,31348.0,"Dr Reddy’s, Cipla, Aurobindo units recall products in US market","As per the enforcement report by the US Food and Drug Administration (USFDA), the US-based unit of Dr Reddy’s Laboratories is recalling 2,838 ampules of vitamin K deficiency treatment drug Phytonadione Injectable Emulsion. According to the USFDA, Dr Reddy’s Laboratories is recalling the affected lot…",negative,neutral,0.4398826979472098,neutral,1.1685782298203895,positive
2022-10-23 11:59:50,4364.8,4384.0,4355.0,4384.0,31348.0,"Dr Reddy’s, Cipla, Aurobindo Units Recall Products In U.S. Market","According to the USFDA, Dr Reddy’s Laboratories is recalling the affected lot due to “failed stability specifications.”",neutral,negative,0.4398826979472098,neutral,1.1685782298203895,positive
2022-10-23 12:08:51,4364.8,4384.0,4355.0,4384.0,31348.0,"Dr Reddy’s, Cipla, and Aurobindo units recall products in US market","Leading drug firms Dr Reddy’s Laboratories, Cipla and Aurobindo Pharma are recalling different products in the US market for various issues, according to the US Food and Drug Administration",negative,negative,0.4398826979472098,neutral,1.1685782298203895,positive
2022-10-27 15:36:43,4485.0,4502.75,4430.0,4444.2,352468.0,"F&O expiry: Sensex rises 213 pts, Nifty holds 17,750; metals rally, IT slip","CLOSING BELL: Tata Steel, Power Grid, Sun Pharma, Axis Bank, Bharti Airtel, Kotak Bank, M&M, HDFC, Dr Reddy’s Labs, and Titan were the leading winners",positive,positive,-0.9096989966555225,negative,-2.285367468549993,negative
2022-10-28 17:30:00,4485.0,4502.75,4430.0,4444.2,352468.0,"Stocks in news: Maruti Suzuki, Vedanta, SBI Cards, Tata Chemicals and more","Stocks to watch out for today: Maruti Suzuki, Vedanta, Dr Reddy’s Laboratories, Tata Power,Indus Towers, SBI Cards, PNB Housing Finance, Tata Chemicals and more",neutral,neutral,-0.9096989966555225,negative,-2.285367468549993,negative
2022-10-28 17:50:10,4485.0,4502.75,4430.0,4444.2,352468.0,Dr Reddy’s Laboratories consolidated net profit rises 11.89% in the September 2022 quarter,Sales rise 9.41% to Rs 6305.70 crore,positive,positive,-0.9096989966555225,negative,-2.285367468549993,negative
2022-10-28 18:27:00,4485.0,4502.75,4430.0,4444.2,352468.0,"Dr Reddy’s Laboratories sees generic Revlimid, other launches to keep US business firing","The Hyderabad-based drug maker on Friday reported its highest ever revenues, largely driven by generic Revlimid launch during the second quarter of FY23, and partly due to favorable movement of forex rates and rebound of Russia business.",positive,positive,-0.9096989966555225,negative,-2.285367468549993,negative
2022-10-28 18:49:50,4485.0,4502.75,4430.0,4444.2,352468.0,"Dr Reddy’s PAT up 12% at Rs 1,113 cr in Q2; revenue rises 9% to Rs 6,305 cr","Dr Reddy’s Laboratories Ltd said its consolidated profit after tax (PAT) for the quarter ended September 30, 2022 was up by 12 per cent at Rs 1,112.80 crore",positive,positive,-0.9096989966555225,negative,-2.285367468549993,negative
2022-10-31 22:11:18,4435.25,4580.0,4435.25,4539.85,1068419.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest future percentage, there were 107 stocks including Nifty Financial, Voltas, JK Cement, Dr Reddy’s Laboratories, and Metropolis Healthcare, in which a long build-up was seen.",neutral,neutral,2.358378896341815,positive,0.3289292747054448,neutral
2022-11-01 18:25:47,4545.05,4645.0,4545.05,4560.0,740895.0,Buy Dr Reddy’s Laboratories; target of Rs 5215: ICICI Direct,"ICICI Direct is bullish on Dr Reddy’s Laboratories recommended buy rating on the stock with a target price of Rs 5215 in its research report dated October 29, 2022.",neutral,positive,0.3289292747054448,neutral,0.8418118160965037,neutral
2022-11-01 19:05:54,4545.05,4645.0,4545.05,4560.0,740895.0,Buy Dr Reddy’s Labs; target of Rs 5180: Motilal Oswal,"Motilal Oswal is bullish on Dr Reddy’s Labs recommended buy rating on the stock with a target price of Rs 5180 in its research report dated October 29, 2022.",neutral,positive,0.3289292747054448,neutral,0.8418118160965037,neutral
2022-11-02 00:06:40,4545.05,4645.0,4545.05,4560.0,740895.0,ICMR picks 6 firms for monkeypox vaccines,"These companies are: Serum Institute of India, Biological E, Dr Reddy’s Laboratories, Hester Bioscience, Indian Immunologicals and Reliance Life Sciences",neutral,neutral,0.3289292747054448,neutral,0.8418118160965037,neutral
2022-11-06 12:01:49,4531.0,4547.3,4444.4,4485.7,419124.0,"Dr Reddy’s lines up Rs 1,500 cr capex, to focus on biosimilars, injectables","Dr Reddy’s Labs has earmarked a capex of about Rs 1,500 crore for FY23 with major part of it slated to go into building capacities for its biosimilar and injectable businesses, CFO Parag Agarwal said",neutral,neutral,-0.9997792981681788,negative,-0.289647577092503,neutral
2022-11-06 12:16:00,4531.0,4547.3,4444.4,4485.7,419124.0,"Dr Reddy’s Labs lines up Rs 1,500 crore capex with focus on biosimilars, injectables","Elaborating on the overall strategies, Dr Reddy’s Laboratories CEO Erez Israeli said the company’s R&D is focusing on creating “as much as possible on differentiated products, on biosimilars, on products that have bigger potential.”",neutral,neutral,-0.9997792981681788,negative,-0.289647577092503,neutral
2022-11-10 15:49:27,4572.2,4579.0,4502.0,4525.0,324370.0,"Sensex dips 420 pts on weak global cues; Aurobindo Pharma down 12%, TaMo 5%","CLOSING BELL: Hero MotoCorp, HDFC Bank, Kotak Bank, ONGC, Bharti Airtel, and Dr Reddy’s Labs, meanwhile, eked out gains up to 2.6 per cent",negative,positive,-1.032325795022086,negative,-0.7272727272727273,neutral
2022-11-10 17:30:00,4572.2,4579.0,4502.0,4525.0,324370.0,"ITC, Dr Reddy’s Labs, PowerGrid, Tech Mahindra among top gainers & losers as market ends lower","Top Gainers and Losers of the day (November 9): ITC, Dr Reddy’s Labs, Kotak Mahindra Bank, PowerGrid, Tech Mahindra, Sun Pharma, Bajaj Finserv and more",neutral,neutral,-1.032325795022086,negative,-0.7272727272727273,neutral
2022-11-14 14:30:48,4367.2,4442.6,4363.7,4435.0,374058.0,Pharma stocks slip on concerns over first anti-competitive US lawsuit against ‘Revlimid’ makers,"The suit is expected to impact Natco Pharma, Dr Reddy’s Labs, Cipla, and Zydus Lifesciences. All these companies had launched Revlimid during the second COVID-19 wave in September 2021",negative,neutral,1.5524821395860091,positive,0.8198662501550723,neutral
2022-11-15 22:29:17,4433.65,4544.95,4393.2,4470.0,521816.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest future percentage, there were 69 stocks in which a short-covering was seen, including Gujarat Gas, Manappuram Finance, Deepak Nitrite, Crompton Greaves Consumer Electrical, and Dr Reddy’s Laboratories",neutral,neutral,0.8198662501550723,neutral,-1.472901951595086,negative
2022-11-16 15:46:28,4480.95,4488.45,4382.35,4414.95,311790.0,"Taking Stock | Sensex, Nifty end flat amid volatility; power, realty, metals top drags","Kotak Mahindra Bank, Coal India, HDFC Bank, Dr Reddy’s Laboratories and HUL were among the top Nifty gainers",neutral,neutral,-1.472901951595086,negative,-0.4781011585193475,neutral
2022-11-22 17:31:00,4380.0,4420.0,4360.0,4415.2,392528.0,Dr Reddy’s Laboratories among other generic pharma companies in US to face antitrust litigation,"“The complaint, which purports to be on behalf of a class of indirect purchasers, asserts claims under federal and state antitrust laws and other state laws alleging that the defendants improperly restrained competition and maintained a shared monopoly in the sale of brand and generic Revlimid throu…",negative,neutral,0.8036529680365256,neutral,-0.2416604557670984,neutral
2022-12-04 12:04:00,4529.9,4532.0,4450.15,4475.6,391997.0,"Dr Reddy’s, Sun Pharma recall products in US for manufacturing issues","New Jersey-based Dr Reddy’s Laboratories, Inc initiated the Class III recall on November 21 this year. As per USFDA, a Class III recall is initiated in a “situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences”.",negative,neutral,-1.1987019581006044,negative,-1.9013026613753097,negative
2022-12-04 13:13:15,4529.9,4532.0,4450.15,4475.6,391997.0,Why Dr Reddy’s and Sun Pharma are recalling certain products from US market,"As per the enforcement report by the US health regulator, the US-based arm of Dr Reddy’s Laboratories is recalling over 48,000 cartons of a drug used to treat sneezing, runny or stuffy nose. It is recalling 25,176 cartons of 30-count tablets and 22,968 cartons of 20-count tablets.",negative,negative,-1.1987019581006044,negative,-1.9013026613753097,negative
2022-12-05 15:36:33,4460.1,4474.45,4359.05,4375.3,348271.0,"Sensex, Nifty end flat after volatile day; Metal index up 2%, RIL down 1.5%","CLOSING BELL: RIL (down 1.45 per cent), Tech M, Dr Reddy’s Labs, Bharti Airtel, Axis Bank, and TCS were the top laggards",positive,neutral,-1.9013026613753097,negative,-0.3997709049255399,neutral
2022-12-06 15:54:45,4365.0,4383.0,4320.0,4347.55,330836.0,"Taking Stock | Sensex down 208 points, Nifty slips below 18,650; all eyes on RBI policy","BPCL, Tata Steel, Hindalco Industries, Dr Reddy’s Laboratories and UPL were among the top Nifty losers",negative,negative,-0.3997709049255399,neutral,-0.6184341384789533,neutral
2022-12-06 21:25:24,4365.0,4383.0,4320.0,4347.55,330836.0,Trade setup for today: Top 15 things to know before the opening bell,"Based on the open interest future percentage, a short build-up is seen in 62 stocks, including IRCTC, Colgate Palmolive, Dr Reddy’s Laboratories, Tata Chemicals, and Crompton Greaves Consumer Electrical",neutral,neutral,-0.3997709049255399,neutral,-0.6184341384789533,neutral
2022-12-19 14:07:00,4380.0,4390.0,4308.1,4366.9,242621.0,Dr Reddy’s Lab completes Phase 1 study of proposed arthritis drug,Dr Reddy’s Laboratories Ltd on Monday said it has successfully completed the Phase 1 study of its proposed biosimilar of Tocilizumab to be used in the treatment of rheumatoid arthritis in adults.,positive,positive,-0.2990867579908759,neutral,0.7545748239135192,neutral
2022-12-19 17:30:00,4380.0,4390.0,4308.1,4366.9,242621.0,"Stocks in news: Tata Motors, YES Bank, Sun Pharma, Tech Mahindra, and more","Stocks to watch out for today: Sun Pharma, Tech Mahindra, Tata Motors, Dr Reddy’s Laboratories, YES Bank, Jindal Steel, The Phoenix Mills, PNB Housing Finance and more",neutral,neutral,-0.2990867579908759,neutral,0.7545748239135192,neutral
2022-12-19 22:04:19,4380.0,4390.0,4308.1,4366.9,242621.0,Pharma industry needs govt’s research-push to scale innovation challenges: Satish Reddy,The Chairman of Dr Reddy’s Laboratories has said the current approval process for biotech products needs an overhaul,neutral,positive,-0.2990867579908759,neutral,0.7545748239135192,neutral
2022-12-27 17:41:16,4250.85,4266.65,4215.95,4251.7,217286.0,Broker’s call: Dr Reddy’s Laboratories (Buy),Axis Securities,neutral,neutral,0.0199960007998271,neutral,-0.4023391812865455,neutral
2022-12-29 09:50:22,4275.0,4354.65,4223.05,4257.8,809946.0,Dr Reddys Lab climbs after US court dismisses claims against generic Revlimid,Dr Reddy’s Laboratories rose 1.10% to Rs 4300 after a US court dismissed all claims against the pharma major in an anti-trust complaint pertaining to cancer drug Revlimid.,positive,positive,-0.4023391812865455,neutral,-1.053738317757018,negative
2022-12-29 11:53:00,4275.0,4354.65,4223.05,4257.8,809946.0,Claims against Dr Reddy’s over Revlimid in US dismissed,"Dr Reddy’s Laboratories on Thursday said all claims against it in the antitrust litigation filed in the US, related to a prescription medicine Revlimid, used in treatment of multiple myeloma have been dismissed.",negative,negative,-0.4023391812865455,neutral,-1.053738317757018,negative
2022-12-29 14:17:42,4280.0,4285.1,4225.0,4234.9,176121.0,There’s no going back on digitalisation: Satish Reddy of Dr Reddy’s Laboratories,"In a recent interaction with businessline, he speaks on multiple issues, including quality concerns involving drugmakers and the M&A activity in the industry",neutral,neutral,-1.053738317757018,negative,-0.5518051071323745,neutral
2022-12-29 14:26:42,4280.0,4285.1,4225.0,4234.9,176121.0,Claims against Dr Reddy’s Laboratories over Revlimid in US dismissed,"Dr Reddy’s Laboratories on Thursday said all claims against it in the antitrust litigation filed in the US, related to a prescription medicine Revlimid, used in treatment of multiple myeloma have been dismissed.",negative,negative,-1.053738317757018,negative,-0.5518051071323745,neutral
2023-01-22 11:43:00,4359.95,4365.45,4319.35,4340.0,153887.0,"Q3 results this week: Axis Bank, Maruti Suzuki, Tata Motors, Bajaj Finance, NTPC and more","Tata Motors, Bajaj Auto, DLF, Cipla, Dr Reddy’s Laboratories, Torrent Pharmaceuticals, Patanjali Foods, Tata Elxsi, Solar Industries India, and Indian Bank, are slated to come out with Q3 earnings on Jan 25.",neutral,neutral,-0.4575740547483301,neutral,-2.1227827689472387,negative
2023-01-25 17:30:00,4260.0,4268.9,4175.1,4200.0,293583.0,"Dr Reddy’s PAT up by 77% at Rs 1,247 crore in Q3","Dr Reddy’s Laboratories Ltd on Friday said its consolidated profit after tax (PAT) for the quarter ended December 31, 2022, was up by 77 percent at Rs 1,247.1 crore as against Rs 706.5 crore in the same quarter a year ago",positive,positive,-1.4084507042253522,negative,0.7581775700934537,neutral
2023-01-25 17:38:55,4260.0,4268.9,4175.1,4200.0,293583.0,"Dr Reddy’s Lab Q3 net up 77% at Rs 1,247 cr, revenue from operations jump","Dr Reddy’s Laboratories on Wednesday reported a 77 per cent increase in its consolidated net profit at Rs 1,247 crore in the third quarter ended December 31, 2022.",positive,positive,-1.4084507042253522,negative,0.7581775700934537,neutral
2023-01-27 07:51:22,4280.0,4380.9,4253.35,4312.45,952089.0,Dr Reddys shares: Should you buy the pharma stock as Q3 net profit rises 77%?,Dr Reddy’s Laboratories Ltd reported a bigger-than-expected 77% jump in third quarter ended December 2022 net profit,positive,positive,0.7581775700934537,neutral,0.2303267398928186,neutral
2023-01-27 09:51:18,4280.0,4380.9,4253.35,4312.45,952089.0,Dr Reddy’s Q3 consolidated profit jumps 77%; what should investors do with the stock?,"Dr Reddy’s Laboratories reported a 77 percent growth in consolidated net profit at Rs 1,247 crore for the quarter ended December 31, 2022 as against Rs 707 crore a year ago. On a sequential basis, the profit grew 12 percent.",positive,positive,0.7581775700934537,neutral,0.2303267398928186,neutral
2023-01-27 10:17:42,4280.0,4380.9,4253.35,4312.45,952089.0,"Dr Reddy’s Lab jumps Q3 PAT soars 76% to Rs 1,247 cr","Dr Reddy’s Laboratories surged 3.41% to Rs 4,348 after the drug major’s consolidated net profit jumped 76.52% to Rs 1,247.1 crore on 27.26% rise in revenues to Rs 6,770 crore in Q3 FY23 over Q3 FY22.",neutral,positive,0.7581775700934537,neutral,0.2303267398928186,neutral
2023-01-27 10:34:00,4280.0,4380.9,4253.35,4312.45,952089.0,"Hot Stocks: Brokerages on Bajaj Auto, Dr Reddy’s Laboratories, Tata Motors and Cipla post Q3 results","EBITDA margin improved by 176 bps YoY to 24.2% despite soft Revlimid sales, mainly driven by an improvement in the mix. The net profit grew by 9.9% YoY to Rs8bn mainly on the back of a strong operational performance, which was partially offset by a higher tax rate on account of DTA reversal.",neutral,positive,0.7581775700934537,neutral,0.2303267398928186,neutral
2023-02-06 17:30:00,4380.65,4468.25,4360.25,4434.0,596434.0,"Tata Motors, Bajaj Auto, Coal India: Nifty cos that led FY24 earnings upgrades post Q3 results","Tata Motors (up 19.3 per cent), followed by Bajaj Auto (5.9 per cent), Dr Reddy’s Labs (5.3 per cent), and Coal India (4.2 per cent) have seen the highest upgrades to FY24 earnings estimates.",positive,positive,1.2178557976556077,positive,0.7640449438202248,neutral
2023-02-07 15:53:31,4450.0,4496.6,4432.65,4484.0,239117.0,"Sensex drops 221 pts day ahead of RBI decision; Adani Ent up 15%, Paytm 5%","CLOSING BELL: Adani Enterprises (up 15 per cent), Dr Reddy’s Labs, Adani Ports, Kotak Bank, IndusInd Bank, Bajaj Finance, Bajaj Auto, ONGC, JSW Steel, and Eicher Motors led the recovery",positive,positive,0.7640449438202248,neutral,0.9225922592259226,positive
2023-02-17 11:47:52,4501.2,4535.0,4463.5,4520.1,210078.0,Dr Reddy’s Labs trades lower despite robust Q3 as Credit Suisse flags EBITDA worries,"According to Credit Suisse, Suboxone still constitutes about 7 percent of Dr Reddy’s Labs’ base EBITDA, and the entry of Apotex could potentially impact 40 percent of DRL’s EBITDA from Suboxone or 3 percent of consolidated EBITDA.",negative,neutral,0.4198880298587165,neutral,-1.0121681415929202,negative
2023-02-21 16:38:43,4486.9,4520.2,4469.4,4482.0,176341.0,Pharma sector gets first tranche of payment under under PLI scheme,"Dr Reddy’s Laboratories Limited, Biocon Limited, Strides Pharma Science Limited and Premier Medical Corporation Private Limited have been granted the incentives in the first phase",neutral,neutral,-0.1092068020236608,neutral,-0.5372980943231871,neutral
2023-03-06 16:48:00,4437.0,4458.8,4416.05,4440.0,175306.0,Sun Pharma reports “information security incident”; isolates impacted IT assets,"“The company is investigating the matter and appropriate containment and remediation actions are being taken in a controlled manner to address the incident,” the drug maker said. In 2020, drug makers Dr Reddy’s Laboratories and Lupin had also reported cyber security breaches.",neutral,neutral,0.0676132521974307,neutral,-0.3913828107376577,neutral
2023-03-07 17:13:00,4433.0,4444.0,4401.25,4415.65,234316.0,"Dr Reddy’s Lab recalls over 4,000 bottles of generic drug in US","New Jersey-based Dr Reddy’s Laboratories Inc, a unit of the company, is recalling the affected lot due to “Presence of one Tacrolimus 1 mg capsule co-mingled in a bottle containing and labeled as Tacrolimus 0.5 mg capsules,” USFDA said in its latest Enforcement Report. The affected lot was produced …",negative,negative,-0.3913828107376577,neutral,-0.8186790166793029,neutral
2023-03-07 19:35:39,4433.0,4444.0,4401.25,4415.65,234316.0,"Dr Reddy’s Laboratories Recalls Over 4,000 Bottles Of Generic Drug In U.S.","Dr Reddy’s Laboratories is recalling over 4,000 bottles of a generic drug in the U.S. due to a packaging error.",neutral,negative,-0.3913828107376577,neutral,-0.8186790166793029,neutral
2023-03-07 22:56:16,4433.0,4444.0,4401.25,4415.65,234316.0,"Dr Reddy’s recalls over 4,000 bottles of drug in US due to packaging error","Dr Reddy’s Laboratories is recalling over 4,000 bottles of a generic drug in the US due to a packaging error.",negative,negative,-0.3913828107376577,neutral,-0.8186790166793029,neutral
2023-03-16 15:14:43,4405.7,4463.15,4383.75,4455.25,618099.0,Eris Lifesciences Acquires Nine Derma Brands From Dr Reddy’s For Rs 275 Crore,The brands owned by Dr Reddy’s Laboratories earned Rs 62.1 crore in the 11 months through February 2023.,neutral,neutral,1.1246793926050385,positive,-0.0970435567592006,neutral
2023-03-16 18:06:00,4405.7,4463.15,4383.75,4455.25,618099.0,Eris Lifesciences acquires 9 dermatology brands from Dr Reddy’s for Rs 275 cr,"The transaction will be financed through borrowings and will achieve financial closure in the next few days, the drug firm said. In a separate statement, Dr Reddy’s Laboratories said Eris Lifesciences will be assigned the trademark of the brands.",neutral,neutral,1.1246793926050385,positive,-0.0970435567592006,neutral
2023-03-17 17:30:00,4405.7,4463.15,4383.75,4455.25,618099.0,Eris Lifescience shares hit 52-week low; here’s why analysts see up to 40% potential rise,Eris Lifesciences will acquire the part of the dermatology portfolio of Dr Reddy’s Labs including nine trademarks along with their applicable line exentions for a consideration of Rs 275 crore.,positive,neutral,1.1246793926050385,positive,-0.0970435567592006,neutral
2023-03-24 13:50:01,4449.95,4498.0,4449.95,4455.1,225340.0,Dr Reddy’s Laboratories to surrender certificate of registration of NBFC arm,"Dr. Reddy’s Laboratories Ltd stated that the Board of Directors has decided to surrender the certificate of registration of Imperial Credit Pvt Ltd as a non-banking finance company, in an exchange filing today. Imperial Credit Pvt Ltd is a wholly-owned subsidiary of the company and was acquired in …",neutral,neutral,0.1157316374341407,neutral,-0.0890868596881959,neutral
2023-03-27 17:30:00,4498.95,4547.1,4480.0,4541.55,366805.0,"Bajaj Finserv, Dr Reddy’s Labs, Hindalco: How should you trade these stocks",Bajaj Finserv is maintaining lower top-lower bottom formation. The momentum indicator viz MACD is negatively poised and the stock has poor relative strength.,neutral,negative,0.9468876071083334,positive,0.3428985921375191,neutral
2023-03-29 07:43:26,4549.45,4575.0,4522.15,4565.05,416085.0,"Bias for Nifty likely to remain bearish below 17,210: Vinay Rajani","Among individual stocks, the technical & derivative analyst from HDFC Securities recommends to Buy Mahanagar Gas and Dr.Reddy’s Labs.",neutral,neutral,0.3428985921375191,neutral,1.2437268164957451,positive
2023-03-29 09:05:29,4549.45,4575.0,4522.15,4565.05,416085.0,"Bias for Nifty likely to remain bearish below 17,210: HDFC Securities","Among individual stocks, the technical & derivative analyst from HDFC Securities recommends to Buy Mahanagar Gas and Dr.Reddy’s Labs.",neutral,neutral,0.3428985921375191,neutral,1.2437268164957451,positive
2023-04-12 17:30:00,4888.0,4888.0,4831.2,4854.0,232079.0,"Taking Stock | Sensex slips 398 points, Nifty below 17,000; PSU bank, metal, realty worst hit","Bajaj Finserv, Bajaj Finance, Adani Enterprises, Tata Steel and Hindalco Industries were among the biggest Nifty losers. Cipla, Kotak Mahindra Bank, Dr Reddy’s Laboratories, Infosys and Apollo Hospitals gained the most",negative,positive,-0.6955810147299509,neutral,-0.5772050154297181,neutral
2023-05-05 16:56:00,4974.95,4989.0,4925.55,4927.05,91839.0,Dr Reddy’s Laboratories launches Regadenoson injection in US market,"The injection is a pharmacologic stress agent for radionuclide myocardial perfusion imaging (MPI) in patients unable to undergo adequate exercise stress. In a separate filing, Dr Reddy’s said it has issued a Form 483 with one observation by the USFDA after a routine GMP inspection at its API manufac…",neutral,neutral,-0.962823746972324,negative,-0.788675429726997,neutral
2023-05-05 17:30:00,4974.95,4989.0,4925.55,4927.05,91839.0,Taking Stock: Market manages to close higher after 3-day losing streak; pharma stocks fall,"NTPC, Adani Ports, Tata Motors, Bajaj Auto and Asian Paints were among the top gainers on the Nifty, while losers included Divis Labs, Eicher Motors, HUL, Dr Reddy’s Laboratories and JSW Steel",positive,positive,-0.962823746972324,negative,-0.788675429726997,neutral
2023-05-10 11:33:07,4964.85,4964.85,4839.9,4869.0,453306.0,Dr Reddy’s likely to post 20-22% growth in Q4 net,Pharma major Dr Reddy’s Laboratories’ fourth quarter results are due today,positive,neutral,-1.930571920601838,negative,-3.144385026737968,negative
2023-05-10 17:30:00,4675.0,4700.0,4524.05,4528.0,2750352.0,"Lupin, Dr Reddy’s Labs, Gujarat Gas: What should be your trading strategy for these stocks?",Lupin witnessed a breakout of a rounding bottom formation with strong volumes on the daily chart. Rounding bottoms are found at the end of extended downward trends.,neutral,neutral,-3.144385026737968,negative,-1.7150903750316244,negative
2023-05-10 17:30:00,4675.0,4700.0,4524.05,4528.0,2750352.0,Dr Reddy’s Labs Q4 results: Profit surges 11 folds to Rs 959 crore; Rs 40 dividend announced,"Dr Reddy’s Labs said revenue for the quarter rose 16 per cent to Rs 6,296.80 crore compared with Rs 5,436.80 crore in the coresponding quarter last year.",positive,positive,-3.144385026737968,negative,-1.7150903750316244,negative
2023-05-10 17:54:38,4675.0,4700.0,4524.05,4528.0,2750352.0,"Dr Reddy’s Labs Q4 result: PAT up 9 times, div declared at Rs 40 per share","Its revenue from operations stood at Rs 5,843 crore in Q4 FY23, up 15.28% YoY as compared to Rs 5,068.4 crore in Q4FY22",positive,positive,-3.144385026737968,negative,-1.7150903750316244,negative
2023-05-10 19:03:40,4675.0,4700.0,4524.05,4528.0,2750352.0,"Dr Reddy’s Laboratories Q4 PAT grows nine-fold riding on US, India biz","For the full year 2022-23, DRL’s revenues were up 15 percent to Rs 24,587.9 crore while the PAT grew by 91 percent to Rs 4,506.7 crore",neutral,positive,-3.144385026737968,negative,-1.7150903750316244,negative
2023-05-10 19:20:33,4675.0,4700.0,4524.05,4528.0,2750352.0,India’s Dr Reddy’s Labs posts 11-fold jump in Q4 profit | The Financial Express,"Dr Reddy’s consolidated revenue jumped 15.8% to 62.97 billion rupees, while total operating expenses fell 13.3%.",positive,positive,-3.144385026737968,negative,-1.7150903750316244,negative
2023-05-10 19:32:05,4675.0,4700.0,4524.05,4528.0,2750352.0,Dr Reddy’s Q4 net profit soars to ₹959 crore,"Dr Reddy’s Laboratories’ net profit increased manifold to ₹959 crore in the fourth quarter ended March 31, 2023 as against ₹88 crore in the same period last year.",positive,positive,-3.144385026737968,negative,-1.7150903750316244,negative
2023-05-11 10:53:49,4675.0,4700.0,4524.05,4528.0,2750352.0,Dr Reddy’s Labs sinks 7% on disappointing Q4 operating performance,"In Q4, the company’s North America’s revenue declined 17 per cent QoQ to Rs 2,530 crore, due to fluctuations in demand for new launches.",negative,negative,-3.144385026737968,negative,-1.7150903750316244,negative
2023-05-11 11:25:00,4675.0,4700.0,4524.05,4528.0,2750352.0,Dr Reddy’s tumbles 7% post Q4 results! Here’s what brokerages recommend,"Dr Reddy’s Laboratories reported an 890% YoY surge in March quarter profit at Rs 960.1 crore but shares tumbled nearly 7% to Rs 4,545 in Thursday’s trade. While its revenue from operations increased by 15.28% YoY to Rs 5,843 crore, total expenses were down 4% at Rs 5,132.2 crore. US revenues fell 17…",negative,negative,-3.144385026737968,negative,-1.7150903750316244,negative
2023-05-11 11:58:09,4675.0,4700.0,4524.05,4528.0,2750352.0,Dr Reddy’s Laboratories Ltd (RDY) Q4 2023 Earnings Call Transcript,"Dr Reddy’s Laboratories Ltd (NYSE:NYSE:RDY) Q4 2023 Earnings Conference Call May 10, 2023 10:00 AM ETCompany ParticipantsRicha Periwal - IRGunupati Prasad - Co-ChairmanParag Agarwal -...",neutral,neutral,-3.144385026737968,negative,-1.7150903750316244,negative
2023-05-11 14:20:03,4544.95,4544.95,4445.0,4467.0,1036527.0,"Dr Reddy’s Labs share price outlook: Weak Revlimid sales to hurt as pharma grows; Check brokerage calls, target | The Financial Express","Dr Reddy’s Laboratories share price plunged nearly 7% on Thursday after the pharma major posted a lower-than-expected EBITDA, net profit and higher OPEX.",negative,negative,-1.7150903750316244,negative,1.003322036173291,positive
2023-05-11 17:30:00,4544.95,4544.95,4445.0,4467.0,1036527.0,"RVNL, IRCON International, YES Bank, Zomato shares rally amid high volumes; L&T, Dr Reddy’s Labs log high turnovers","RVNL shares climbed 4.97% to Rs 127.90. This counter saw 2,29,40,445 shares changing hands, amounting to Rs 287 crore. IRFC shares jumped 3.65% to Rs 34.05, IRCON International advanced 7%.",positive,positive,-1.7150903750316244,negative,1.003322036173291,positive
2023-05-11 17:30:00,4544.95,4544.95,4445.0,4467.0,1036527.0,"Dr Reddy’s Labs shares at Rs 4,200? Stock sees price target cuts as gRevlimid sales wane","Dr Reddy’s Labs share price: Motilal Oswal Securities said while Dr Reddy’s Labs delivered 39 per cent YoY earnings growth in FY23, it expect moderation in the earnings CAGR to a mere 3.6 per cent over FY23-25.",negative,positive,-1.7150903750316244,negative,1.003322036173291,positive
2023-05-11 18:57:01,4544.95,4544.95,4445.0,4467.0,1036527.0,Dr Reddy’s Laboratories QoQ showing catches a cold on weak US sales,"While pharma major has maintained its margin guidance, expensive valuations limit upside",negative,positive,-1.7150903750316244,negative,1.003322036173291,positive
2023-05-12 08:16:00,4544.95,4544.95,4445.0,4467.0,1036527.0,"Big Movers on D-St: What should investors do with Ratnamani Metal, DR Reddy’s Laboratories and FSL?","The S&P BSE Sensex and Nifty50 in India closed flat with a negative bias. Stocks in capital goods, healthcare, metals, and energy sectors experienced selling pressure, while consumer durables, FMCG, power, and utilities saw some buying. Ratnamani Metals rose over 6%, Dr Reddy’s Laboratories fell nea…",neutral,positive,-1.7150903750316244,negative,1.003322036173291,positive
2023-05-12 22:34:13,4544.95,4544.95,4445.0,4467.0,1036527.0,Neutral Dr Reddy’s Labs; target of Rs 4500: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Dr Reddy’s Labs with a target price of Rs 4500 in its research report dated May 11, 2023.",neutral,positive,-1.7150903750316244,negative,1.003322036173291,positive
2023-06-06 17:30:00,4650.0,4678.0,4645.1,4669.0,227362.0,"Tata Motors, Bharti Airtel, HDFC Life: Stocks that saw upgrades in FY24 earnings estimates; should you buy these shares?","Companies that reported less-than-expected earnings included ONGC, Infosys, Coal India, Maruti Suzuki, Bajaj Finserv, Tata Steel, UPL, Dr Reddy’s Labs and Cipla, among others.",positive,negative,0.4086021505376344,neutral,-0.3529411764705882,neutral
2023-06-23 17:30:00,4901.0,5015.0,4901.0,4992.95,557881.0,Dr Reddy’s Laboratories share price rises as drug maker enters trade generics biz,"Dr Reddy’s Laboratories shares rose 2.35 per cent to hit a high of Rs 5015 on BSE. A total of 47,000 shares changed hands on the counter on BSE, nearly six times the average two-week volume of 8,028 shares.",positive,positive,1.8761477249540872,positive,1.0040281368364168,positive
2023-06-26 11:35:27,4989.9,5074.0,4952.0,5040.0,719892.0,Neutral Dr Reddy’s Labs; target of Rs 4680: Motilal Oswal,"Motilal Oswal recommended Neutral rating on Dr Reddy’s Labs with a target price of Rs 4680 in its research report dated June 23, 2023.",neutral,positive,1.0040281368364168,positive,-0.3887654712789662,neutral
2023-06-26 17:30:00,5041.6,5086.55,5016.0,5022.0,682754.0,"Dr Reddy’s, ICICI Lombard, Airtel, HCL Tech, among stocks to buy as per brokerages",Dr Reddy’s Labs’ price had been gradually inching higher and presently is on the verge of giving a breakout from the 6-month-old resistance level.,neutral,positive,-0.3887654712789662,neutral,1.7401080478753532,positive
2023-06-28 17:32:00,5025.55,5119.4,5004.35,5113.0,884668.0,"Titan, NTPC and 3 other Nifty stocks reach new 52-week high","Several stocks such as Titan Company, Dr Reddy’s Laboratories, Tata Motors, JSW Steel and NTPC have reached their 52-week highs as Nifty breached the 19,000 mark. Dr Reddy’s Laboratories has impressed investors with its stock price reaching Rs 5,119.40 and a PE ratio of 18.9. Titan Company’s experti…",positive,positive,1.7401080478753532,positive,0.7417904612978854,neutral
2023-07-05 00:23:46,5185.0,5201.8,5137.0,5176.85,281130.0,Aurigene Pharma to set up facility with $40 million in Genome Valley,"A step-down subsidiary of pharma major Dr.Reddy’s Laboratories, it intends to invest $40 million (around ₹330 crore), which will be generating around 200 direct jobs and 60-70 indirect employment opportunities over the next three years.",neutral,neutral,-0.1571841851494626,neutral,0.9954716179551832,positive
2023-07-10 18:12:41,5144.0,5215.0,5113.55,5145.0,209459.0,Dr Reddy’s migrates SAP platform entirely on to AWS,"Amazon Web Services (AWS), a cloud solutions company from Amazon, has announced that pharma major Dr Reddy’s Laboratories Ltd has decided to migrate its SAP platform entirely on to it",neutral,positive,0.0194401244167962,neutral,0.7825242718446637,neutral
2023-07-11 13:47:00,5150.0,5198.95,5130.0,5190.3,240254.0,"Dr Reddy’s to enhance presence in emerging segments like nutraceuticals, gene therapy","Dr Reddy’s Laboratories plans to expand its presence in nutraceuticals, cell and gene therapy and new chemical entities, as well as exploring integrated digital healthcare services, digital therapeutics and disease management, according to its annual report. The pharmaceuticals firm also stated that…",positive,positive,0.7825242718446637,neutral,-0.8564547206165668,neutral
2023-07-11 17:30:00,5150.0,5198.95,5130.0,5190.3,240254.0,"Persistent Systems, JSW Steel, Dr Reddy’s Labs shares to turn ex-dividend today",Persistent Systems had announced a final dividend of Rs 12 per share and a special dividend of Rs 10 per share. The dividends will be paid on August 17.,neutral,neutral,0.7825242718446637,neutral,-0.8564547206165668,neutral
2023-07-19 21:08:02,5249.0,5394.7,5240.0,5324.0,1201039.0,Dr Reddy’s Srikakulam plant clears USFDA ’s inspection,"Dr Reddy’s Laboratories, a pharmaceutical company, announced that its API facility in Andhra Pradesh has successfully completed a Pre-Approval Inspection (PAI) and a routine GMP inspection by the US Food & Drug Administration (USFDA). The inspection, conducted from July 10-19, 2023, concluded with n…",neutral,positive,1.428843589255096,positive,-0.6903612420866756,neutral
2023-07-20 05:00:00,5249.0,5394.7,5240.0,5324.0,1201039.0,"Stocks To Watch: Dr Reddy’s Laboratories, Olectra Greentech, Shree Cement, TTK Prestige, LIC, Reliance",Here are the stocks to watch before going into trade today.,neutral,neutral,1.428843589255096,positive,-0.6903612420866756,neutral
2023-07-20 14:24:00,5323.3,5339.75,5277.6,5286.55,228592.0,"Canara Bank, Oberoi Realty among 8 stocks hit new 52-week high","Several BSE 200 stocks, including APL Apollo Tubes, Canara Bank, Dr Reddy’s Laboratories, HDFC AMC, ITC, Oberoi Realty, PNB, and Polycab, reached new 52-week highs on July 20, 2023, indicating investor confidence and resilience in the face of market fluctuations. However, the data only pertains to t…",positive,positive,-0.6903612420866756,neutral,2.1171789892483304,positive
2023-07-20 15:51:26,5323.3,5339.75,5277.6,5286.55,228592.0,"Taking Stock: Nifty inches closer to 20,000, Sensex up 474 pts; IT underperform","Top gainers on the Nifty included ITC, Kotak Mahindra Bank, Dr Reddy’s Laboratories, ICICI Bank and Cipla.",positive,neutral,-0.6903612420866756,neutral,2.1171789892483304,positive
2023-07-26 12:53:49,5530.0,5614.0,5420.05,5515.05,1495677.0,"Dr Reddy’s likely to gain from US sales, new launches in Q1","Dr Reddy’s Labs is expected to post strong growth in revenue and profit in Q1 FY24 due to new product launches and recovery in US market. Analysts forecast net sales and profit in the range of ₹61,000 million - ₹65,000 million and ₹8,900 million to ₹11,000 million respectively. Last year, the compan…",positive,positive,-0.2703435804701594,neutral,1.2010159651669052,positive
2023-07-26 17:40:27,5530.0,5614.0,5420.05,5515.05,1495677.0,"Dr Reddy’s Laboratories Q1 Results: Profit Up 18%, Beats Estimates","Revenue up 29% to Rs 6,758 crore, while Ebitda margin was at 30.5% versus 18% a year ago.",neutral,positive,-0.2703435804701594,neutral,1.2010159651669052,positive
2023-07-26 18:40:48,5530.0,5614.0,5420.05,5515.05,1495677.0,"Dr Reddy’s Q1 net up 18% at ₹1,402 crore on strong US sales","Dr Reddy’s Labs Q1 net profit up 18%, total revenue rises 29%. Highlights: USFDA inspections closed, forays into child nutrition & trade generics, progress in filing of biosimilars in regulated markets.",positive,positive,-0.2703435804701594,neutral,1.2010159651669052,positive
2023-07-27 02:30:23,5530.0,5614.0,5420.05,5515.05,1495677.0,Dr Reddy’s Laboratories Ltd (RDY) Q1 2024 Earnings Call Transcript,"Dr Reddy’s Laboratories Ltd (NYSE:NYSE:RDY) Q1 2024 Earnings Conference Call July 26, 2023 10:00 AM ETCompany ParticipantsRicha Periwal - IRErez Israeli - CEOParag Agarwal - CFOConference...",neutral,neutral,-0.2703435804701594,neutral,1.2010159651669052,positive
2023-08-09 15:46:30,5880.1,5916.65,5806.0,5866.0,550598.0,"Taking Stock: Last-hour buying pushes Nifty above 19,600, Sensex up 149 points","Top gainers on the Nifty included Dr Reddy’s Laboratories, Hindalco Industries, JSW Steel, Tata Motors and M&M, while losers included Divis Labs, Apollo Hospitals, Maruti Suzuki, ICICI Bank and Bajaj Finance",positive,neutral,-0.2397918402748314,neutral,-0.4783054321831226,neutral
2023-08-14 07:52:00,5829.95,5879.0,5800.0,5812.05,432977.0,"Auto, pharma stocks offering margin of safety top funds’ buy list in July","Shares in the pharma and automotive sectors were among those that fit the bill. Fund managers lapped up pharma given the recent underperformance, lower input prices and attractive valuations. With first-quarter results encouraging, they bought into stocks like Dr Reddy’s Laboratories, Aurobindo Phar…",neutral,neutral,-0.3070352232866429,neutral,0.8962264150943396,neutral
2023-08-23 22:43:44,5980.0,5989.7,5891.2,5921.9,824294.0,Trade setup for Thursday: Top 15 things to know before the opening bell,"Based on the OI percentage, 54 stocks were on the short-covering list. These included State Bank of India, Axis Bank, Dr Reddy’s Laboratories, Maruti Suzuki, and Hindustan Copper.",neutral,neutral,-0.9715719063545212,negative,-1.7826825127334467,negative
